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Abstract 
A new highly hydrophobic 5'-hydroxyl protecting group (Tbf-DMTr) has been 
designed for the purification of synthetic oligonucleotides. Thf-DMTr-
oligonucleotides are strongly retained on RP-HPLC allowing a facile separation from 
truncated sequences. Subsequently the group can be removed in acidic conditions. 
The fluorescent properties of Thf-DMTr enable easy detection. The synthesis and 
purification of long oligonucleotides (> 100-mer) has been undertaken. Additionally a 
new fluorescent label for oligonucleotides has been developed which enables detection 
of DNA probes to concentration down to 10 -11 mol/l. 
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Chapter 1: Introduction 
1.1 History of DNA Synthesis 
The golden age of DNA began with the first important evidence that DNA, an 
organic phosphate macromolecule, is the genetic material in all living organisms. 
Reported in 1944, Avery a al. 1 discovered that the DNA from one strain of 
pneumococcus could "transform" another strain. The discovery of the complementary 
double-stranded (duplex) structure of DNA by Crick and Watson 2 in 1953, and with 
it the recognition of how the molecule can be replicated was the second important 
milestone in the history of DNA. These discoveries led to an understanding of the 
functions of the molecule that holds the key of life. One major function of DNA is to 
carry the genetic code for each organism. DNA is transcribed into RNA and the RNA 
is translated into the amino-acid language of proteins. The second major function of 
DNA is that it carries out a self replication. These discoveries have generated a 
considerable interest in investigating the DNA molecule and the chemical complexity 
of such compounds. 
The fundamental objective in DNA synthesis is the formation of an ester linkage 
between an activated phosphoric acid function of one nucleotide and the hydroxyl 
group of another nucleoside/nucleotide, thus forming the natural phosphodiester 
bridge between the 5'-OH of one nucleoside unit and the 3'-OH of the next. Early 
synthetic efforts concentrated on the search for suitable protecting groups for the 
I 
bases and the ribose moiety and for proper condensating agents for the, 
phosphodiester bond formation. 
The first synthesis of a nucleic acid in the laboratory was reported in 1955 by 
Todd3 who successfully synthesized and isolated a dithymidine dinucleotide. Khorana 
used and developed the phosphodiester approach and finally synthesized the structural 
gene for tyrosine tRNA, a DNA segment containing 200 bp, highlighting many years 
of continuous efforts in nucleic acid synthesis 4. During the same period other organic 
chemists such as Letsinger, 5 Reese6 and Eckstein 7 started to explore the phosphate 
triester approach which was later modified by Narang 8 and Cramer9 independently 
who used it to make biologically active material. 10 In the mid seventies, the phosphite 
triester approach originated in the laboratory of Letsingert I  who also reaffirmed the 
solid phase synthesis method which he had introduced earlier with the phosphate 
triester approach. 5 A new procedure for the preparation of deoxyoligonucleotides was 
finally devised by Caruthers et al., 12,13  generally known today as the phosphoramidite 
method. This approach, which is currently widely used, perhaps has been so 
successful because it is readily adaptable to automated DNA synthesis machines 14 and 
allows the rapid and inexpensive automated synthesis of oligodeoxyribonucleotides up 
to ca. 150 nucleotides long. Oligodeoxyribonucleotides which would have taken 
several months to synthesize by solution-phase methods can be synthesized in 24 It by 
solid-phase methodology. 
1.2 Biochemical Application of Synthetic Oligomicleotides 
Thirty years ago the chemical synthesis of oligodeoxyribonucleotides did not 
have any obvious biochemical application, but was rather the interest of the organic 
2 
chemist. Since the development of rapid and efficient synthesis and simultaneously, 
the advent of molecular cloning techniques, synthetic DNA has found use in most 
fields of biology and biochemistry. The availability of synthetic oligonucleotides 
transformed the way of thinking of biologists and hence new approaches to problems 
arose. Some of the applications of synthetic oligonucleotides include the use in the 
cloning and synthesis of man-made genes 15, as primers for various polymerase chain 
reaction (PCR) applications, 16 to sequence DNA, 17 for mutagenesis of genes in a 
site-specific manner, 18 as probes for examining how proteins interact with 
polynucleotides, 19 in antisense therapy for the treatment of viral diseases and 
cancer,20 and for studies on nucleic acid structure. 21 The predominant application of 
oligonucleotides is in recombinant DNA technology. 
Most of the medically important proteins are difficult to obtain from biological 
specimens, and they are too difficult to synthesize in sufficient quantity by present 
peptide synthesis technology. As an alternative, the recombinant DNA technology 
was developed in the late seventies. Genes for a specific protein are chemically 
synthesised and expressed in micro-organisms. The use of micro-organisms is not a 
recent innovation since they have been used by man for a long time to produce food, 
e.g. cheese, bread, beer and wine, but until recently such applications were restricted 
to the use of naturally occurring organisms. With DNA recombinant technology these 
micro-organisms can be genetically altered to produce a wide range of useful products 
in agriculture and medicine. The first synthesis of a functional polypeptide product 
from a gene of chemically synthesized origin was performed by Itakura a al.22 in 
1977 with the production of the hormone somatostatin. Later in 1982 the glucose 
level regulation protein insulin was produced on a large scale after its gene was 
successfully synthesized and inserted in to Escherichia coiL23 Human growth 
hormone which is a 191 amino acid protein, a deficiency of which leads to dwarfism, 
was usually extracted from human cadaver with tragic consequences at the time of 
3 
writing. But the alternative source now provided by cloning the recombinant DNA in 
Escherichia coU24 has taken over. Since then many other hormone proteins and also 
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Fig. 1.1: Principle of action of an antisense oligonucleotide 
Novel approaches to therapeutics using oligonucleotides have also been 
developed in the past few years. The transfer of genetic information in most 
organisms functions from DNA to mRNA to protein. In the case of retroviruses, the 
information originates in viral RNA. These genetic processes can now be altered by 
insertion of synthetic oligonucleotides. Oligonucleotide therapeutics include antisense 
therapy whereby an oligodeoxyribonucleotide (antisense) complementary to a target 
mRNA (sense) will hybridize and block the translation. Thus, expression of a specific 
protein can be regulated or inhibited. Zamecik and Stephenson 25 were the first to 
propose the use of antisense oligodeoxyribonucleotides for therapeutic purposes. 
They observed that a 13-mer synthetic oligodeoxyribonucleotide that was 
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complementary to the RNA of the Rous sarcoma virus, could inhibit the growth of 
this virus in cell cultures. In vitro applications that have been successful in the cancer 
area for example, include inhibition of expression of oncogenes such as c-myc;26 and 
in vivo antisense experiments have been successful in the area of cardiovascular 
disorder. 27 Applications to viral inhibition, including HJV inhibition, have also been 
reported. 28 Fig. 1.1 illustrates simply the inhibition of protein biosynthesis by an 
antisense oligodeoxyribonucleotide being bound to the mRNA. As yet, few 
applications of synthetic oligodeoxyribonucleotides of clinical relevance have been 
reported29 '30.31 and the in vivo characteristics of oligodeoxyribonucleotides are only 
now being investigated. 32'33 Serious problems remain to be overcome before an 
oligonucleotide reaches the clinic. Nevertheless, it is very probable that such 
informational drugs will be used against a variety of human diseases in the not too 
distant future. 
1.3 DNA Structure 
1.3.1 Primary Structure 
The primary structure of DNA was established after the works of Thannhauser 
and 10ein34 in  1933. DNA is from its constitution a linear polyester with phosphoric 
acid as the diacid component (the third acidic function has no role in the chain 
synthesis) and a substituted deoxyribose as the diol component. Thus the primary 
structure of DNA consists of a chain of 2'-deoxy-D-ribose rings linked by 3'-5' 
phosphodiesters with each of the sugars having a base attached at the V-position in 
the 3-configuration as shown in Fig. 1.2. There are no 5'-5' or 3'-3' linkages in the 
regular DNA primary, structure. Carrying out the hydrolysis of a DNA chain by a 
deoxyribonuclease enzyme, would result in the basic units of DNA called nucleotides. 
The four nucleotides Adenosine phosphate, Guanidine phosphate, Thymidine 
phosphate and Cytidine phosphate can further be cleaved by the nucleotidase enzyme 
to phosphoric acid and the corresponding nucleosides, deoxythymidine, 
deoxycytidine, deoxyadenosine and deoxyguanidine, which are the deoxyribose units 
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Fig. 1.2: Primary Structure of DNA 
Besides DNA the other nucleic acid RNA can occur in different types of cells 
and differs in its sugar group, being D-ribose instead of 2'-deoxy-D-ribose, and from 
the occurrence of the base uracil in place of thymine, see Fig. 1.3. Molecular weights 







Fig. 1.3: Uridine 
1.3.2 Secondary Structure 
The presence on three of the bases, adenine, guanine and cytosine Of exocycic 
amino functions having the potential to form hydrogen bonds and ionisable 
phosphates groups, make oligodeoxyribonucleotides soluble in aqueous rather than 
organic solvents. The property of the hydrogen bonding is also very important in the 
formation of the secondary structure of DNA, it involves specific base pairing 
between adenine and thymine, and between guanine and cytosine, by the formation of 






N-' 	'tN \ 
N-HIuuIIuIQ 	
N 














Fig. 1.4: Hydrogen bonding between base pairs in DNA duplexes 
7 
Watson and Crick2 demonstrated by model-building studies that natural DNA 
consists of an antiparallel duplex held together by hydrogen bonds between A:T and 
(IC, see Fig 1.5. Since then various DNA conformations have been discovered 
merely by changing the environment in which the duplex was formed (e.g. salt 
concentration, humidity) and base sequence. The major regular secondary structures 
are the A-DNA and B-DNA with right-handed double-helices and Watsón-Crick base 
pairs. These and other DNA secondary structures have been reviewed by Dickerson et 
al.,35 Jurnmk36 and Saenger. 37  Base pairing can also occur intramolecularly to form 
hairpin loop type structures, see Fig. 1.6. 
Fig. 1.5: DNA duplex 
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Fig. 1.6: Hairpin loop in DNA strands. 
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1.4 Chemical Synthesis of Oligodeoxyribonucleotides 
1.4.1 Introduction 
From a chemical point of view, oligodeoxyribonucleotides are very sensitive 
molecules which possess diverse functionalities, unusual solubility and pose difficult 
purification problems in the conventional chemical sense. Even more difficult is their 
structure analysis by the standard physico-chemical methods. In spite of these 
obstacles, theft synthesis is a fascinating challenge to organic chemists because of theft 
great importance in living organisms. The aim in oligodeoxyribonucleotide synthesis is 
to join a 5'-hydroxyl on a nucleoside to a 3'-hydroxyl on another nucleoside via a 
phosphoric acid linkage to form a correct phosphodiester bridge, forming the 
backbone of a DNA strand. In order to achieve this, one must use selective blocking 
and deblocking procedures for primary and secondary hydroxyl (two in the case of 
ribonucleosides), for primary amino groups and often two of the three oxygens of the 
phosphate group. One must also be aware of the sensitive glycosidic bonds of the 
purine and pyrimidine bases with the sugar group, and the variable reactivity of the 
substituted phosphates. Stereochemical and neighbouring group effects affect 
noticeably the chemistry as the chain grows. All protecting groups must be removed 
without causing side-reactions and damage of the DNA sequence. Finally the desired 
product must be separated from impurities, requiring several purification steps. One 
can understand that a well thought out strategy has to be formed before starting an 
oligodeoxyribonucleotide synthesis. 
The methods for the chemical synthesis of oligodeoxyribonucleotides have 
advanced greatly since Todd3 first made a dinucleotide in the 1950's. Considerable 
efforts have resulted in the progression from a coupling reaction using a 
phosphodiester reagent in solution phase to using phosphotriester, H-phosphonate 
and mainly phosphite triester reagents on solid phase today. 
9 
1.4.2 The Phosphodiester Approach 
The phosphodiester approach was the first method used in the 1950's and 1960's 
for the synthesis of di- and polynucleotides. It was developed and championed by 
Khorana a al.38 who used it first to synthesize dinucleotides with a C5'-C3' linkage in 
1958 and until the 1970's when they successfully synthesized the genes of an alanine 




MMTrO 	 T 	-O_P_O__i)- i. wsci 	o 
+ 	0 	 L 
ii OW 	 II 0 
­10 
OH 	 OAc 	ill. Solvent extracon 
OAc 
(1) 	 (2) 	 (3) 
Scheme 1.1: Khorana's phosphodiester approach 
The phosphodiester method involves the condensation of commercially available 
deoxynucleotides; one bearing a 5'-hydroxyl protecting group and the 3'-hydroxyl free 
to react (1) and the other bearing a 3'-hydroxyl protecting group and a phosphate 
group at the 5'-hydroxyl (2). The exocyclic amino groups on the nucleobases are also 
suitably protected. Condensating agents such as dicyclohexylcarbodiimide (DCCI) or 
iriisopropylbenzenesulphonyl chloride (TPSCI) are used to give the dinucleotide (3), 
see Scheme 1.1. The dinucleotide thus obtained, may be elongated by further 
condensation reactions after prior phosphorylation of the deprotected 5'-hydroxyl. 
Unfortunately long reaction times, decreasing yields as the chain grows, and time 
consuming anion-exchange chromatography purification made this method 
impracticable when synthesising large oligodeoxyribonucleotides. 
10 
1.4.3 The Phosphotriester Approach 
A possible solution to some of these problems (water solubility, ion exchange 
chromatography and low yields) inherent in the phosphodiester method could be 
partially resolved by protecting the free phosphate and thus forming a neutral organic 
molecule easier to manipulate by standard organic chemistry techniques. 
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Scheme 1.2: Todd's phosphotriester approach 
The basic principle of the phosphotriester method is to mask each 
intemucleotidic phosphodiester function by a suitable protecting group. In Todd's 
synthesis, 5'-acetyl-3'-benzylphosphochloridate (4) was reacted with 3'-acetyl-
thymidine (5) to give the fully protected dinucleotide (6), containing the 
intemucleotidic 3151  phosphodiester linkage. This approach was found to be useful for 
larger scale synthesis and gave shorter purification time periods. 
In 1965 Letsinger ci al.5 ' 40 introduced the 3-cyanoethyl phosphate protecting 
group using a one pot procedure with the solid phase synthesis principle. 
11 
Subsequently the solid phase chemistry was found suitable for small scale synthesis 
only 4 l.42 and thereafter Letsinger used the phosphotriester method in solution phase 
synthesis as pictured in Scheme 1.3. First the 3t-OH of a 5'-protected thymidine (1) 
was phosphorylated with the 3-cyanoethyl phosphate in the presence of mesitylene 
sulphonyl chloride (MSCI) to give the phosphodiester (7). Subsequent condensation 
with the primary 5'-OH of unprotected thymidine in the presence of 2,4,6-
triisopropylbenzenesulphonyl chloride gave the fully protected dithymidine (8). The 
monomethoxytrityl (MMTr) protecting group and the phosphate $3-cyanoethyl 
protecting group were removed by treatment with acetic acid and aqueous ammonia 
respectively, to give the thymidine dimer (10) in what is essentially a one pot 
procedure. Synthesis of oligodeoxyribonucleotides containing nucleosides other than 
thymidine have also been reported by Letsinger. 43 
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Scheme 1.3: Letsinger's phosphotriester approach 
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The incomplete phosphorylation in the first step followed by the coupling with 
unreacted (1) can lead to a complicated reaction mixture including the 3'-3' and the 5'-
5' coupled products. The products of these side-reactions can be difficult to separate 
from the desired product. An attempt to remedy this was undertaken by Letsinger et 
al. when they developed the 3-benzoylpropionyl 3'-hydroxyl protecting goupA 
During that period other chemists contributed to the development of the 
phosphotriester approach essentially by introducing new phosphate and hydroxyl 
protecting groups. Eckstein a al.45A.7  investigated the 2,2,2-trichioroethyl 
phosphate protecting group, Reese et al.6 '47 and Van Boom a al.48 proposed aryl 
phosphate protecting groups with electron-withdrawing substituents in order to 
increase their base lability. Reese also proposed the methoxytetrahydropyranyl group 
for the 5'-hydroxy protection. 49 
In order to overcome the problem of side-reactions giving rise to 3'-3' and S'-S' 
linkages, a "two step" sequential procedure starting from the fully protected 
mononucleotide containing fully masked 3'-phosphoiriester group was developed by 
Cramer etal.50 in 1973, see Scheme 1.4. 
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Scheme 1.4: Cramer's phosphotriester approach 
A nucleoside protected with dimethoxytrityl 	(11), 	an acid 	labile 5-01-1 
protecting 	group, 	was first 	phosphorylated with 2,2,2- 
inchloroethylphosphodrnnidazolidate and treated with triethylamine and water to 
remove the remaining imidazole to afford (12). This nucleotide was then condensed 
with 3-cyanoethanoI using triisopropylbenzenesulphonyl chloride (TPSC1) to afford 
the fully protected phosphotriester (13). After treatment with dilute aqueous 
trifluoroacetic acid (TFA), to remove the dimethoxytrityl group, the nucleotide (14) is 
formed. Compounds (14) and (12) are then reacted with the condensing agent 
triisopropylbenzenesulphonyl chloride to give the protected dinucleotide (15) which 
can be deprotected using trifluoroacetic acid to remove the dimethoxytrityl group, 
sodium hydroxide to remove the 3-cyanoethyl group and Cu/Zn then ammonia to 
remove the 2,2,2-trichloroethyl group, to give (16). 
Narang a al.8 developed several modified triesters using phenyl, o-chlorophenyl 
and p-methylthiophenyl protecting groups instead of the 2,2,2-thchloroethyl group 
used by Cramer. Using this method Narang synthesised oligodeoxyribonucleotides of 
up to 15 monomer units. 
14 
The next development came in 1975 when Narang developed the "modified" 
phosphotriester method whereby he proposed arysulphonyltria.zoles as condensing 
agents and bis(triazolyl)-p-chlorophenyl phosphate as a phosphorylating agent. 5 ' 
Narang used the block synthesis approach in conjunction with this phosphotriester 
method to produce a hexamer containing guanosine, cytosine and adenosine residues 
and claimed that these new reagents increased the yields and reduced suiphonation. 
Later Narang used arylsuiphonylten-azoles which were found to be more reactive than 
triazoles and triisopropylbenzenesulphonyl chloride. 52 In 1978 Reese a al.53 
developed the now widely used 1-mesitylenesulphonyl-3-nitro,1,2,4-triazole (17), 
MSNT, see Fig. 1.7, and Sproat and Bannwarth 54 introduced the 1-methylimidazole 
which used in conjunction with MSNT forms an intermediate N-methylimidazolium 
cation possessing a high phosphorylating capability. Coupling times could be reduced 
to under 10 min. Subsequent research focussed essentially on developing more labile 
phosphate protecting groups, e.g. Pfleiderer used the -eliminating 2-(p-
nitrophenyl)ethyl, NPE, group; 55 '56 and more efficient condensing agents (see Fig. 
1.7). Ohtsuka a al.57 developed the regiospecific condensating agent 1-
mesitylenesuiphonyl 5-(pyridin-2-yl)tetrazolide (18), MSPy; Matteucci a al. 59 
introduced the intramolecular nucleophilic condensating agent attached to the 
phosphorous atom 1-methyl-2-(2-hydroxyphenyl)imidazole (19) and Eflmov a 
al.58 '60 introduced the 0-nucleophiic catalysts based on pyridine N-oxides 
derivatives also attached to the phosphorus atom (20). The latter intramolecularly 
attached nucleophilic catalyst improved the phosphotriester method further as it jacks 
up the coupling yield to 98 % and reduces the time taken by a synthesis cycle to 7-8 
mm. Nevertheless, the principle of the modified phosphotriester approach originally 












Fig. 1.7: 1 -Mesitylensulphonyl-3-nitro-1,2,4-triazole, MSNT 
With the development of phosphate protecting groups and efficient condensing 
agents, coupling steps in the phosphotriester method could be reduced from several 
hours in solution3 to less than 5 min on solid phasefl enabling the synthesis of 
oligodeoxyribonucleotides with long chain lengths in satisfactory yields. The synthesis 
of a 20-residue oligodeoxyribonucleotide can be performed in 8 h. 61 In spite of the 
improved yields and coupling times, the phosphotriester method does not have the 
speed and efficiency of the phosphite triester method described in the next section. 
Moreover two side-reactions give rise to further limitations. Firstly during the 
coupling the 5'-hydroxyl can be sulphonylated by the coupling agent, therefore 
reducing the coupling efficiency to 97-98 % which limits the synthesis of 
oligodeoxyribonucleotides to a maximum of 40 residues. 62 Secondly, deoxyguanosine 
units can be phosphorylated and substituted with nitrotriazole at the 0 6-position 
unless an extra protecting group is used. 62 
16 
1.4.4 The Phosphite-Triester Approach 
In 1975, Letsinger et al. 1 ' introduced the phosphite-triester method which was 
based on the great reactivity of phosphorochloridite reagents upon alcohols to give 
phosphite-triesters. Two nucleotide units could be coupled in a matter of minutes 
instead of hours and could easily be oxidized to the required phosphotriester by 
aqueous iodine, see Scheme 15. 
OC H 2COO 
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Scheme 1.5: Leisinger's phosphite-triester approach 
5'-O-Phenoxyacetyl-thymidine (21) was reacted with o-chlorophenyl 
phosphorodichloridite to give the phosphitylated nucleoside (22), which in turn was 
coupled with 3'-monomethoxytritylthymidine to give the phosphite dimer (23) which 
was oxidised by iodine and water to produce the protected thymidine 3'-5' linked 
dinucleotide (24). Unfortunately further coupling of nucleosides after cleavage of the 
17 
phenoxyacetic ester with ammonium hydroxide resulted in low yields caused mainly 
by the instability of the protected phosphothester group towards the phosphitylating 
agent. The 2,2,2-trichloroethyl group was later shown to be suitable for the synthesis 
of a thymidine tetranucleotide. 63 Several other phosphate protecting groups were 
investigated by Ogilvie a al.M such as 2,2,2-tribromoethyl, benzyl, methyl, p-
chlomphenyl, 2-phenylethyl, 2-p-nitrophenylethyl and f3-cyanoethyl. They concluded 
that methyl and (3-cyanoethyl were the most useful and remain as the most widely 
used phosphate protecting groups. The synthesis of several diners using the methyl 
protecting group resulted in coupling times less than two minutes and yields over 
90%.65 
The phosphite-triester method via phosphorochloridites presents some 
drawbacks, for example introducing the oxidation step can lead to symmetrical as well 
as unsymmetrical products over which there is no control and this makes purification 
more difficult and gives lower yields. Also phosphorochloridites are very moisture and 
oxidation sensitive so that great care has to be taken during manipulations. In 1981, 
Beaucage and Caruthers 67 introduced the deoxynucleosides phosphoramidites which 
have the advantage of being more stable at room temperature and less succeptible to 
hydrolysis. A direct result of this development is that oligodeoxyribonucleotide 
synthesis was to become transformed from a manual to a semi-automated procedure 
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Scheme 1/: Caruthers' phosphite-triester approach 
The phosphoramidite approach to oligodeoxyribonucleotide synthesis as 
described by Caruthers a al.67 is shown in Scheme 1.6. 5'-Dimethoxytritylthymidine 
(25) was reacted with chlom-N,N-dimethylaniinomethoxyphosphine to give the 
nucleotide (26) which was activated by 1H-tetrazole to give the intermediate (27) 
which in turn was coupled to 3'-0-levulinylthymidine giving the corresponding 
phosphite-triester (28). After oxidation with aqueous iodine the protected phosphate 
dimer (29) was obtained. 
Further investigations made by McBride and Caruthers 68 on other possible 
N,N-dialkylaminomethoxyphosphines, included the diisopmpylamino (30a), the 
morpholino (30b), the pyrolidino (30c) and the 2,2,6,6-tetramethylpiperidino (30d) 
substituents, see Fig. 1.8. In each case they used the chloro phosphytilating agent 
derivative for its introduction on the 3-hydroxyl of nucleosides. The diisopropyl and 
the morpholino phosphoramidite compounds were found the easiest to handle and 
conferred the most stability. This observations were later confirmed by Adams et al.69 
and from then on the N,N-diisopropyl and N-morpholino phosphoramidites were 
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Fig. 1.7: Various phosphilylating agents 
In 1983, Sinha et al.73 '74 combined the N,N-diisopropylamino group with the 
13-cyanoethyl group in the preparation of phosphorainidites reagents. The J3-
cyanoethyl group has the advantage over the methyl group that it is cleaved in 
concentrated ammonia at the same time as the base protecting groups, whereas the 
methyl group requires a second treatment with thiophenol in order to obtain a fully 
deprotected oligodeoxyribonucleotide. Since that time several workers 75 '76 '77 '78 '79 
have examined other potential phosphate protecting groups but the 3-cyanoethyl 
group in conjunction with the N,N-diisopropylamino group remains unchallenged. 
One of the most recent advances in the phosphoramidite method was proposed 
by Uznanski et al.,80 see Scheme 1.6. The difference from the common 
phosphoramidite approach is that the oxidation of the phosphite-thesters is performed 
with aqueous iodine at the end of the synthesis instead of at every step. 
Chlorodimorpholinophosphine (31) was reacted with a 5'-O-dimethoxytritylnucleoside 
(11) to give a 5'-O-dimethoxytritylnucleotide-3'-O-phosphordimorpholidite (32). The 
latter phosphorarnidite (32) was then coupled with a solid support bound nucleoside 
in the presence of tetrazole to give a dimer (33). The phosphoramidite P-N bond was 
subsequently cleaved by mild acid hydrolysis to give (34) which in turn was treated 
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Scheme 1.6: Uznanski's phosphoramidite method 
Perhaps the most significant improvement in recent years to increase the quality 
of synthetic DNA has been the substitution of N-methylimidazole by N,N-
dimethylaminopyridine (DMAP) in the capping solution. 81 After each coupling step 
the unreacted 5'-hydroxyl functions are normally capped with acetic anhydride but 
when N-methylimidazole was used as a catalyst, a small but detectable amount of 2,6-
diaminopurine, a modification of guanine, was formed. None of this side-product was 
observed when using DMAP during the acetylation steps. The final deprotection step 
using concentrated ammonia at 55°C for 4 h to remove the exocyclic base protecting 
groups has been almost unchanged since Khorana introduce it over 20 years ago. The 
focus of attention has recently been on developing protecting groups removable under 
much milder conditions; these developments are described in section 1.6. 
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The advantage of the phosphite-triester method or more precisely the 
phosphoramidite method over the phosphotriester method, is that it offers short 
reaction times, extremely high coupling efficiencies (>98 %) and is the only reliable 
chemistry for synthesis beyond 50 residues. However this method involves relatively 
unstable starting materials dueie high reactivity of P 111 reagents. 
1.4.5 The H-Phosphonate Approach 
During the past few years, the H-phosphonate method for 
oligodeoxyribonucleodde synthesis, which was first described by Todd et al.82 in 
1957, has been re-examined by various laboratories.83,84$5 This renewed interest is 
due to the fact that the H-phosphonate chemistry combines the advantages of both the 
phosphotriester approach, with its stable nucleotides, and the phosphite-triester 
approach, with its speed of reaction. An example of this approach is shown in Scheme 
1.7. 
A 5-unprotected nucleoside (35) attached to a solid support is coupled to a 5'-
0-dimethoxyirityldeoxynucleoside 3'-H-phosphonate (36) in the presence of an 
activating agent like TPSCI or sterically hindered carbonyl chlorides (adamantoyl and 
pivaioyl). The resulting phosphite diester (34) is capped, detritylated with acid and 
condensed with the next 5'-dimethoxytrityldeoxynucleoside 3'-H-phosphonate. When 
the synthesis of the DNA segment is completed, the phosphite diester internucleotide 
linkages are oxidised with tert-butyl hydroperoxide or iodine to the phosphate diester 
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Scheme 1.7: The H-Phosphonate approach 
Moreover, the H-phosphonate approach has the advantage that no phosphate 
triester protecting group is required, nullifying the problems associated with its 
removal. Furthermore one step in the synthesis cycle is eliminated, as oxidation of all 
intemucleotide linkages is carried out after the complete oligodeoxyribonucleotide 
assembly. The H-phosphoñate procedure is currently cheaper and more efficient for 
synthesis of many modified backbone oligodeoxyribonucleotides. Indeed, the 
oxidation step is subject to general base catalysis and this allows nucleophiles other 
than Water to be substituted during oxidation to give a range of 
oligodeoxyribonucleotide analogues. 86'87 
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1.5 Solid Phase Synthesis 
As for most organic chemistry reactions, the first workers performing 
oligodeoxyribonucleotide synthesis carried out the reactions in solution phase; the 
products of which thus required one or several purification techniques. When in 1963 
Merrifleld88 developed a new method of synthesis involving an insoluble solid support 
which had been developed for peptide synthesis, other workers soon found the 
principle of solid phase synthesis applicable to many areas of synthetic chemistry. In 
1965, Letsinger5 first applied this method to the synthesis of di- and trinucleotides. 
The first successful solid phase synthesis of an oligonucleotide by the phosphotriester 
method was achieved in 1979 by Itakura et al.98 who made dT 19 in 49 % yield. Then 
Ogilvie a aL99 made an RNA hexamer with the phosphite-triester chemistry while 
Matteucci and Caruthers 90 used similar conditions to produce a DNA 
dodecanucleotide in 30 % yield. Since these pioneering experiments, the solid phase 
synthesis (SPS) concept has largely been accepted throughout the world for the 
synthesis of oligodeoxyribonucleotides, using mostly the phosphoramidite method. 
The SPS method is fundamentally a heterogeneous coupling reaction between a 
deoxynucleotide derivative in solution and another residue bound to an insoluble 
support. For this, it uses a functionalized support where the oligodeoxyribonucleotide 
chain attached via a linker can grow during the course of the synthesis. The chemical 
synthesis of DNA is normally carried out in the 3' to 5' direction to take advantage of 
the high chemical reactivity of the primary 5'-hydroxyl function. This method has 
several advantages over the solution phase method: 
The removal of reagents etc from the product, which is covalently bound to the solid 
support, can be performed simply by repetitively washing the solid support and 
filtering the solution without loss of product. All the reagents can be used in excess, 
hence achieving high yields. The reactions are all carried out in one flask and therefore 
24 
the loss of product is minimized. The operations to be carried out are fairly simple, 
mixing, washing and filtering, making it possible to have them performed by people 
unskilled in organic synthesis like biologists. The reaction processes were successfully 
automated thus reducing the amount of labour and the synthesis time. 
Many types of solid support have been investigated for solid phase 
oligonucleotide synthesis but four are in common use; styrene/divinylbenzene 
copolymer,5 '89 aminoalkylsilica gel,65 .90'91 polyamide92'93 and, most importantly, 
controlled pore glass (CPG) beads54,94t95  which are found to be ideal as they are rigid 
and do not swell. Automated syntheses on CPU supports are however limited to 
scales !9 10 j.unol. Recently Rapp et al.96 have developed a solid support based on a 
polystyrene polyethylene glycol graft copolymer with improved synthesis efficiency 
and high loading capacity enabling automated synthesis up to 1 mmole scale. The 
growing oligonucleotide chain is attached to the solid support via a long spacer in 
order to extend the sites away from the surface and ensure accessibility to all reagents. 
The length of the linker was found to have an effect on the final yield of the 
product.97 Succinate derivatives are generally used and are cleaved at the end of the 
synthesis by mild alkaline hydrolysis, using ammonium hydroxide which at the same 
time is used to remove the base protecting groups. 61 
In both the phosphotriester and the phosphoramidite approach, the solid support 
to be used is first functionalized by addition of the linker and the first nucleoside to 
give a loaded support. The assembly of the protected oligonucleotide chain is carried 
out by packing a small column with the deoxynucleoside loaded support (as little as 
10 mg of nucleoside loaded CPU can be used for a 0.2 ismol scale synthesis) and 
allowing solvents and reagents to flow through in predetermined order. The 
succession of operations is most reproducibly accomplished using a commercial, 
automated DNA synthesizer, alternatively a manual flow system or a small sintered 
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glass funnel can be substituted. The outline of the phosphotriester synthesis cycle is 
shown in Scheme 1.8. 
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Scheme 1.8: The phosphotriester solid phase synthesis cycle 
The nucleoside attached to the polymer (38) first undergoes a detritylation step 
with TCA to depmtect the 5'-hydroxyl affording (39) and is then coupled to a suitably 
protected nucleotide (40) in the presence of MSNT as a condensating agent and 1-
methylimidazole as an accelerating agent to give a fully protected dimer (41). It is 
then capped with acetic anhydride and 1-methylimidazole as a safety step to block 
chains which have somehow not reacted. The cycle is repeated until the desired length 
of oligonucleotide is obtained. At this point all the protecting groups are removed and 




















Scheme 1.9: Phosphite-triester solid phase synthesis cycle 
The synthesis cycle used in the phosphite-triester approach is very similar except 
it involves an extra oxidation step to obtain the phosphate linkages, see Scheme 1.9. 
The dimethoxytrityl protecting group is removed from the polymer attached 
nucleoside (38) with TCA, to give a free 5'-hydroxyl (39). A phosphoramidite 
nucleotide (42) is activated with tetrazole and added to the polymer bound nucleotide 
(39) to form a phosphite-triester dimer (43). The synthesis cycle then performs the 
capping of the unreacted free hydroxyl functions and a fortuitous benefit of this step is 
that phosphitylation of the 0-6 position of guanine is reversed. The intermediate 
phosphite (43) is then oxidized to the phosphotriester (44) with iodine and water. 
Pyridine or 2,6-lutidine is used to neutralize the hydrogen iodide released during the 
oxidation step. The cycle is then repeated by detritylation of the dimer (44) and 
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addition of further nucleotides until the desired chain length is obtained, at which 
point it is cleaved from the solid support and deprotected with ammonium hydroxide. 
The orange colour due to the dimethoxytrityl cation, liberated into solution is usually 
compared in intensity with the detritylation of the previous cycle to obtain a measure 
of the coupling efficiency. The avenge coupling efficiency in the phosphoramidite 
method of DNA synthesis, when carried out on an automatic machine is —98.5 % and 
sequences in excess of 100 residues can be prepared. 
So far all the chemical steps (described above) involved in the synthesis of 
oligonucleotides by solid phase synthesis, can be performed with automated DNA 
synthesizers whióh are now widely available commercially. The purification of the 
crude oligonucleotides is the only remaining step which requires manual 
manipulations; these will be discussed in section 1.8. When programmed with the 
desired sequence and loaded with the correct reagents DNA machines automatically 
synthesize DNA without manual intervention. Most machines are able to synthesize 
more than one oligodeoxyribonucleotide sequence at a time. Recently the solid phase 
gene assembly has been investigated, using new technologies for multiple chemical 
synthesis of oligonucleotides and stepwise hybridization on solid-phase support. An 
economical, rapid and efficient solid-phase gene synthesis is under scrutiny. 100 
1.6 Protecting Groups 
1.6.1 Introduction 
The problem of DNA synthesis entails the formation of a linear polymeric sugar 
phosphate ester by the stepwise addition of ester bonds at exactly the correct 
phosphorus atoms and hydroxyls of the sugar residues. This is accomplished by 
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selective protection/deprotection of reactive sites in the appropriate sequence. The 
protecting groups must be easily introduced and removed, the latter being especially 
important. Due to the sensitive nature of the monomer units and DNA itself, great 
care must be taken to circumvent two of the biggest problems: intemucleotide bond 
cleavage (breaking of the DNA strand) and depurination (loss of adenine or guanine 
via cleavage of the glycosidic bond). Nucleotides contain many potentially reactive 
sites. The reactive nucleophilic centres that need protection are amino groups on the 
bases, sugar hydroxyls (3' or 5'), oxo and imino functions and phosphate groups. As 
well as the stability of the protecting groups under various synthesis conditions, it is 
also vital to take into consideration how each group fits into the overall protecting 
group strategy of the molecule. Thus two classes of protecting groups have been 
developed: 
- Permanent groups that remain intact on the oligomer throughout the course 
of the synthesis and are only removed at the end. These include the oxo/imido, amino 
and phosphate protecting groups. 
- Transient groups which are removed whenever desired during the synthesis. 
These include the sugar hydroxyl protecting groups (5-01-1). 
In general protecting groups should have the property of being easy to 
introduce into the nucleosides and nucleotides and provide great stability and 
lipophilicity, hence facilitating storage and purification. Furthermore they should be 
cleaved under very mild conditions so as not to affect the oligonucleotide adversely. 
The reagents used for their introduction should show high regioselectivity. The 
mutual compatibility of these groups is necessary, and by virtue of their steric and 
electronic effects, the chemical synthesis should be facilitated even under 
heterogeneous conditions like solid phase synthesis. Easy detection of the protecting 
groups is desirable also. 
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1.6.2 Protection of the Nucleic Bases 
The exocyclic amino functions on the heterocyclic bases are permanently 
protected during DNA synthesis, generally as amides; the most common derivatives 
being benzoyl (Bz) for N-6 of dA (45), anisoyl (An) (less frequently) (46) or benzoyl 
(Bz) for N-4 of dC and isobutyryl (iBu) for N-2 of dO (47), see Fig. 1.8. The 
thymidine residue is usually not protected in DNA synthesis since it does not carry 
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Fig. 1.8: Common protecting groups for dC, dA and dG 
These protecting groups are introduced by acylation of the parent 
deoxynucleosides. The amino groups of adenine and guanine being too weakly basic 
for selective reaction, two acylation procedures were developed to overcome this 
problem: the classic method developed by Khorana 10t in 1972 involves prior 
peracylation of the nucleosides and subsequent removal of the 0-acyl groups by 
treatment with sodium hydroxide in alcohol, see Fig. 1.9 route A (exemplified with 
dA N-protection). The selectivity here is due to the greater stability of amides than 
esters at high pH. This rather tedious process involving a complicated work-up 






Jones et at, 103  see Fig. 1.9 mute B (exemplified with dA N-protection). The term 
"transient protection" is based on persilylation of the nucleoside, followed by in situ 
N-acylation and silyl ether hydrolysis yielding the N-acylated nucleobases in a one pot 
reaction. In the example shown above, benzoyl chloride is similarly used with dC but 
in the case of dG, acylation is effected with isobutyric anhydride; all these protecting 













Fig. 1.9: Route to N-6-benwyl-2'-deoxyadenosine 
The protection of deoxyguanidine and especially deoxyadenosine requires 
special comment, because the chemical stability of the nucleoside is profoundly altered 
by the protection of the exocyclic amino function. Purine nucleotides and 
oligonucleotides can loose their purine residue in either strongly basic or moderately 
acidic conditions, leaving an unsubstituted sugar. Since the growing chain is 
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repeatedly subjected to acid treatment (during removal of DMTr), the risk of 
depurination always exists. The mechanism of acid depurination involves a rapid pre-
equilibrium of protonation or diprotonation of the purine residue, followed by the 
rupture of the glycosidic bond that is the rate determining step. 104,105  The acidic 
depurination mechanism of deoxyadenosine is shown in Scheme 1.10. The site of the 
first protonation is N-i, only a small concentration of the N-i monoprotonated form 
may exist at equilibrium. The acidic depurination is thus limited by the rather difficult 
access to a N-i protonated form of deoxyadenosine. If, however, the adenine residue 
is N-6 acylated, the site of first protonation becomes N-7. Since a carbocation is 
generated at C-l' in the rate determining step, electron withdrawing substituents on 
the 3'- and 5'-oxygen atoms (like phosphate groups) reduce the extent of 
depurination. Depurination of deoxyadenosine is lower when it is in the middle of a 
sequence than when used as a nucleoside. The site of protonation in deoxyguanosine 
is N-7, and the site of acylation is N-2. The tendency of N-2 iBu-dG to depurinate is 
lower than that of N-6 Bz-dA. 106 
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Scheme 1.10: Acidic depurination mechanism of deoxyadenosine 
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In an effort to prevent depurination side-reactions to occur, Froehier and 
Mattèucci72 introduced the N-6 di-n-butylformamidine (N-6 di-n-
butylaminomethylene) group (48) (oommeroiulized under FOD) which greatly reduced 
depurination of deoxyadenosine and could be removed under mild ammoniacal 
conditions, see Fig. 1.10. Schulhof et al.107 then developed the phenoxyacetyl group 
for deoxyadenosine (49) and deoxyguanidine (commercialised under PAC), and 
obtained similar results than with FOD nucleotides. These groups prevent N-
protonation through steric factors as well as their electronic environment and thus 
minimize depurination. More recently the 2-(tert-butyldiphenylsilyloxy methyl)benzoyl 
group (SiOMB) has been reported by Dreef-Tromp et al. 108 to be idea] for the 
protection of dC, dA and dO, and is rapidly removed by fluoride ion. Another 
promising protecting group for all three heterocycles is the allyloxycarbonyl group, 109 
removable with a palladium (0) complex in formic acid. In the reported assembly of a 
60-mer in which the phosphate protection was also changed to allyl, the allyl and 
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Fig. 1.10: N-6 di-n-butylformamidine protected deoxyadenosine 
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Hata et al. 110- 111 investigated the use of the monomethoxyirityl (MMTr) group 
as an amino protecting group for dC, dA and dO and the dimethoxytrityl (DMTr) 
group for dA. Both these groups are deprotected with dilute HCI but remain intact 
when the DMTr group on the 5'-hydroxyl is deprotected with zinc bromide. 
A complication with dO is that the 0-6 position is vulnerable to reaction with 
certain reagents used in oligonucleotide synthesis, particularly in the case of the 
coupling agents (sulphonylation) and phosphoiylating agents used in the 
phosphotriester method. 112 '113 One of the best protecting groups was proposed by 
Pfleiderer et al. 114  who used the p-nitrophenylethyl (NPE) group to protect dO, dT 
and U on the oxygen of their amide functions. NPE could be deprotected via 13-
elimination with DBU in pyridine at the same time as it is removed from the 
phosphate triester. The efficiency of this group was later confirmed when Pon et 
al. 115  synthesized a 36-mer with this dO 0-6 protecting group. Another promising 0-
6 protecting group is the 13-cyanoethyl (CNE) group developed by Gaffney et al.,] 16 
cleaved with triethylamine or DBU via 13-elimination. Several other workers have 
investigated different oxo and imido protecting groups, e.g. Reese et al. 117  described 
the phenyl, the 2,4-dimethylphenyl and the 2-nitrophenyl groups, which may all be 
removed by oximate ions; Gaffney and Jones 118 used the trimethylsilyl group which is 
cleaved under neutral conditions with TBAF; Chattopadhyaya 119 used [3-elimination 
to cleave the Fmoc protecting group and Hata et al. 120 developed the 
(butylthio)carbonyl group cleaveable in aqueous ammonia. These protecting groups 
often have the second advantage of increasing the lipophilic character of the 
intermediate products and thus lead to better crystallization and purification. 
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1.6.3 Protection of the Deoxy-Ribose 
1.63.1 Introduction 
The chemical synthesis of oligonucleotides necessitates the proper protection of 
sugar hydroxyls. The 2'-deoxyribose sugar in DNA and the ribose sugar in RNA have 
two and three hydroxyl functions respectively. The 5'-hydroxyl, being a primary 
alcohol function , it is more reactive than both the 3', and where it occurs, the 2'-
hydroxyl functions which are both secondary alcohols. Hence the protecting group 
strategy for RNA is more complex than that of DNA because as well as having one 
more hydroxyl to protect, it has to differentiate between two alcohols. The first 
protecting groups used for sugar protection were acetyl 3 '38 and benzoyl 121 both 
cleaved by alkaline hydrolysis, but to fit in with the modem oligonucleotide synthesis 
strategy, acid labile protecting groups were developed. In the solid phase approach in 
particular, when frequent deprotection is required, basic media and nucleophiles 
would degrade the succinate link with the support, the triester and the N-acyl 
functions of the growing sequence. 
1.6.3.2 Primary 5'-OH Protecting Groups 
The mono- and dimethoxytrityl groups originally used by Khorana et al.,121 
continue to be the most popular 5'-hydroxyl protecting group, Fig. 1.11. The trityl 
group was found to be too stable in 80 % acetic acid 122 and so to make it more labile 
a methoxy group was introduced on the phenyl ring. The introduction of a p-methoxy 
substituent enhances the rate of acid cleavage by a factor of 10; the dimethoxytrityl 
group (DMTr) was finally found to have the adequate acid lability for the solid phase 
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Fig. 1.11: The trityl protecting groups 
The 4,4'-dimethoxytrityl (DMTr) protecting group presents several advantages: it is a 
very selective alkylating agent for the primary 5'-hydroxyl; the protected nucleosides 
are lipophilic, rendering solvent extraction and chromatographic purification easier, 
upon treatment with an acidic spray on t.l.c, the DMTr substituted compounds are 
specifically stained; the rate of acid deprotection is high, the deprotection is 
quantitative and the yield of deprotection can be monitored spectroscopically during 
synthesis on the solid support. Strong organic acid under anhydrous conditions is 
usually used for the recurrent deprotection in solid phase oligonucleotide synthesis. 
The duration of this treatment requires to be strictly controlled, moreover it was 
found that strong acid as for example benzene sulphonic acid and related acids cause 
extensive depurination of N-6-benzoyl(dA). 123 A weak concentration of 
dichloroacetic add (TCA) in an aprotic solvent is the reagent of choice as its action is 
rapid (c 2 mm) and depurination is kept to a minimum. 61 The most selective reagent 
for the cleavage of the 5'-O-DMTr group without depurination is zinc bromide in an 
aprotic solvent, unfortunately this reaction is too slow for a solid supported 
synthesis. 24 Interestingly, removal of DMTr groups using 80% acetic acid at the end 
of the oligonucleotide synthesis is easily accomplished with no depurination, provided 
the base N-acyl groups have been removed. 12 
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In 1978, Chattopadhyaya and Reese 125 developed the 9-phenylxanthen-9-yl 
(pixyl) protecting group, Fig. 1.12, whose acid lability is comparable to the 
dimethoxytrityl group, but whose deoxynucleosides unlike dimethoxytritylnucleosides 
can almost invariably be induced to crystallise, hence facilitating their purification. 
Reese a al. 126 later developed a number of pixyl structures with the intention of 
making a wide range of acid sensitive pixyl derivatives which promoted the 
adaptability of this primary alcohol protecting group to various chemical conditions. 
Nevertheless, the dimethoxytrityl group remains the most frequently used group, 
probably because of the general commercial availability of the corresponding chloride. 
Other acid labile groups were developed, like the tert-butyldimethylsilyl group 127 and 
the tert-butyldiphenylsilyl group 116  which could be cleaved not only in 80% acetic 
acid but also by tetra-n-butylammonium fluoride (TBAF) which is particularly useful 
for acid sensitive nucleosides. 
Fig. 1.12: A S'-O-pixylprotected nucleoside 
Several examples of base labile hydroxyl protecting groups have been reported. 
Khorana and Weimann 128 investigated the pivaloyl group and Letsinger and Ogilvie 
proposed the p-nitrophenyl group 129 and the isobutyloxycarbonyl group 130 which 
have good selectivity for the primary hydroxyl. Pfleiderer et al.131 used the j3-
elimination process to cleave the 2,4-dinitrophenylethoxycarbonyl group with tertiary 
amines. This group was found to be more base sensitive than the f3-cyanoethyl group. 
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Chattopadhyaya 132 introduced the fluoren-9-ylmethoxycarbonyl group (Fmoc) to 
DNA synthesis from peptide synthesis. This group is also cleaved by p-elimination 
using a base such as triethylamine or piperidine and its use as a 5'-protecting group 
was demonstrated by the synthesis of (dT)8. He also showed that this group is 
compatible with the phosphoramidite method 133 on solid phase by synthesizing an 
oligonucleotide and using DBU for the recurrent removal of Fmoc. 
The concept of a "protected" protecting group was introduced by Reese et 
al.lM by using the 2-dibromomethylbenzoyl group whose ester is comparatively 
stable to acid and alkali but when oxidised with silver perchlorate to the aldehyde and 
then treated with morpholine yields the free alcohol. Seliger et al. 135 introduced 4-
alkoxytrityl protecting groups as novel type of hydrophobic protection for the 5'-end 
of oligonucleotides, consequently varying the chromatographic behaviour of 
oligomers which proved to be useful in their purification. By replacing the phenyl by a 
pyrenyl substituent in the dimethoxytrityl group, Fourrey et al.136 obtained a 
fluorescent acid labile protecting group which exhibited similar chemical properties to 
those of DMTr but enabled easy UV detection of the products. Fisher and 
Caruthers 137 also developed the idea that the colour of acidic solutions containing 
triaryl methyl cations is directly influenced by the nature of the aryl substituents 
attached to the central carbon atom, they demonstrated that almost any colour can be 
produced by subtle substitution. When the four nucleotide monomers were protected 
with a different triaryl methyl group, then the collection of the consecutive coloured 
trityl cation solutions could give a simple and rapid check on the veracity of the 
synthetic sequence. 
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1.63.3 Secondary 3'- and 2'-OH Protecting Groups 
DNA synthesis sometimes requires 3'-protection, this is most frequently 
achieved with the base labile acetyl group, first used by Todd, 3 and later Khorana. 128  
In the case of ribonucleotides the 2'-hydroxyl functions are often protected with a 
different protecting group from the 3'-hydroxyl functions, for this reason Ogilvie et 
al. 138 ' 139 developed the tert-butyldimethylsilyl (TBDMS) group for the selective 
protection of the 3'-hydroxyl. Pfleiderer et al)31 also developed the p-
nitrophenylethyl group as a 3'-hydroxyl protecting group. The 2'-hydroxyl occurs only 
in RNA and must be protected as RNA is sensitive to alkaline hydrolysis. It usually 
involves the generation of a 2'-oxyanion which subsequently attacks the neighbouring 
internucleotide linkage leading to migration of the phosphate to the 2'-position or to 
chain cleavage. For a long time the most popular protecting groups for the protection 
of the 2'-hydroxyl during RNA synthesis had been the acid labile tetrahydropyran-l-yl 
(THP) group and the 4-methoxyhydropyran-4-yl (MTHP) group; 48 the former having 
the disadvantage of forming a mixture of diastereoisomers during the protection 
reaction of a nucleoside. However these two protecting groups are not completely 
stable to the recurrent acid treatment used for the deprotection of the 5'-DMTr group. 
Van Boom et al. 140  exchanged the ring oxygen for sulphur to produce a thioether and 
in a different experiment an SO 2 group to give a suiphone. These groups are achiral, 
the former being slightly more acid labile and the latter considerably less acid labile 
than the MTHP group. Two acid stable protecting group were then developed, the o-
nitrobenzyl group 141 removed by irradiation with US' light in a solution of ammonium 
formate and the TBDMS group removed by TBAF and first introduced by 00vie. 142 
2'-Silyl ribonucleoside phosphoramidites are now commercially available but loss of 
the 2'-silyl groups and subsequent internucleotide cleavage during ammonia 
deprotection has been acknowledged; the conditions for ammonia deprotection had to 
be altered and a new base protecting group removable under milder ammoniacal 
conditions had to be used. 143  In the search for a protecting group which would be 
stable to strongly acidic conditions but cleaved at higher pH, Reese 144 first suggested 
the 1-(2-chloromethyl)phenyl-4-methoxypiperidin-4-yl (Cpmp) group and subsequent 
workers 145 justified the use of the more effective 1-(2-fluorophenyl)-4-
methoxypiperidin-4-yl (Fpmp) group, see Fig. 1.13, which was cleaved faster at pH> 
1.0. 2'-Fpmp protected nucleoside phosphoramidites are expected to become widely 
available commercially and will probably rival their 2'-silyl counterparts in tents of 
effectiveness. 
HO -wBase 
OH n CH3 
Fig. 1.13: The Fpmp protecting group 
Multiple hydroxyl protection has also been achieved, an example of this is the 
reaction of p-nitrophenyl chioroformate and a ribonucleoside which results in the 
formation of a 2',3'cyclic carbonate 146 which can be removed by alkaline hydrolysis. A 
bifunctional silylating reagent 1,3-dichloro- 1, 1,3,3-tetraisopropyldisiloxane, known as 
the "Markiewicz reagent" 147 has significantly improved synthetic routes. It 
distinguishes between the 2'- and the 3'-hydroxyl on a ribose by selective protection of 
the 5'- and 3'-hydroxyls leaving the 2'-hydroxyl free to react with another protecting 
group. The "Markiewicz reagent" can be removed with fluoride ions. 
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1.7 Purification of Synthetic Oligodeoxynucleotides 
1.7.1 Introduction 
The deprotection of an oligonucleotide involves removing the various 
protecting groups and cleavage from the solid support. Incomplete deprotection will 
adversely affect analysis and purification, as well as biological activity. The traditional 
automated solid phase synthesis of oligodeoxyribonucleotides usually involves 
treatment of the final product with concentrated ammonium hydroxide to 
simultaneously cleave the product from its support and deprotect the 
cyanoethyiphosphate groups. Deprotection of the exocyclic amines is achieved by 
heating the sample in concentrated ammonium hydroxide for a minimum of 4 h at 
55°C. The phosphoramidite synthesis also employs a capping scheme that acetylates 
the 5'-hydroxyl functions that have failed to undergo coupling. These truncated 
sequences remain capped during the synthesis but are uncapped during base 
deprotection in ammonia. The product oligonucleotide which is not acetylated, has a 
5'-hydroxyl that is protected by a DMTr group, which can be automatically removed 
by the instrument or retained if trityl-on purification methods are used. Therefore, the 
crude mixture dissolved in ammonium hydroxide from the final deprotection contains 
a variety of impurities, including extraneous ammonium salts derived from the 
removed protecting groups. It also includes the desired full length oligonucleotide 
product, shorter failure sequences resulting from incomplete coupling and subsequent 
capping, a collection of oligonucleotides resulting from other low level side-reactions 
that were cleaved during ammoqiblysis and organic by-products resulting from the 
removal of protecting groups, e.g. benzamides. Therefore one can understand that a 
rapid and efficient separation method is of great importance to obtain satisfactory 
purity of the final product. 
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For most applications of synthetic oligodeoxynucleotides in molecular biology, 
where only a small amount (!~ 1 O.D. unit, —40 jig) is required, this amount of 
material can be easily purified by analytical high-performance liquid chromatography 
(HPLC). For purer and for higher amounts of oligodeoxynucleótides, it is necessary 
to apply a combination of two orthogonal methods of purification: (a) either anion-
exchange HPLC or trityl-on reverse-phase HPLC (RP-HPLC) and (b) trityl-off 
reverse-phase HPLC. Method (a) separates the full-length product from failure 
sequences, and Method (b) separates the desired product from sequences containing 
base modifications. Polyacrylamide gel electrophoresis (PAGE) is also applied to 
oligonucleotide purification as a powerful technique; in particular for long sequences 
beyond 100 residues where single nucleotide resolution is possible, however it is 
limited to small scales (c 1 mg). A good review on the practical aspect of synthetic 
DNA purification has been published by Gait61 and Brown and Brown. 148 
1.7.2 Anion-Exchange Chromatography 
Ion-exchange chromatography is a widely used technique for the purification 
and analysis of charged compounds, such as oligonucleotides. The separation is based 
largely on charge per unit weight, which is determined by the base length (the number 
of phosphate S groups in the molecule) and the base composition (the respective 
charges on the bases), the size of molecules to be separated is also an important 
criteria as the stationary phase is macroporous. The separation of the crude mixture is 
accomplished by slowly increasing the ionic strength (concentration) of the mobile 
phase. The desired product is always eluted later than the shorter sequences. 
Phosphate groups can be masked by secondary structures which will exhibit a 
different charge ratio, however this phenomenon can be minimized by addition of a 
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denaturant, such as fonnamide in the mobile phase. Anion-exchange HPLC should 
also be carried out with the products of the irityl-off syntheses, as trityl-on 
oligonucleotides elute very late by this technique and therefore an extremely shallow 
gradient is necessary. The resolution also decreases as longer oligonucleotides are 
separated because the relative difference in charge between longer oligonucleotides is 
less than between shorter oligonucleotides. Moreover peak broadening effects start to 
appear. This method usually uses standard anion-exchange columns, such as 
Aquapore AX-300 or Partisil 10 SAX. The mobile phase is 20 % acetonitrile in a 
potassium phosphate buffer system, pH 6.4. Standard gradient is 100-400 mM of the 
phosphate buffer over 30-40 mm. Oligonucleotides greater than 25 bases usually 
require a higher concentration of phosphate buffer, however anion-exchange HPLC 
purification is limited to oligonucleotide lengths up to 50 monomer units. 
1.7.3 Reverse-Phase Chromatography 
When the reverse-phase, trityl-on chromatography method is used to purify 
synthetic oligonucleotides, it is necessary for the final 5'-DMTr group to be left 
attached to the oligonucleotide product. This is usually carried out by simple 
programming on the synthesizer, the oligonucleotide is then completely deprotected 
with concentrated ammonia except for the DMTr group. The product is a mixture of 
the full-length tritylated sequence and a number of untritylated failure sequences. 
Separation of the desired product by RP-HPLC is made easy as the DMTr group is 
lipophilic. Normally the first eluted peak contains the oligonucleotides corresponding 
to the failure sequences (hydrophilic) and the second peak is the desired DMTr 
bearing product (hydrophobic). A typical RP-HPLC trace of a 6-mer can be seen in 
section 2.6.2. Analysis and purification of trityl-on oligonucleotides is generally 
accomplished with a C-8 or sometimes a C-18 RP-column such as, Aquapore RP-300 
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or Spheri-5. The mobile phase most often used for RP-HPLC analysis and purification 
of oligodeoxyribonucleotides is an increasing gradient of acetonitrile in 0.1M 
triethylammonium acetate (TEAA) or 0.1M ammonium acetate, pH 7.0. UV detection 
of the oligonucleotide products is usually achieved at wavelengths between 260 to 
295 rim. Typical gradients useful in the trityl-on and trityl-off method can be seen in 
the experimental section. Generally the retention time of tritylated oligonucleotides 
decreases as chain length increases, because of the increasing hydrophilic character 
introduced by the increasing proportion of nucleotide units over the proportion of the 
hydrophobic DMTr group. 
The thtyl-on peak fraction is collected during chromatography and the product 
is then detritylated to render a biologically active compound. After evaporation of the 
solution under vacuum, the trityl-product is treated with 80 % acetic acid at room 
temperature. This acidic treatment does not cause depurination because the bases are 
much more stable to acid after evaporation. The volatiles are then removed by several 
co-evaporations with distilled water and the oligonucleotide product is then extracted 
with ether or precipitated with ethanol or desalted on a gel size-exclusion matrix 
before being subject to the second stage of purification: the trityl-off RP-HPLC. 
There are a number of limitations to the RP-HPLC purification technique for 
oligodeoxyribonucleotides: if the capping reaction is not efficient, the desired product 
will coelute with a number of trityl-on impurities. Full length sequences that have 
undergone some base modification will not be resolved from the desired product as 
the difference in their hydrophobicity can be minimal. The trityl-on oligonucleotides 
must be handled carefully as some detritylation can occur due to the acid lability and 
the sensitivity to heat of the trityl group. It is therefore advised to dissolve the trityl-
oligonucleotides in an aqueous buffer between pH 7.0 and 7.5 before and during 
trityl-on HPLC. In spite of these drawbacks, the trityl-on RP-HPLC purification 
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method, when carried-out carefully, remains the method of choice for longer 
oligonucleotides (> 25 residues to beyond 100 residues) and large scale synthesis (g 
scale). 
Trityl-off RP-HPLC with single-base resolution can often be achieved, at least 
to 25 bases and sometimes longer, depending on the sequence. In that case, the last 
DMTr group on the 5'-end of the oligonucleotide is removed prior to ammonia 
deprotection, usually on the DNA synthesizer. The product identification is however 
not as obvious or predictable as in trityl-on HPLC. The main advantage is that the 
product recovered after purification is in a ready to use form. However the trityl-off 
RP-HPLC method is more often used in the final HPLC purification step, following 
either thtyl-on RP-HPLC or anion-exchange HPLC, and therefore attaining the 
objective of combining two orthogonal approaches to purification. 
In thtyl-off HPLC, the sample preparation is much simpler than with trityl-on 
HPLC. The product does not bear a DMTr group and is therefore more stable during 
handling. The ammonia solution containing the crude mixture is generally evaporated 
in vacuo at 50°C and the residue can be redissolved in distiled water to be injected 
into an HPLC. Analysis and purification of trityl-off oligonucleotides is generally 
accomplished with similar equipment as in the trityl-on method; a C-8 or sometimes a 
C-18 RP-column such as Brownlee Aquapore RP-300, moderately hydrophobic with 
large average pore size. The mobile phase most often used for RP-HPLC analysis and 
purification is an increasing gradient of acetonitrile in 0.1 M triethylammonium acetate 
(TEAA) or 0.1 M ammonium acetate, pH 7.0. UV detection of the oligonucleotide 
products is usually achieved at wavelengths between 260 to 295 nm. Compounds with 
shorter length than the product elute faster than the product as they are less 
hydrophobic. The product peak is collected so as not to include any of the shoulder 
peaks; an analytical HPLC of this fraction is then carried out in order to confirm the 
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purity, If some impurity remains, the entire procedure must be repeated. Once the 
product has been purified it is desalted by precipitation in ethanol or eluted on size-
exclusion chromatographic columns. A rapid extraction method using n-butanol was 
recently devised and obviates the need for prior ammonia or buffer removal. 149 
Problems can sometimes arise with RP-HPLC for example when the sequence 
to be purified is deoxyguanosine rich 150 or if it contains palindromic regions; it can 
result in multiple peaks with unpredictable retention times. The ability of reverse-
phase adsorbents to resolve oligonucleotides diminishes as oligonucleotide length 
increases. Longer oligonucleotides that differ in length by a single base exhibit small 
differences in hydrophobicity, resulting in loss of resolution. The conditions under 
which RP-HPLC is carried out has little denaturing effect on oligonucleotide that 
form stable conformations. 
1.7.4 Gel Electrophoresis 
Resolution of DNA fragments with only one charge difference is possible by 
electrophoresis on a polyacrylamide gel in the presence of a denaturing agent such as 
urea. Polyacrylamide gel electrophoresis (PAGE) is now widely used for 
oligonucleotide analysis and purification. Usually a polymerized, cross-linked 
acrylamide gel matrix is held between two glass plates and the ends of the gel slab are 
immersed in buffer chambers containing an electrolytic salt solution through which an 
electric field of controlled voltage or current is applied. The charged molecules of 
DNA migrate through the gel matrix, separating on the basis of charge and mass. The 
rate of migration of molecules to a lesser extend also depend on molecular shape, net 
hydrophobicity and size. 
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The dimension and shape of the slab gels are not essential as long as the minimal 
length is 15 to 20 cm and a thickness of 0.4 to 1.6 mm. The more critical choice is the 
size of the sample wells as best resolution for preparative samples is obtained by using 
the sample band as narrow as possible, e.g. 1cm width is useful for sample loads of —1 
O.D. unit. Common electrophoresis buffer consists of a solution of tris base, boric 
acid and EDTA. A high concentration of urea is maintained in the gel in order to 
minimize the formation of secondary structures with single stranded oligonucleotides. 
The polyacrylamide concentration is also varied depending on the oligonucleotide 
length. Higher concentrations decrease the avenge pore size of the gel therefore 
slowing migration and increasing separation of the sample molecules. A 
polyacrylamide concentration of 20 % is commonly used for oligonucleotides <25 
residues long. Oligonucleotides which are suspected of forming secondary structures, 
are heated to 90°C for several min in a denaturing buffer prior to loading and 
immediately cooled on ice. The warming of the sample helps in the denaturation 
process. After electrophoretic separation, the products can be visualised on the gel 
slab by UV shadowing whereby the gel is transferred to a fluorescent media and 
observed under short-wavelength UV light However the interpretation of UV 
shadowing is subjective and comparison with oligonucleotides in adjacent lanes of 
known quality and length is required. The band containing the purified oligonucleotide 
is then excised and the product extracted into an aqueous buffer (Tris-HC1, sodium 
chloride and EDTA) to be obtained in a pure form. 61 This method is particularly 
useful for long oligonucleotides (> 50 residues), but is limited to small scale (up to 1 
mg). 
MicmGel capillary electrophoresis (CE) separates DNA fragments in a gel-filled 
capillary according to the same ratio of mass to charge than polyaciylamide gel slab 
electrophoresis. This powerful technique offers single-base resolution beyond 100 
bases in a quantitative manner so that the resulting electropherograms can be 
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displayed, stored and integrated like HPLC chromatograms. The combination of gel 
materials and heating of the capillary confers a significant denaturing effect to the 
method. However CE remains in the domain of analytical techniques as the loading 
scale is limited to 10 pg. 
1.8 Labelling of Oligonucleotides 
1.8.1 Introduction 
Oligodeoxyribonucleotides tagged with various ligands have been widely used 
as research tools for genetic analysis, to assign gene function and to elucidate 
mechanisms in molecular biology. 151 ' 152 In addition to their use as hybridization 
probes 153 they have been used in diagnostic procedures. 154 Labelled 
oligodeoxyribonucleotides carrying a reporter group now have widespread use for 
automated sequencing, 155,156  fluorescence microscopy 157 and hybridization affinity 
chromatography. 158  With the advent of the "Human Genome Project" 159 large-scale 
automated DNA sequencing has taken on an increased importance. 
DNA labelling with radioactive atoms is commonplace in molecular biology, as 
it offers very sensitive detection of the labelled probes. Radioactive atoms such as 
are introduced in oligonucleotides by the action of polynucleotide kinase and y- 32P-
dATP. DNA radioiodinated probes are required in some diagnostic applications. For 
this purpose a pyrimidine phosphoratnidite is substituted at the 4-posidon 1 60 or at the 
5-position 161 by a phenyl group via a suitable spacer arm; and after incorporation of 
the derivative in the DNA synthesizer, the deprotected oligonucleotide can be 
iodinated by the chloramine T procedure. 160 1251  labelled primers have also been used 
in polymerase chain reactions in conjunction with a biotin label. Various radio- 
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isotopes such as 35S, 14C and 3H are currently being used. 162 Although these 
techniques are very sensitive, they have several major drawbacks. The half-life of a 
radio-isotope, 14.2 days for 32P, can be inconveniently short, thus requiring repeated 
labelling of the DNAprobe in long term experiments. Radioactive labelling techniques 
are time consuming, expensive and involve hazardous exposure to ionising radiation 
for the technician. It was also found that the specific activity of the radio-labelled 
DNA varies with time and batch. Moreover, these techniques require special training 
and special equipment to ensure proper shielding, monitoring, containment and waste 
disposal. For these reasons non-radioactive labelling techniques for oligonucleotides 
have been developed in preference to radioactive labels. 
1.8.2 Non-Radioactive Labelling Groups 
In the class of directly detectable labels, the fluorescent dyes are the most 
prominent; they can be detected visually by means of fluorescence microscopy or 
fluorimetry. A wide range of fluorescent dyes have been used in the covalent labelling 
of oligonucleotides, these include among others: fluorescein, 163 4-chloro-7- 
nitrobenzo-2oxa-l-diazole 	(NBD),164 	Texas red,lM dansyl' 65 and 
bathophenanthroline-ruthenium 	(II) 	complexes' derivatives, see 	Fig. 1.14. 
Fluorescently-labelled oligonucleotides are finding considerable application in DNA 
sequencing and more especially as diagnostic reagents. A set of phosphoramidite 
reagents useful in preparation of 5'-fluorescence-tagged oligonucleotides for DNA 
sequencing has been developed by Du Pont. 167  The fluorescent labels can be chosen 
with regerd to their fluorescence wavelength maxima, allowing simultaneous 
detection of different oligonucleotides labelled with different fluorophores. This 
approach is applied to Sanger's enzymatic method of DNA sequence analysis. 164 - 168  
49 
The use of a single fluorophore in automated DNA sequencing has also been 
reported. Fluorescent in situ hybridization (FISH) techniques 169 use labelled primers 
for the mapping of genes in cancer diagnosis, where fluorescence microscopy is used 
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NHS-carboxyalkyl-bathophenanthroline-Ru (II) complex 
Fig. 1.14: Fluorescent labels 
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Enzymes have also been attached covalently to oligonucleotides, and are 
detected by addition of an enzyme substrate which produces either a coloured product 
or a light signal via a chemiluminescent reaction. Such enzymes include alkaline 
phosphatase (AP) or horseradish peroxidase (}{RP)) 70' 171 The colorimetric detection 
of AP is usually carried out using a mixture of 5-bmmo-4.-chloro-3-indolyl phosphate 
and nitro blue tetrazolium, resulting in the production of a blue-purple precipitate. 172 
The use of the enzyme HRP offers a wider range of substrate available, for instance 
3,3'-diaminobenzidine which produces an insoluble coloured precipitate. Other 
substrates produce soluble conjugates which are useful in the quantitative 
measurement of binding affinity by spectrometry. When HRP is bound to an 
oligonucleotide, it can oxidize 3-aminophthalhydrazide (luminol) 173 in the presence of 
hydrogen peroxide to produce chemiluminescence. The intensity of the 
chemiluminescence can be increased by addition of some enhancers such as p 
hydroxycinnanñc acid or p-iodophenol. Alkaline phosphatase (AP) has also been 
found to produce chemiluminescence when reacted with the dioxetane generated by 
photooxygenation of 3-phosphate-9H-xanthen-9-ylideneadamantane monopyridinium 
salt, see Fig. 1.15.174  Chemiluminescent detection offers several advantages over 
colorimetric detection: the background is theoretically zero, detection is very rapid, 
measurement of the observed signal is relatively easy using a charge-coupled device 
and the labelled probe can be washed off allowing several hybridizations to be carried 
out. On the other hand the synthesis and purification of the enzyme-oligonucleotide 
conjugate is expensive and time consuming, only one enzyme can be attached per 
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Fig. 1.15: Chemiluminescence for Alkaline Phosphatase 
Another class of labelling group involve those that are detected indirectly. 
Biotin is in fact the non-radioactive labelling agent most frequently used to tag 
oligonucleotide probes primarily because of its exceptionally strong binding to the egg 
white glycoprotein avidin and with its non-glycosylated bacterial counterpart 
streptavidin, both of which have four biotin binding sites. 174  For the detection of the 
biotinylated oligonucleotide, this is incubated with an avidin (or steptavidin) -enzyme 
conjugate which results in the formation of an oligonucleotide-biotin-avidin-enzyme 
complex which in turn is incubated with the appropriate enzyme substrate to give a 
calorimetric or chemiluminescent signal. 175  Anti-biotin antibodies have also been used 
for detection. 176  However biotin is a expensive hapten and is unsuitable for use in 
certain in situ hybridization applications due to the high level of endogeneous biotin 
present in some tissues. Various other indirectly detectable labels have been 
incorporated into oligonucleotides whose antibody had been raised and is obtainable 
in reasonable quantities. Phosphotyrosine phosphoramidite for example has been 
reacted with an oligonucleotide and subsequently detected using a commercially 
available anti-phosphotyrosine antibody followed by a secondary antibody-HRP 
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conjugate. 176  Even the fluorescent reporter group fluorescein can be detected using 
anti-fluorescein antibodies. 177 
1.8.3 Introduction of Labelling Groups 
The common methods to introduce non-radioactive labels into oligonucleoddes 
are either post synthetically, where the label is attached by an enzymatic or by a 
chemical reaction after the complete synthesis and purification of the oligonucleotide; 
or during the solid phase synthesis of the oligonucleotide. The former method is not 
suitable for automation and is therefore dine-consuming whereas the latter can easily 
be automated and is therefore more convenient. 
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The enzymatic labelling of ohgonucleotide generally involves a modified 
nucleoside triphosphate carrying the labelling group which can be incorporated into 
oligonucleotides via enzymes such as deoxynucleotidyl terminal transferase which 
attaches a tail of ribo- or deoxyribonucleotides at the 3'-end. 177 A number of modified 
nucleoside triphosphates are now available, the most common being 5-(N-(N-biotinyl-
e-aminocaproyl)-3-ammo-allyl) uridine 5'-triphosphate (Bio-1 i-UTP) and 5-((N-
biotinyl)-3-amino-allyl) uridine 5'-triphosphate (Bio-4-UTP) and their 2'-deoxyuridine 
analogues. 177,178  DNP derivatives of 8-aminohexyl adenosine 5'-triphosphate' 79 and 
digoxigenin-O-succinyl-e-aminocaproyl-[5-(3-aminoallyl)-2'-deoxyuridine-5'- 
triphosphate] (Dig-i 1-dUTP) 180 have also been successfully incorporated into DNA. 
However, enzymatic labelling remains a time-consuming exercise which is used in 
small scales only. 
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The post-synthetic approach to the chemical labelling of oligonucleotides 
involves the attachment of a reactive group (usually a nucleophile such as an aliphatic 
amine or thiol) to the oligonucleotide either during or after the solid phase synthesis, 
and subsequent reaction of the reactive group with an activated labelling molecule. 
These reporter groups tethered to the base residue can therefore be introduced site-
specifically (depending upon the sequence location of the base). Typically these 
methods employ a linker arm containing a primary aliphatic amino function attached 
to the C-5 position of thymine or the N-4 position on cytosine which subsequently can 
be reacted with an amino-reactive labelling molecule, such as an active ester or an 
isothiocyanate. A variety of useful procedures for the attachment of amine reactive 
labels to base modified oligonucleotides have been described by Urdea et al. 71 
A large number of examples where primary amino functions have been 
introduced onto the 5'-end of an oligonucleotide, exist at the present time. The most 
prominent example of a 5'-amino linker that has been commercialized under the name 
"Aminolink 2" by ABI, is the 2-cyanoethyl phosphoramidite of 1-
trifluoroacetylaminohex-6-ol. Using this linker, a four step procedure is required to 
label an oligonucleotide, see Fig. 1.15. This useful amino linker is reactive with a wide 
variety of amine-reactive labelling groups, such as fluorescein isothiocyanate and 
other fluorophores active esters or isothiocyanates. Other examples of post-synthetic 
labelling of oligonucleotides involving aliphatic amino-hydroxy-alkyl linkers include 
the phosphoramidite and H-phosphonate monomers of N-trityl 6-amino-hexan-l-ol 
developed by Sinha and Cook 181 and the 2-cyanoethyl phosphoramidite of N-Fmoc-
aminoethanol among others. 182 Aliphatic amines have also been introduced into 
oligonucleotides by methods other than phosphorylation. For example at the N-4 
position of cytidine via a bisulfite-catalysed transamination reaction 183 or at the C-5 
position of uridine via a palladium mediated olefination reaction. 184 But this approach 
can lead to destabilization of the helix structure as the incorporation of such 
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functional groups can interfere in the Watson-Crick hydrogen bonding. 185 In addition, 
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Fig. 1.15: Chemical fluoresceination of amino-modified oligonucleotides 
Instead of chemical labelling using a amino linker, some workers have examined 
the possibility of using thiol linkers followed by reaction with sulphur reactive 
labelling molecules such as iodoacetamides, y-bromo-a43-unsaturated carbonyls and 
aziridinyl sulphonamides. Thiol linkers have been attached to the 3'-end of 
oligonucleotides during solid phase synthesis with functionalized supports. 186,187  
Usually the thiol function is protected in the form of its disulphide during the synthesis 
and deprotected after synthesis with dithiothreitol. Alternatively 5'-thiol modified 
oligonucleotides have been used, based on S-trityl-mercaptoalkanols and H-
phosphonate monomers. 181 The trityl group is removed after synthesis using silver 
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ions to give the free thiol which can be reacted with sulphur reactive fluorophores, 
such as biotin maleimide. Agrawal and Zamecnik 188 developed the synthesis of 
oligonucleotides containing two different labels, whereby they first synthesized an 
oligonucleotide containing both a phosphorothioate-diester intemucleotidic linkage 
and an aminoalkyl phosphoramidate link. An hetembifunctionally labelled 
oligonucleotide was subsequently obtained by successive reaction of the modified 
oligonucleotide with a sulphur reactive labelling group and then with an amine 
reactive labelling group. 
A more convenient way to introduce a non-radioactive labelling group onto an 
oligonucleotide is achieved during the synthesis of the oligonucleotide on the solid 
support. Generally labelling groups have been used in the form of their 
phosphoramidite derivatives. This enables the labelling reaction to proceed in an 
entirely automated way and, additionally, the purification of the labelled 
oligonucleotide after cleavage from the support is made easier as the product is likely 
to behave differently in HPLC and PAGE than the unlabelled failure sequences. The 
attachment of multiple labels can be achieved in a controlled manner, in order to 
increase the signal and thus improve sensitivity of detection. The biotin 
phosphoramidite monomer has been developed by Po& 89 and is now the standard 
way of introducing biotin into oligonucleotides, see Fig. 1.16. DNP phosphoramidite 
monomers 190 as well as fluorescein phosphoramidite monomers 191 have also been 
developed and successfully applied using the standard automated DNA synthesis 
conditions, see Fig. 1.16. These labelled oligonucleotides were found to be stable to 
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Fig. 1.16: Phosphorwnidite labelling monomers; (a) Biotin, 
(b) DNP, (c) Fluorescein 
In order to increase the signal sensitivity of labelled oligonucleotides, Misiura ci 
al. 176 introduced the multiple biotin, see Fig. 1.17, and phosphotyrosine labelling 
using a non-nucleoside phosphoramidite based on a 3-carbon glyceryl backbone. The 
synthesis of the biotin phosphoramidite monomer was achieved by reacting the anion 
of solketal with acrylonitrile followed by the reduction of the resulting 2-cyanoethyl 
solketal to give 3-aminopropyl solketal. This amine was then reacted with the N-
hydroxysuccinimide ester of biotin, followed by the removal of the isopropylidene 
protecting group with aqueous HCI and dimethoxytritylation of the primary hydroxyl 
function, and phosphitylation of the secondary hydroxyl function. The presence of the 
DMTr group enables the coupling efficiency to be monitored after deprotection and 
the free hydroxyl function can then react with a further phosphoramidite label. 
Recently Theisen ci at 192 achieved multiple addition of fluorescein using 5- 
carboxyfluorescein phosphoraniidite and the same backbone as that used by Misiura et 
al.,176 see Fig. 1.17. These labelling group derivatives have the advantage of being 
soluble in acetonitrile and require minimum changes to the standard protocol used in 
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Fig. 1.17: Multiple addition phosphoramidites; (a) Biotin phosphoramidite, 
(b) Fluorescein phosphoramidite 
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Chapter 2: Discussion 
2.1 Basis for the Design of a Hydrophobic S'-Protecting Group 
In the chemical synthesis of oligonucleotide fragments, chromatographic 
methods are very important for their purification, as described in section 1.7. Two 
powerful methods are routinely used, ion-exchange chromatography and the perhaps 
more widely used reverse-phase HPLC (RP-HPLC) which enables the efficient 
purification of quantities up to 50 mg.62 The main chromatographic separation 
criterion for reverse-phase HPLC is a difference in hydrophobicity of the components 
in a crude mixture. More commonly, the identification of the desired product is 
achieved by leaving the 5'-DMTr (di-para-anisylphenylmethyl) group on the final 
monomer so that the product can be resolved from non-5'-DMTr terminated 
sequences by reverse-phase HPLC. 148 The fraction containing the product can be 
separated, detritylated and obtained in a pure form following an additional 
chromatography step. 
The chromatographic behaviour of oligonucleotides can be varied within certain 
limits by attachment of a hydrophobic group at the 5'-terminus; generally an unspecific 
change in the overall polarity of the molecule is produced. Unfortunately the change 
in the total polarity introduced by the addition of a single DMTr group is greatly 
reduced when synthesizing longer oligonucleotides (>30-mer). Consequently when a 
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long oligonucleotide is purified by reverse-phase HPLC, the retention time of the 5'-
DMTr terminated product is near to the retention time of the failure sequences and 
separation is not easily achieved. 
Several workers have attempted to modify the DMTr group in order to increase 
its hydrophobic character, see Fig. 2.1. Seliger and G6rtz 135 introduced para-
alkyloxy groups on triphenylmethylcarbinol (50). Letsinger and Fmnan 193 substituted 
one phenyl ring by a naphthyl group (51) but strong acidic conditions were required 
for deprotection, hence producing depurinated by-products. Later Fourrey a al. 136 
introduced the fluorescent pyrenyl group (52). However in all three cases only the 5'-
protected phosphoramidite monomer of thymidine has been successfully prepared. 
Because of the steric bulk of these protecting groups, the reaction with the 5'-
hydroxyls of purine nucleosides proved to be difficult. 
A = 
n = 7.9,11,13,15 
(50) 	 (51) 	 (52) 
Fig. 2.1: Hydrophobic 5'-OH protecting groups 
Recently, Ramage and Raphy 194 demonstrated that amino acid and peptide 
derivatives of tetrabenzo[a,c,g,i]fluorene (53), see Fig. 2.2, possess strong 
hydrophobic properties and were retained on porous graphitised carbon (POC). 
However these derivatives were base labile and therefore incompatible with the 
strategy used in the phosphoramidite chemistry for oligonucleotides. 
Tetrabenzo[a,c,g,i]fluorene, Thf, (53) nevertheless exhibited some interesting 
properties, e.g. strong hydrophobicity and fluorescence both of which could be 
usefully exploited in oligonucleotide synthesis. Subsequently we investigated 
tetrabenzo[a,c,g,i]fluorene (53) for the design of a highly hydrophobic 5'-hydroxyl 
protecting group useful in the purification of both short and long oligonucleotidei 
is 	 2 
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Fig. 22: Tetrabenzo[a,c,g,iJfluorene (TbJ) 
The strong hydrophobic character of tetrabenzo[a,c,gJ]fluorene  (53) can 
influence the polarity of its adducts but a 5'-hydroxyl protecting group requires further 
properties for practical use in the purification of oligonucleotides: 
- The protecting group would be regioselective for primary alcohols in order 
to leave the secondary 3'-hydroxyl of nucleosides unprotected. 
- Removal of the protecting group would be carried out under mild acidic 
conditions in order to minimize the depurination side-reactions. Hence the 
protecting group should be very acid labile. 
- The introduction of a chiral centre would complicate the purification of 
derivatives, therefore the protecting group should be achiral. 
- To avoid any chemical interaction with the oligonucleotide strand, the 
protecting group should not contain any reactive functionality. 
- The protecting group should be introduced under simple reaction conditions 
which do not affect the oligonucleotide, in order to be of practical use. 
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- The protecting group should be accessible in reasonable quantities, using 
optimised synthesis conditions. 
- Finally it would be a great advantage if the protecting group would confer 
crystalline properties to the protected nucleosides and therefore would ease 
theft purification. 
2.2 Tetrabenzo[ac,g,i]fluorene, Historical Background 
The design of a new hydrophobic protecting group for oligonucleotide synthesis 
was primarily based on a benzofluorene structure, see Fig. 2.3, because of their strong 
hydrophobic properties and theft reactivity at the methylene bridge, moreover they are 
known to have fluorescent properties. Polycycic aromatic compounds containing 
fluorene have been extensively described in the chemical literature. 195,196,197,198 
Monobenzofluorenes and dibenzofluorenes in particular have been reviewedl99.® 
and their preparation and chemical reactivity discussed. Perina et al.201 investigated 
the adsorption properties of benzo[c]fluorene  type derivatives on chromatographic 
supports. However the tetrabenzo[a,c,g,z]fluorene system (53) has not been 
considered in those respects. 
Ph 	 Ph 
Fig. 2.3: Benzofluorenes 
De Ridder and Martin reported the first synthesis of tetrabenzo[a,c,gj]fluorene (53) 
in 1960195.  The synthesis, shown in Scheme 2.1, required harsh conditions (e.g. 
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several hours > 260°C) and gave a poor yield (< 12%). Methyl-9-bromo-10- 
phenanthroate (54) underwent an Ullmann reaction at 265°C in the presence of 
copper to give dimethyl-9,9'-biphenanthryl-10,10'-dicarboxylate (55) in 80% yield. 
Base hydrolysis gave the corresponding diacid (56) which on treatment, with acetic 
anhydride gave the anhydride (57) which underwent pyrolysis to give 
tetrabenzo[a,c,g,i]fluorenone (58) in 60 to 75% yield. Tetrabenzo[a,c,gjjfluorene 
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Scheme 2.1: Synthesis of Tbf by De Ridder and Martin' 95 
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In a second synthetic mute, shown in Scheme 2.2, Martin et al.202 used milder 
reaction conditions. They prepared various benzofluorenes via the Wagner-Meerwein 
rearrangement of the fluorene structure. The synthesis of (60) was achieved by 
condensation of the potassium salt of ethyl-9-fluorenecarboxylate (59) and 9-
chiommethyiphenanthrene in 68% yield. The ester (60) was hydrolysed by potassium 
hydroxide in dioxane-methanol to give the corresponding acid (61) which in turn was 
cycised in the presence of phosphorus pentoxide under reflux in toluene to give the 
spiro ketone (62) in 60% yield. The ketone (62) was then reduced to the secondary 
alcohol (63) with lithium aluminium hydride in 90% yield. Fmally 
tetrabenzo[a,c,g,i]fluorene (53) obtained in 70% yield by dehydration and 
rearrangement of (63) with phosphorus pentoxide under reflux in xylene. Both routes 
involved several steps with moderate yield and difficult conditions, making it 






















Scheme 2.2: Synthesis of Tbf by Martin et al. 202 
Since these two synthetic routes were published, ca. 30 years ago, neither 
tetrabenzo[a,c,gjjfluorene (53) nor any of its derivatives have been reported in the 
literature in spite of their interesting properties. Recently, Ramage and Raphy 194 
synthesized three derivatives of tetrabenzo[a,c,g,i]fluorene:  17-ethoxycarbonyl 
tetrabenzo[a,c,gJ]fluorene (66), 17-hydroxymethyltetrabenzo[a,c,g,i]fluorene (67) 
and 17-methylenetetrabenzo[a,c,g,z]fluorene (68), see Scheme 2.3. For the synthesis 
of these molecules they used the procedure developed by Hopkinson a al. 203 for the 
synthesis of benzofluorenes via the rearrangements of a-alkoxycarbonyldiarylmethyl 
cations. Ethyl, 2-oxo-2-(phenanthren-9'-yl)acetate (64) was obtained in 63% yield by 
treating diethyl oxalate with 9-phenanthrenyl lithium at 0°C. Compound (65) was 
subsequently synthesized in a similar fashion using (64) as the keto ester component. 
The tertiary alcohol (65) was then treated with polyphosphoric acid at 140°C which 
led to the formation of the cyclic ester (66) in 49% yield. Reduction of ester (66) to 
the corresponding alcohol (67) was carried out at -65°C in DCM using DIBAL. 
Finally, the alkene (68) was obtained in 15% yield when treating the alcohol (67) with 
phosgene in the presence of a strong base such as triethylamine. Clearly the acidic 
proton at position 17 on tetrabenzo[a,c,g,i]fluorene means that basic reaction 
conditions produce the elimination product (68). Although a successful synthesis of 
the target compound (67) was achieved, a low overall yield (10%) after several 
chromatographic separations, made it unattractive for large scale preparations. 
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Scheme 2.3: Synthesis of tetrabenzo[a,c,g,ijfluorenyl-I  7-methanol 
Base labile derivatives of tetrabenzo[a,c,g,i]fluorene (53) such as described 
above were designed to be compatible with the peptide synthesis methodology. N-
tetrabenzo[a ,c,g , illfluorenyl-17-methyloxycarbonyl (Tbfmoc) derivatives of a-amino-
acids and peptides, see Fig. 2.4, were subsequently used in affinity purification on 
porous graphitised carbon (PGC). Oligonucleotide synthesis in general requires 
several base treatments (eg. phosphate deprotection), therefore Tbfmoc adducts 





R = -Peptide 
A = NHCHR'COOH 
Fig. 2.4: Tbfmoc derivatives of amino acids and peptides 
2.3 Synthesis of Tetrabenzo[a,cg,ijfluorene and Derivatives 
2.3.1 Novel Synthesis of Tetrabenzo[a,c,g,i]fluorene 
The only two available syntheses of tetrabenzo[a,c,g,i]fluorene  (53), described 
above, possess several drawbacks since they involve many low yield steps and 
somewhat harsh conditions. The need for a new synthesis was obvious. A more 
efficient synthesis of tetrabenzo[a,c,g,i]fluorene (53) was achieved involving 
organomagnesium reagents and the Hopkinson rearrangement of diarylmethyl cations. 
A Grignard reagent derived from 9-bromophenanthrene was generated in THE 
Following the addition of 0.5 equivalent of ethyl formate, the secondary alcohol (69) 
was isolated in 52% yield. When using methyl formate instead of ethyl formate, a 
slight improvement of the yield (60%) was observed. Under these conditions the 
carbonyl carbon is more accessible to the attacking nucleophile. The cycisation of 
alcohol (69) was attempted with various acids such as polyphosphoric acid, conc. 
sulphuric acid and aluminium chloride and thermally by heating the solid to melting; 
but proved to be unsuccessful. Finally a [2+2] cycisation of di(phenanthren-9-
yl)methanol (69) was achieved with trifluoroacetic acid in dichloromethane to give the 
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C. 
Fig. 2.5: UV spectra of (53) (a) and (70) (b) in DCM 
Although compound (70) had a similar melting point to the literature value for 
(53), 280-2820C, 195 and the mass spectrum showed the expected molecular ion at 
366, the proton nmr spectrum showed only one proton signal at 8 = 5.40 wm 
whereas (53) would require two. Moreover the aromatic signals in the proton nmr had 
a complex pattern when a simple pattern was expected for symmetrical 
tetrabenzo[a,c,g,i]fluorene (53). Also, the UV spectrum of (70) run in DCM was 
different from the spectrum of (53), see Fig. 2.5. The structure of (70) was finally 
assigned after taking into account the various possible intermediates that would be 
formed had the reaction proceeded according to the mechanism shown in Scheme 2.5. 
The isomerisation to (53) did not occur during the cycisation reaction because it 
would require an intermediate anti-aromatic cation. Tetrabenzo[a,c,g,z]fluorene (53) 
was formed in 90% yield through a base catalysed isomerisation. The overall yield 
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Scheme 2.5: Mechanism of cyclisation of di(phenanthren-9-yl)methanol (69) 
2.3.2 X-Ray analysis of Tbf and the Tbf/picric acid complex 
Tetrabenzo[a,c,g,ijfluorene (53) is insoluble in polar solvents, slightly soluble in 
DCM, chloroform and THF and soluble in benzene and toluene. Suitable crystals for 
X-ray analysis were obtained by recrystallisation from benzene. The crystal structure 
of Thf reveals several interesting features see Fig. 2.6 and Table 2.1. 
The molecule is symmetrical about the C2 axis. A significant twist between the 
two phenanthrene moieties indicates that the molecule is not planar. Responsible for 
iii: 
the non-planarity is the interaction between H8 and 1-19. Both protons are about 2.14A 
apart whereas the Van der Waal's radius for hydrogen is 1.2A. The twist can be 
defined by the dihedral angle between C8, C, C8b and C8c which has a value of 
14.50. When the torsion angles between atoms H8, C8, C, C8b,  C, C8d, C9 and 
1-19 are 00  then theoretical calculations indicate a H8-H9 distance of 0.62A which is 
nearly half the radius of one hydrogen atom. The molecule of 
tetrabenzo[a,c,g,z]fluorene is therefore chiral when it adopts a fixed orientation as in 
the solid state. 
Molecular formula C29H17 
Formula weight 365.4 
Crystal dimensions [mm3] 0.5 10.4 10.15 
Crystal system Monoclinic 
Cell dimensions a [A} 18.446(6) 
Cell dimensions b [Al 5.101(3) 
Cell dimensions c [A] 19.155(9) 
Cell dimensions a [°] 90.00 
Cell dimensions 5 [ C ] 90.86(3) 
Cell dimensions y [0] 90.00 
Melting point [*Cl 281 
Density 	k. EWcm31 1.35 
Z 4 
Table 2.1: Crystallographic information of tetrabenzo(a,c,g,ijfluorene 
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Fig. 2.6: X-Ray structure of tetrabenzo[a,c,g,ijfluorene (Tbf) 
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Fig. 2.7: X-Ray structure of the TbflPicric Acid Complex 
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The charge-transfer complex between phenanthrene and picric acid is known 
and its crystal structure has been determined by X-ray analysis. 204 Phenanthrene and 
picric acid molecules are stacked alternately along the C-axis making theft molecular 
planes parallel. Given the fact that polycydic aromatic hydrocarbons are active it-
donors 5 in general, Tbf and picric acid were co-crystallized in benzene and the 
crystals examined by X-ray analysis, see Fig. 2.7 and Table 2.2. The evidence of 
complex formation was visible; when a yellowish solution of Thf in benzene and a 
yellowish solution of picric acid in benzene were mixed together a dark red coloured 
solution appeared. The same observation was made between Thf and 2,4,6-
lrinitrobenzene although theft complex did not give satisfactory crystals for X-ray 
analysis. The crystal structure resolution started with the assumption that there was 
one picric acid molecule associated with each TV molecule but this proved to be 
wrong. During the crystallization in benzene, yellowish crystals and dark brown 
crystals were observed, the former being an excess of TV crystallising and the latter 
being the crystals of the complex; this also indicated that the complex did not 
crystallise in equimolar proportions. The dark brown crystals were then subsequently 
recrystallised separately to give the crystals finally used in the X-ray analysis which 
confirmed that two molecules of picric acid bind to one molecule of Thf. From Fig. 
2.7, it appeared that TV and picric acid molecules are both severely disordered in the 
crystal. The solvate, benzene, was also found in the crystal. It was found that the 
planes of Thf and picric acid have an intermolecular distance of 33A. The angular 
rotation about the axis perpendicular to the ring plane in the Thf molecule and 
between the two picric acid molecules are ±200.  The picric acid molecules do not lie 
directly in the same plane as their opposite phenanthrene moities in the Thf molecule 
but appear to have an angular twist of ±5.00.  The hydroxyl groups of the picric acid 
molecules were subject to pseudo three-fold symmetry which caused random 
delocalisation over the three possible sites; no significant intermolecular contact could 
be determined. 
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Two large electron intensities were located in position 17 of Thf, but neither 
could be modelled as hydrogens but instead appeared to fit in with two oxygen atoms 
which raised some questions. As outlined in section 2.3.3.3, position 17 is particularly 
reactive towards oxidation reaction even with air. The reactivity of methylene-bridged 
polyarenes and in particular their oxidation has been described. 2 Also X-ray analysis 
accounts for the avenge possible structural unit in reactive molecules. In this case the 
position of the two oxygen atoms may suggest that they belong to an intermediate of 
the oxidation reaction leading to tetrabenzo[a,c,g,i]fluorenone (58) (the C-O 
distances are ±1.20A). Besides, the high anisotropic values of the nitro groups 
indicated to a possible reaction in the crystal which was occuring between a nitro 
group and one of the 17-oxygens which moreover are closely separated by about 
2.4A. However, the fact that the site occupancies of the nitro groups were not likely 
to go beneath 1.0 was contradictory and lead us to conclude that there was no 
reaction proceeding in the crystal but that possibly a stable oxidation intermediate, 
was captured. Further confirmation  of these observation might have been obtained 
with the same crystal being subject to another X-ray analysis, but this could not be 
achieved. UV studies were unsuccessful as the charge-transfer complex is dissociated 
by greater solvation forces in the highly dilute conditions for UV measurements. 
Nevertheless we could prove that Thf can act as a it-donor in the formation of organic 
molecular complexes or charge-transfer complexes and that it presents the potential to 
be investigated in the search for organic semi-conductors perhaps. 
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Molecular formula C44H23 N6014 
Formula weight 859.63 
Crystal dimensions [mm3 ] 0.43 x 0.27 a 0.04 
Crystal system Triclinic 
Cell dimensions a [A] 6.89 1(5) 
Cell dimensions I, [Al 16.070(9) 
Cell dimensions c [A] 18.304(12) 
Cell dimensions a [°] 67.9 1(5) 
Cell dimensions 0 [1 82.18(5) 
Cell dimensions y [°] 82.72(5) 
Melting point [°C] 210 
Density Sc.  [g/cm3 ] 1.54 
Z 2 
Table 22: Crystallographic information of the Tbf/Pkric Acid Complex 
2.3.3 Chemical Reactions of Tetrabenzo[a,c,g,i]fluorene 
2.3.3.1 Formation of 17-Alkylated Tetrabenzo[a,c,g,i]fluorene 
In order to introduce additional properties to the Thf group, detailed in Section 
2. 1, an investigation of its chemical reactivity was undertaken. The first idea was to 
modify the Thf structure at the position 17 by introducing an alkyl chain containing a 
functionality during the formation of the ring system. Richter 207 used the 
cyclodehydration of benzilic acid and its derivatives with aluminium trichloride to 
synthesize fluorene-9-carboxylic acids. We undertook a similar approach when 
hydroxy-esters were synthesized via a Grignard reaction in a first step and 17-
tetrabenzo[a,c,gj]fluorenylallcyl esters by cyclodehydration in a second step. The first 
attempt shown in Scheme 2.6, involved the reaction of 0.5 equivalent of succinic 
anhydride with 1 equivalent 9-bromomagnesiumphenanthrene. But the y-hydroxy-
propanoic acid derivatives (7 1) could not be obtained; only the y-keto acid 
intermediate could be isolated in 8% yield. Keto-carbonyl band at 1670 air' distinct 
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from the acid carbonyl band at 1710 cm -1 and a mass spectrum peak at 278 confirmed 
the structure of the y-keto acid. The Grignard reagents were reacted with 
diethylnialonate but this also proved unsuccessful. Diethyl succinate has a more 
accessible carbonyl carbon and contains less acidic methylene protons than the 
malonate esters but its reaction with 9-bromomagnesiumphenanthrene failed to give a 
product either. Instead of the magnesium compound, 9-lithium phenanthrene was 
reacted with dimethylsuccinate but only phenanthrene could be isolated. Subsequently 
the synthesis of Tbf derivatives was investigated with the Thf ring structure already 
formed. 
'-.. 	 Br 	LMgTHF 
I 	 ii. Succinic anhydride 
iii. NHCI aq. 
(71) 
Scheme 2.6 
2.33.2 Nucleophilic Substitution 
The most significant feature is the attractive reactivity of the methylene group at 
position 17 where the hydrogen atoms are strongly acidic. This reactivity resembles 
the one observed for the methylene in position 9 of fluorene. 208.209  The acidity is 
attributed to the high stability of the cyclopentadienyl anion. This anion exhibits an 
aromatic character as the five-membered ring has two double bonds and the fifth atom 
possesses an unshared pair of electrons in an orbital perpendicular to the ring-plane. 
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The four it electrons of the double bonds and the unshared two electrons form an 
aromatic sextet. The relatively strong acidity of the methylene group was first used for 
Michael-addition reactions: 
1 7-Ethoxycarbonyltetrabenzo[a,c,g,ijfluorene (66), synthesized according to 
Ramage and Raphy, 194 was reacted with ethyl acrylate in the presence of a base, see 
Scheme 2.7. When potassium hydroxide was used as a base, the reaction did not 
proceed. It is possible that the hydrolysis of the ester interfered. However, the 
expected product (72) was obtained after 4 days in the presence of piperidine to give 
yellow crystals in 20% yield. Subsequent hydrolysis and decarboxylation was 
unsuccessful. 
Piperidine 





The Thf anion can also be generated from the reaction of 
tetrabenzo[a,c,g,i]fluorene (53) or 8bH-tetrabenzo[a,c,gj1fluorene (70) with n-
butyllithium at -78°C in THF. The subsequent reaction of ethyl acrylate with the 
organolithium compound (73) gave the adduct ethyl 3-(17'-
tetrabenzo[a,c,g,i]fluorenyl) propanoate (74) in 16% yield, see Scheme 2.8. When 
using an excess of butyl lithium in the formation of (73), ethylacrylate reacted in 
unimolecular proportions without forming any bis-17,17-(ethylpropionate) 
tetrabenzo[a,c,g,i]fluorene, therefore indicating a steric hindrance around carbon 17. 
In order to improve the yield we attempted to reduce the possibility of a 1,2-addition 
on the carbonyl group. The more hindered tert.-butylacrylate was used for this 
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purpose but failed to react. One should thaw attention on the fact that the available 
17-hydrogen is rendered more reactive in compound (66) due to the stabilising effect 
of the neighbouring ester group on the anion intermediate. Hence a better yield was 
obtained in the synthesis of ethyl- i 7-ethoxycabonyl-(17-tetrabenzo[a,c,gj]fluorenyl)-
3'-propionate (72) over ethyl 3-(17'-tetrabenzo[a,c,gJ]fluorenyl) propanoate (74) in 




















Scheme 2.8: Allcylation reactions with Tbf 
Oxetane, acmlein and 1,3-dibromopropane were also used as substrates in 
alkylation reactions with (73); neither of them gave any product. It was therefore 
decided to investigate more reactive substrates such as allyl bromide or benzyl 
bromide. 
The rate of formation of allyl or benzyl cations is relatively high and steric 
hindrance is low therefore nucleophilic attack is favoured. This point was confirmed 
when the tetrabenzo[a,c,g,i]fluoreny!  anion (73) was treated with allyl bromide and 
methyl-(para-bromomethyl)-benzoate (78). 1-( 1T-Tetrabenzo[a,c,g,i]fluorenyl)-prop-
2-ene (75) was obtained in 63% yield and methyl 4-(17'-
tetrabenzo[a,c,g,i]fluorenylmethyl) benzoate (76) in yields ranging from 60 to 71% 
after chromatographic purification, see Scheme 2.8. These two products are 
accessible in three steps with reasonable yields and possess reactive functionalities 
which can be used in further chemical reactions. Methyl-(para-bmmomethyl)-
benzoate (78) was synthesized from methyl-(para-methyl)-benzoate (77) via a free 
radical bromination reaction according to Scheme 2.9. Because of the electrophilic 
character of the bromine radical, the reaction almost exclusively proceeded at the 
electron richer methyl a to the the aromatic ring. 
80 
0 
CH3 N- Br 	Br 
40 
Rad., 77% 
COOGH3 	 COOCH3 
(77) 	 (78) 
Scheme 2.9: Brominadon of methyl-2-methylbenzoate 
23.3.3 Oxidation 
When the anion (73) is generated at -78°C with n-butyllithium, extreme care 
must be taken to remain under inert atmosphere. In the first experiments one could 
observe an intense red coloration in the reaction mixture. After isolation of the 
product by flash chromatography and analysis by mass spectrometry (M+ = 38 1) and 
infra-red spectroscopy (carbonyl band at 1700 cm -1 ) tetrabenzo[a,c,g,i]fluorenone 
(58) was identified. A more efficient deliberate synthesis of the ketone was 
subsequently developed, by stirring a solution of tetrabenzo[a,c,g,z]fluorene (53) in 
THF with sodium methoxide overnight in an open flask, see Scheme 2.10. 
Tetrabenzo[a,c,g,i]fluorenone (58) was isolated in 52% yield after purification as dark 
red crystal with poor solubility in most organic solvents. In the same manner as 
fluorene, oxygen in the air can oxidise Thf in the presence of a base to form (58). The 
mechanism for the formation of the ketone rather than hydroperoxide products from 
the reaction of the 17-Thf anion with molecular oxygen presumably involves intra- or 
intermolecular abstraction of a 17-proton of the intermediate (80) by the peroxy anion 















The reduction of tetrabenzo[a,c,g,z]fluorenone (58) was carried out with 
sodium borohydride in THF to produce a yellow solid, 17-
hydroxytetrabenzo[a,c,g,i]fluorene (79) in 71% yield, see Scheme 2.10. Neither 
compound (79) nor (58) fluoresced in contrast to Thf. 
2.3.3.4 Bromination 
Free radical bromination of the methylene group was readily achieved with N-
bromosuccinimide, a radical initiator and irradiation with a halogen lamp, see Scheme 
2.12. The reaction afforded 17-bromotetrabenzo[a,c,gj]fluorene (81) as a bright 
orange solid in high yield (75%). The fact that neither 17-
bromoteu-abenzo[a,c,g,i]fluorene (81), tetrabenzo[a,c,g,z]fluorenone (58) nor 17- 
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hydroxytetrabenzo[a,c,g,ilfluorene (79) were fluorescent, enables us to conclude that 
substitution of Thf by a heteroatom results in the disappearance of fluorescence. The 
attempt to prepare the Grignard reagent of (81) in either diethylether or THF failed, 
therefore one can summarise that the space available around the methylene group 
does not allow the somewhat bulky formation of the magnesium-solvent complex. 
Instead bromine was used for its good leaving group properties in nucleophilic 
substitution. 17-Bromotetrabenzo[a,c,g,z]fluorene  (8 1) was reacted with methyl-para-
hydroxybenzoate according to Scheme 2.12. The phenoxyether methyl 4-(17'-
tetrabenzo[a,c,g,i]fluorenyl)oxybenzoate (82) was obtained in 26% yield as a bright 









2.4 Synthesis of Tetrabenzo[a,c,g,i]fluorenyltrityl Derivatives 
As a general starting material in the design of a 5'-hydroxyl protecting group for 
nucleosides, methyl 4-( 1 7'-tetrabenzo[a,c,g,z]fluorenylmethyl) benzoate, compound 
(76) was chosen. Its trityl derivatives can be directly formed via a Grignard reaction. 
Tetrabenzo[a,c,g,i]fluorene-trityl compounds would fulfil the requirements outlined in 
section 2.1 for the design of a 5'-hydroxyl protecting group, in particular the 
selectivity for primary alcohols. Moreover the well known chemistry of the trityl 
group as a protecting group can be adapted to these new nucleosidic derivatives. 
The Grignard reaction of ester (76) with 2 equivalents of bromobenzene was 
first investigated, see Scheme 2.13. The triphenylcarbinol derivative, 4-(17'-
tetrabenzo[a,c,gJ]fluorenylmethyl) -trityl alcohol (83), was obtained in 63% yield as a 
white, crystalline, fluorescent compound. Before the thtyl alcohol derivative (83) 
could be used as a protecting group, the trityl chloride equivalent had to be generated. 
The latter compound, 4-(17'-Tetrabenzo[a,c,g,i]fluorenyhnethyl)-trityl chloride (85), 
was synthesized according to the methodology used for trityl chloride. 210 From (83) 
and an excess of acetyl chloride in benzene or cyclohexane 4-(17'-
tetrabenzo[a,c,g,i]fluorenylmethyl)-trityl chloride (85) was isolated in 88% yield after 
recrystallisation in benzene. In order to increase the reactivity two electron donating 
methoxy groups were added to form dimethoxytrityl derivative (86) which was 
synthesized in a similar fashion from the ester (76) and 4-(17'-
tetrabenzo[a,c,g,z]fluorenylmethyl)-4",4"-dimethoxytrityl alcohol (84) in 16% yield 
overall starting from 9-bromophenanthrene. [Compounds (83) and (85) have been 
abbreviated Thf-Tr-OH and Thf-Tr-Cl respectively; compounds (84) and (86) Thf-
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Scheme 2.13 
The crystallization of Thf-DMTr-OH (84) enabled single crystals, satisfactory 
for X-Ray analysis, to be prepared. Fig. 2.8 represents molecule (84) in the solid 
state; the crystallographic information is presented in Table 2.3. The crystal structure 
presents the same twist between the two phenanthrenyl groups as in the molecule of 
tetrabenzo[a,c,g,ijfluorene ( 53) along the C2 axis. The dihedral angle measured 
between C8, C8a, C8b and  C8c  with a value of 15.5° is 1° greater than in the 
tetrabenzo[a,c,g,i]fluorene molecule. The value of the angle between C 17 , C 18 and C4 , 
is 113.2°, thus greater than a sp3 carbon bond angle. The trityl group is 
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Figure 2.8: Crystal structure of Tbf-DMTr-OH (84) 
86 
Molecular formula C51 H3803 
Formula weight 698.3 
Crystal dimensions [mm 3 ] 0.08 x 0.08 x 0.39 
Crystal system Monoclinic 
Cell dimensions a f 	1 13.6213(22) 
Cell dimensions b [Al 14.530(6) 
Cell dimensions c [A] 18.422(11) 
Cell dimensions a [0] 90.00 
Cell dimensions A[°] 99.71(3) 
Cell dimensions y[0] 90.00 
Melting point [°C] 210 
Density s.  [g/cm3 ] 1.291 
Z 	. 4 
Table 2.3: Crystallographic information for Tbf-DMTr-OH (84) 
Later, we attempted to generate a TV trityl derivative starting from 17-
ethoxycarbonyl tetrabenzo[a,c,g,i]fluorene (66) originally synthesized by Rainage and 
Raphy 194 and kindly donated by S. Irving. 211 Compound (66) underwent a Grignard 
reaction with 2 equivalents of benzenemagnesium bromide but failed to form the trityl 
derivative, 1,1 -bis(phenyl)- 1 '-tetrabenzo[a,c,g,i]fluorenyl-methanol  (88), Scheme 
2.14. Analytical data, mass spectra (peak at 470) and IR (C=O band 1705 cm -1 ) 
indicated the presence of the intermediate ketone (87) in the reaction mixture. The 
elimination product that could be formed from compound (88), was not detected in 
the mass spectra. Consequently the compound is probably too hindered for a second 
addition of a benzene ring onto the carbonyl function to occur. 
Benzenemagnesium bromith 
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Scheme 2.14 
2.5 Tbf-Trityls as 5'-Hydroxyl Protection for Nucleosides 
2.5.1 5'-Hydroxyl Protection 
In order to investigate the possibility of using the Thf-Trityl group for 5'-
hydroxyl protection, it was necessary to synthesize a nucleotide monomer which 
would then be converted into an oligonucleotide. It was decided that thymidine would 
be the most convenient nucleoside to employ for these studies as it could be used 
without having to consider exocyclic-amine protecting groups. 
The Thf-Tr and Thf-DMTr groups were introduced into the nucleoside via their 
chloride. These reacted with the 5-hydmxyl function to form an ether linkage, 
following a 5N1  mechanism. The irityl cation intermediate is mesomei4tbilized due 
to the delocalization of the positive charge over the aromatic system. For sterical 
reasons a Walden inversion 212 following an SN2  mechanism is improbable, 
furthermore the reaction seem to proceed better in polar solvents (stabilization of the 
ionic intermediates). The primary hydroxyl reacted much faster than the secondary 3'- 
hydroxyl and so very little of the 3'-protected or 3',5'-protected products were 
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observed. This result was expected as primary hydroxyl groups are more nucleophilic 
than secondary hydroxyls. The yields of the 5'-protected thymidine obtained from this 
reaction were moderate when compared to that obtained when 4,4'-dimethoxytrityl 
chloride DMTr-Cl is used because of the difference in the steric bulk. Following this, 
the phosphoramidite thymidine monomer was prepared in high yields from N,N-
diisopropyl $-cyanoethyl phosphoramidyl chloride, according to the procedure 
developed by McBride and Caruthers. 68 The reaction scheme leading to the 
phosphoramidite monomer is shown in Scheme 2.15. 
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2'-Deoxythymidine was protected using Thf-Tr-C1 (85) and Thf-DMTr-Cl (86) 
in pyridine with the presence of triethylaniine as a base and DMAP as a nucleophilic 
catalyst,213 to give the corresponding 5'-protected nucleoside (89) and (90). After 
optimisation of the reaction conditions, a yield of 35 and 40% after chromatographic 
separation for 5'-O-(4-(17"-tetrabenzo[a,c,g,i]fluorenylmethyl)-trityl)-thymidine (89) 
and 	5'-O-(4-( 1 7"-tetrabenzo[a,c,g,iJfluorenylmethyl)-4",4"-dimethoxytrityl)- 
thymidine (90) respectively was obtained. The 5'-protection reaction had to be carried 
out under strict anhydrous conditions in order to avoid hydrolysis of the reactive 
species. The original reaction was carried out in pyridine, but very low yields were 
obtained. When heated up the reaction mixture turned dark and gave several by-
products (3'- and 3'-5'- substitution). The yield was improved by the addition of a 
stronger base, thethylamine, and a catalyst DMAP 213 but the most significant 
improvement was observed when the reaction was carried out in a concentrated 
medium, therefore increasing the absolute rate of the reaction. In the latter reaction 
over 90% of the unreacted protecting group reagent could be regenerated from the 
chromatographic fractions. Thus, despite of the lower yields obtained for the 5'-
protection reaction, compared to DMTr-Cl (80-100%), Thf-Tr-Cl or Thf-DMTr-Cl 
can act as suitable protecting groups for the selective protection of primary hydroxyls. 
The synthesis of the phosphoranildite (91) was performed under thy, oxygen free 
conditions in order to obtain the product in the highest purity possible. N,N-
diisopropyl j3-cyanoethyl phosphoramidyl chloride was reacted with the 5'-protected 
nucleoside (90) with hydrogen chloride being eliminated, to form a phosphite bond 
onto 	the 	3'-hydroxyl 	function. 	The 	phosphoraniidite, 	5'-0-(4-(17"- 
tetrabenzo[a,c,gj]fluorenylmethyl)-4",4"-dimethoxytrityl)-thymidjne-3'-O-N,N-
diisopmpyl--cyanoethyl phosphoramidite (91), was isolated as an oil which could be 
precipitated with n-hexane to give a white powder that can be stored for several 
months in a freezer without decomposition. 31P nmr of this product gave two peaks at 
148.51 and 148.03ppm corresponding to the diastereoisomeric mixture. 
Decomposition products in particular phosphonate by-products were observed in the 
region of +15ppm. Compound (91) is only partially soluble in acetonitrile at the 
concentration normally used on DNA synthesizers (0.1 M) but was found to be very 
soluble in DCM. The phosphoramidite derivative of the less acid labile protected 
nucleoside (89), was not prepared in this instance but its synthesis would proceed 
under similar conditions. The coupling of Thf-DMTr-Cl (86) to deoxycytidine and 
deoxyadenosine was attempted under similar conditions than thymidine. Some adduct 
could be seen by t.l.c of the crude but was too little to be recoverable. 
2.5.2 Deprotection Study 
The deprotection rates of the newly protected thymidine, compound (89) and 
(90) were compared with the deprotection rate of the commonly used 5'-DMTr-
thymidine nucleoside. The deprotection was carried out under acidic conditions. The 
acid labile Thf-Trityl group generates a colourful (deep orange) carbocation the 
absorbance of which at 500 nm was measured against time, see Fig. 2.9. The 
deprotection study was carried out at 50°C in 80% acetic acid/acetonitrile. Under 
these conditions, the kinetics of deprotection could be examined over a realistic time 
scale. The deprotection was considered as a pseudo-first order rate reaction. The 
irreversibility of the reaction being a function of the reaction co-ordinate, we used an 
excess of acid for the reaction to go practically to completion. The apparent rate 
constant were calculated according to: 
Ln((l-A)/A) = -kit 
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Where A. is the absorbance at infinite time and At is the absorbance at time (t). The 
values for A. and At were taken from the polynomial curvefit of Fig. 2.9. The 
reaction rate k was obtained from the gradient of Ln((1-A)/A ) against t. The 
results are summarised in Table 2.4. 
Compound 10-3.k Es-1 1 'r [s] A, 
5'-DMl'r-T 1.8 ± 0.1 385 1.0752 ± 0.012 57.88.10 
5'-Thf-DMTr-T (90) 3.7 ± 0.1 187 0.6094 ± 0.005 7.40-10-5  
5'-Thf-Tr-T (89) not detected - - - 
Table 2.4: Deprotection study results 
Comparing the rate constant values k for the deprotection of thymidine in 
DMTr-T and Thf-DMTr-T, protecting group Thf-DMTr was found to be twice as 
acid labile as DMTr-T under the same conditions. The half-time life t of a first order 
reaction is independent of the initial concentration of the reactant and are obtained 
from the equation t = (Ln 2)/k. From the results in Table 2.4, half the concentration 
of DMTr-T is deprotected after 385 s and half the concentration of Thf-DMTr-T is 
deprotected after 187 s under the experimental conditions described above. This result 
was expected as the methylene group between TV and trityl has inductive electron-
donating properties, making the compound more acid labile. On the other hand the 
rate of deprotection of compound (89) could not be determined under the same 
conditions as it is much lower than the rate of (90) and 5'-DMTr-T. The rate of acid 
cleavage was studied by Khorana; 121 he found that each p-methoxy substituent 
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Fig. 2.9: UV deprotection study of 5'.DMTr-T (a) and 5'-Tbf-DMTr-T (IL') 
2.6 Synthesis of 5'-Tbf-DMTr-Oligodeoxyribonucleotides 
2.6.1 Coupling of 5'-Tbf-DMTr-T-phosphoramidite 
As previously reported in section 2.5.1, the 5'-Thf-DMTr-protected thymidine 
was successfully activated for the solid phase phosphoramidite oligonucleotide 
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synthesis cycle. Subsequently a series of oligonucleotides were synthesized using the 
standard protocol for the -cyanoethyl-phosphoramithte chemistry delivered by ABI 
for their Model 380 DNA synthesizer, see Appendix I. Phosphoramidite (91) was 
used as a 0.1 M solution in acetoniirile/DCM : 9/1 and was connected to the 
synthesizer. The synthesis of oligonucleotide was carried out on a 1 p.mol scale on 
CPU supports. The reactivity of the phosphoramidite (91) was first determined 
qualitatively by synthesizing a polythymidine, 5'-Thf-DMTr-dffl12 (92), using 5'-O- 
(4-( 17"-tetrabenzo[a,c,g,ijfluorenylmethyl)-4",4"-dimethoxytrityl)-thymidine-3'-O-
N,N-diisopropyl-(3-cyanoethyl phosphoramidite (91) in the final monomer addition, 
thus only the desired sequence would bear the fluorescent protecting group. Later a 
randomly selected 6-mer (93) sequence was synthesized in a similar fashion. The 
sequences were as follows: 
5'-Thf-DMTr-1TF-TVF-1TF-1T7-3' 
5'-Tbf-DMTr-TAG-CGT-3' 
In order to increase the coupling efficiency, the coupling time for monomer 
(91) was prolonged to 5 min instead of the usual 30 s. In each case we obtained a 
crude oligonucleotide solution in ammonium hydroxide that was strongly fluorescent 
under UV light (254 nm). This qualitative observation was a clear indication that the 
modified thymidine monomer (91) had coupled to the solid supported oligonucleotide 
chain. As expected control sequences that were left with the standard DMTr group at 
the 5-end did not fluoresce. 
A more thorough investigation was undertaken when oligodeoxyribonucleotides 




5 c'TbTaT3' (1' represents the phosphoramidite 
thymidine monomer protected with Thf-DMTr at the 5'-
hydroxyl, see page 97) 
5'-Tbf-DMTr substituted oligonucleotide (94) was compared to a control 
oligodeoxyribonucleotide (95) bearing DMTr at the 5'-end. Both products were 
deprotected in concentrated ammonia according to the standard protocol and analysed 
by RP-HPLC where the retention times were consistent with the hydrophobicity order 
of the two protecting groups. Fig. 2.10 (a) shows the crude control oligonucleotide 
(95) after ammonia evaporation anj Fij 2.10 (b) the Thf-DMTr bound 
oligodeoxyribonucleotide (94). In both spccutl 'iai1ure sequences elute at —32% 
buffer B (see section 3.1) or after 9 to 11 mm. The more hydrophobic products elute 
at 65% buffer B (see section 3.1) or 21 min in the case of (95) whereas the highly 
hydrophobic oligodeoxyribonucleotide (94) elutes after 10 min at 100% buffer B (see 
section 3.1). One other important advantage of Thf-DMTr substituted 
oligonucleotides is that they can be detected at 365 rim as shown in Fig. 2.11. These 
observations demonstrate that the addition of the TV moiety to DMTr increases the 
lipophilic character of synthetic oligonucleotides drastically and enables detection at 
UV wavelengths which do not damage DNA. The use of this protecting group could 
therefore be useful in RP-HPLC chromatographic purification of crude 
oligonucleotide mixtures. 
95 
(a) 	 lime 	(1)) 	 - 	 Tune 
Fig. 2.10: (a) RP-HPLC spectra of (95) Gradient I, 
(b) RP-HPLC spectra of (94) Gradient III at 280 nm 
lime 
Fig. 2.11: RP-HPLC spectra of (94) at 365 nm, Gradient II! 
A quantitative measurement of overall yield was taken from the integration over 
the HPLC peaks. A yield of 85% is considered to be normal for the synthesis of a 12-
met oligonucleotide when an average coupling yield of 98% is achieved. For the 
DMTr bound oligonucleotide (95), 85% yield of the major peak was obtained 
whereas the product peak of Thf-DMTr bound oligonucleotide (94) yielded only 
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60%. Similar RP-HPLC patterns were obtained for various other sequences and 
different monomer batches. These observations show conclusively that the coupling of 
the final Thf-DMTr-monomer (91) proceeds with poor efficiency. The two sequences 
and (94) were subsequently deprotected in 80% acetic acid/water for 30 min and 
an equal sample of both solutions was co-injected in the HPLC to give one single 
peak after 11 rnin with Gradient II (see section 3.1), thus indicating that the two 
sequences were identical. 
In order to determine the exact coupling efficiency of monomer (91), sequence 
was synthesized. 'Ta 'Tb and  'Tc  represent the phosphoramidite thymidine 
monomer protected with Thf-DMTr at the 5'-hydroxyl (91); a,b or c is the order of 
addition. The coupling efficiencies of each coupling step could be determined by 
comparing the UV absorbance of the released Thf-DMTrityl carbonium ion liberated 
after each 5'-deprotection in the synthesis process. The yellow detritylation solutions 
were diluted in 0.1 M p-toluene sulphonic acid in acetonitrile and the absorbance 
measured at 500 nm. The oligonucleotide required three additions of the monomer, 
resulting in two measurable coupling yield. The results of two experiments carried out 
with different coupling times are shown in Table 25. 
Coupling time Absorbance of Thf- Coupling yield of Coupling yield of 
[min) Trityl cation 'Tb [%] 'Tc [%] 
a: 0.317 
5 b:0.224 71 88 
c:_0.197 __ 
0.284 
15 0.232 82 72 
c:_0.167  __ 
Table 2.5: Coupling efficiency of the 5'-Tbf-DMTr-Tphosphoramidite (91) 
The poor coupling efficiencies observed by RP-HPLC were again confirmed by 
this more accurate method. Even when trebling the reaction time from 5 to 15 mm, 
coupling efficiencies ranging from 71 to 88% were obtained. The discrepancy in the 
yields compared to the yields normally obtained with DMTr-protected nucleosides, is 
difficult to explain but we suggest that the bulky structure of the monomer (91) is the 
cause for low coupling yields. Moreover with this approach, four additional ports for 
the four modified Thf-monomers would have to be available on commercial DNA 
synthesizers, unfortunately complicating their machine design. Therefore in the 
general use of Thf-DMTr-monomer, the problem of low coupling yields and 
additional engineering on synthesizers had to be resolved. 
2.6.2 Reaction of Tbf..DMTr-CI on Solid Phase 
The preparation of phosphoramidite nucleotidic monomers requires a certain 
amount of care, as anhydrous and inert atmosphere conditions are required. These 
compounds are rather unstable and a fresh solution of a phosphoramidite monomer 
has to be used within 5 days of first usage otherwise unwanted by-products such as 
phosphonates and phosphate are formed. The synthesis of these compounds involves 
two steps: 5'-hydroxyl protection and phosphitylation. Thf-DMTr-monomers are only 
used once at the end of the chain elongation cycle and are therefore used infrequently 
when compared to the DMTr-monomers. To overcome these obstacles, the Thf-
DMTritylation reaction was attempted on the 5'-end of the oligodeoxyribonucleotide 
while still attached to the support, usually CPG. As there was no reference in the 
literature of a solid phase tritylation reaction with oligonucleotides; we first 
investigated this reaction with the commercially available DMTr-Cl. The following 
two oligonucleotide sequences were first synthesized: 
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5'-DMTr-TGC-AA-3' (Auto Tritylation) 





Fig. 2.12: Manual DMTrUylation on a DNA column 
Sequence (97) was synthesized according to the standard protocol in the "Trityl-on" 
mode where the 5'-DMTr group is left intact at the end of the synthesis, see Appendix 
I. The synthesis scale was 0.2 Rmol with a CPC support. Oligodeoxyribonucleotide 
(98) was synthesized in the "Trityl-off' mode (removal of the 5'-DMTr group at the 
end of the synthesis) so that a tritylation reaction with DMTr-Cl and the free 5'-
hydroxyls was carried out subsequently with the help of two syringes connected to 
each end of the column, see Fig. 2.12. The syringes contained a 0.5 M solution of 
DMTr-CI in dry pyridine which was flushed through the column over 2 h, in order to 
perform the tritylation reaction (see section 3.4). After a thorough wash of the column 
with pyridine and acetonitrile, it was remounted onto the synthesizer and the product 
was cleaved off the support with concentrated ammonium hydroxide. The ammonia 
used for the cleavage and deprotection was then removed by evaporation or 
liophilisation. It is important to note that the DMTr group is unstable to heat and acid. 
Therefore, evaporation should be done at room temperature, a drop of triethylamine 
should be added periodically throughout the evaporation process as a precaution. 
After the samples were dried, they were redissolved immediately in 1 or 2 ml of the 
HPLC buffer. Then, the oligonucleotides (97) and (98) were compared by RP-HPLC 
with Gradient I (see Section 3.1) and showed identical patterns as seen in Fig. 2.13 
and 2.14. After peak integration similar yields were obtained for both syntheses. 
°0IminI 
Figure 2.13: RP-HPLC of (97) 	Figure 2.14: RP-HPLC of (98) 
Following these results, longer oligodeoxyribonucleotides of 12 and 30 
monomer units of random sequences were synthesized according to the same 
procedure. The yields obtained are presented in Table 2.6. AUTO tritylation is 
indicative for DMTr-oligonucleotide synthesized with the "Trityl-on" mode and 
MANUAL tritylation is indicative for DMTr-oligonucleotide synthesized with the 
"Trityl-off" mode and tritylated with the syringe method described in Section 3.4. 
Clearly, the solid phase DMTritylation of the 5-hydroxyl of an oligonucleotide bound 
to CPCI, is equally efficient when performed post-synthetically as when introduced by 
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a DMTr-monomer during the synthesis cycle. Also, the size of the oligonucleotide has 












DMTr 5 8 92 93 
DMTr 12 34 84 83 






OD units of 
crude (a) 
HPLC Yield 
[% area]  
Theor. Yield 
DMTr 5 9 92 93 
DMTr 12 17 84 83 
DMTr 30 41 60 64 
OD units measured at 260 nm. 
Theoretical yield calculated with 98.5% yield/coupling step. 
Table 2.6: Comparative study of the 5'-OH DMTritylation 
In an identical manner, we synthesized compound (99) and (100) and compared 
the reactivity of Thf-DMTr-Cl and DMTr-Cl on a support bound oligonucleotide. 
(99) : 5'-DMTr-TGC-AA-3' (Manual Tritylation) 
(100): 5'-Tbf-DMTr-TGC-AA-3' (Manual Tritylation) 
Both oligonucleotides were synthesized with the "Trityl-off' mode and were 
subsequently manually reacted with a 0.5 M pyridine solution of their respective 5'-
hydroxyl protective group. The reaction time was set to 2 h. 0.5 M Solutions of Thf-
DMTr-Cl were close to saturation and happened to crystallize with fluctuations in 
ambient temperatures; 0.4 M solutions were later used giving the same results. Both 
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products were analysed by RP-HPLC and gave similar yields according to HPLC peak 
integration. Subsequently we repeated the experiment for longer oligonucleotides as 
summarised in Table 2.7. The results obtained demonstrate that Thf-DMTr-CI reacts 
as efficiently as DMTr-C1 on a support bound oligonucleotide in spite of its greater 
steric bulk, perhaps this is compensated for by a higher chemical reactivity. The 
substitution of the 5'-hydroxyl of oligonucleotides with 0, C or A as the terminal unit, 
was also investigated and gave comparable product quality. This method of 
introduction of the Thf-DMTr group onto an oligonucleotide proceeds to completion 
in all cases, possibly due to the vast excess in Thf-DMTr-CI used (-1000 equivalents) 
and therefore makes the solution phase approach using the monomer (91) much less 
attractive. Although Thf-DMTr-oligonucleotide were successfully synthesized by 
automated addition of Thf-DMTr-Cl, a stability test showed that Thf-DMTr -
Cl/pyridine solution turned dark brown and became inactive after 1 thy. It is therefore 













DMTr 5 9 92 93 
DMTr 12 17 84 83 
DMTr 30 41 60 64 
Tbf-DMTr 5 9 89 93 
Thf-DMTr 12 44 82 83 
Tbf-DMTr 30 69 57 64 
OD units measured at 260 run. 
Theoretical yield calculated with 98.5% yield/coupling step. 
Table 2.7: Comparative study of the Tritylation of 5'-OH 
with DMTr-Cl and Tbf-DMTr-Cl 
TON 
In conclusion, an alternative method to introducing Thf-DMTr as a 5'-terminal 
group has been developed. A single reagent: Thf-DMTr-CI is used for A, C, T or G 
terminated oligonucleotides of various lengths thus avoiding the complicated 
preparation of phosphoranñdite monomers. Moreover the addition of this new 
protecting group can be automated. The fluorescent properties of this protecting 
group facilitates the detection, especially at wavelengths > 300 run. The application of 
this methodology to DNA sequences longer than 50 units is described in section 2.9. 
2.7 Purification of Short Oligonucleotides 
In section 2.2, the Thfmoc group developed by Ramage and Raphy 194 was 
described as an affinity based Na-protecting group for peptides. This protecting 
group improved the purification of crude peptides by affinity chromatography on 
Porous Graphitised Carbon (PGC) columns. PGC acts as a very strong adsorbent for 
polycyclic aromatic structures, it has been studied in detail by Knox 214 ' 215 ' 216 for use 
in liquid chromatography. The Thfmoc group is based on tetrabenzo[a,c,gfluorene 
(53) and likewise is Thf-DMTr, we therefore investigated the purification of 
oligonucleotides by PGC affinity chromatography. Preliminary experiments were 
designed to show the affinity of the Thf-DMTr group to PGC. 5'-Thf-DMTr-
thyniidine (90) and commercial 5'-DMTr-thymidine were dissolved in equimolar 
amounts in methanol and then PGC powder was added and stirred for 10 mm. This 
experiment was monitored by RP-HPLC at 264 nm so that two peaks 1 and 2 were 
observed before the addition of carbon, the peak with the longer retention time 2 
being the more lipophilic 5'-Thf-DMTr-thymidine (90) as shown in Fig. 2.15 (a). Thf 
contributes greatly to the absorbance of (90) hence the greater intensity for peak 2. 
When a sample of the supernatant solution after PGC addition was injected, a single 
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peak was observed at a retention time corresponding to 5-DMTr-thymidine, see Fig. 
2.15 (/4. A total retention of compound (90) was achieved clearly demonstrating the 





Fig. 2.15: Affinity of Tbf-DMTr to PGC; (a) before (b) after addition of PGC 
Encouraged by the above results, we tried to purify a crude oligonucleotide 
bearing the Thf-DMTr group at the 5'-end. For reasons of economy and simplicity, a 
1 smol scale batch of a 5'-Thf-DMTr-(dT) 12 was synthesized and used in the PGC 
affinity experiments. PGC was kindly donated by Knox, 217 and had the following 
physical properties: particle size = 50-100 gm; specific surface area = 68 m 2-g-1 . An 
aliquot of an aqueous solution of the crude oligonucleotide was stirred with PGC 
powder. 10 to 40 % of dioxane was usually added in order to increase the 
homogeneity of the solution with PG C. Dioxane and tetrahydrofuran were described 
by Knox and Kaur214 to have a greater eluotropic strength than acetonitrile or 
methanol in PGC chromatography. The experiments were monitored by HPLC, 
injecting a sample of the supernatant. We found that a weight ratio of oligonucleotide 
to PGC of 1:3, was necessary to have complete adsorption of the Thf-DMTr bound 
thymidine. The absence of Thf-DMTr material in solution was also confirmed by the 
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disappearance of fluorescence under UV light. Following this, the suspension was 
filtered to remove the by-products and the PGC was washed with dioxane/water. The 
PGC bound oligonucleotide was then treated with a 2% water/dioxane solution of 
TFA to be freed into solution. Deprotection times between 5 min and 2 h were 
investigated as well as acid concentrations from 2-100 %. The polarity of the solution 
was varied by using mixtures of water/dioxane, water/acetonitrile but unfortunately no 
free oligonucleotide could be detected in the supernatant. It appeared that 
oligonucleotides tend to be adsorbed irreversibly to PGC. At this stage we did not 
carry out a more thorough investigation but concentrated instead on the highly 
hydrophobic character of Thf-DMTr in the scope of an alternative purification 
procedure for synthetic oligodeoxyribonucleotides. 
Reverse phase silica chromatography for example separates a mixture of 
compounds according to theft hydrophobicity. A simple purification method, based on 
the fact that Thf-DMTr attached oligonucleotides are much more hydrophobic than 
free oligonucleotides, was developed. This method makes use of 1.5 cm long 
polypropylene cartridges, packed with 250 mg C18 silica gel, available commercially 
from Waters under the brand name SEP-PAK. These small and cheap columns are 
normally used for desalting peptide solutions. Each of them contain an inlet and an 
outlet which can be connected to a syringe. In a first instance we determined at which 
solvent polarity failure sequences (impurities) and Tbf-DMTr-bound oligonucleotides 
would elute. By using analytical HPLC, we carried out a series of isocratic runs from 
5% to 45% acetonitrile (or 45% to 5% 0.1 M aqueous ammonium acetate), with the 
following crude oligonucleotide (Fig. 2.16 (a)): 
5'-Thf-DMTr-flC-GAG-CCA-TAT-3' 
The failure sequences started to elute with 5% acetonitrile and finished eluting 
with 10% of acetonitrile. The Thf-DMTr-oligonucleotide did not elute until 40% of 
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acetonitrile. We were then able to use the correct solvent polarity for the isocratic 
purification of oligonucleotides on SEP-PAK cartridges. About 20 OD units of the 
crude oligonucleotide were loaded onto a cartridge and the elution was monitored by 
analytical HPLC, see Fig. 2.16. The best loading was obtained with a flow rate of 
about 1 drop every 2 s. Under UV light, at 254 run, a clear narrow fluorescent band 
could be detected on the top layer of the silica cartridge. The deletion 
oligonucleotides were eluted with 10% acetonitrile/90% 0.1M aqueous ammonium 
acetate without any of the Thf-DMTr-oligonucleotide, as shown on the HPLC trace in 
Fig. 2.16 (1'), Rt = 10.5 mm. The pure oligonucleotide was finally eluted with 20% 
acetonitrile/80% 0.1M aqueous ammonium acetate, retention time = 10.5 mm, after 








Fig. 2.16: Purification on a SEP-PA K cartridge 
This purification method was repeated with various 0.2 j.tmol batches of 12-mer 
oligonucleotide as well as a 1 p.mol batch 6-mer, the same efficiency was obtained in 
each case. Subsequently a 7 point procedure for the purification of short 
oligonucleotides on C18 silica gel SEP-PAK cartridges was drafted: 
Flush the SEP-PAK cartridge with 5 ml acetonitrile, followed by 5 ml 0.1 M 
aqueous ammonium acetate with a properly adapted syringe. 
Take the crude ammonia solution, evaporate it, and dissolve the crude 
oligonucleotide in 2 ml of 0. 1M ammonium acetate. Place the solution in the 
syringe and slowly push it through the cartridge. 
Slowly wash the cartridge with 2 x 5 ml of 10% acetonitrile/90% 0.1M 
ammonium acetate. 
Wash the cartridge with 5 ml of deionized water. 
Push in ca. 2 ml of a 2% solution of trifluoroacetic acid in water to deprotect 
the Thf-DMTr bound oligonucleotide, and wait 10 mm. A yellow coloration 
should appear. 
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Flush the cartridge with 5 ml of deionized water. 
Elute the purified oligonucleotide with 2 ml of 20% acetonithlel80% 0.1 M 
ammonium acetate 
The purification method described above has also been carried out with DMTr 
bound oligonucleotide but gave inconsistent results. The fact that Thf-DMTr is much 
more lipophilic than DMTr and consequently that failure sequences elute nearer to 
DMTr-oligonucleotides, allows to be more flexible in the solvent polarity choices 
when using Thf-DMTr as the protecting group. The purification of an oligonucleotide 
is reduced to 15 mm, instead of 2 h on preparative HPLC. Although the purification 
of longer and more valuable oligonucleotides (> 20-mer) could be envisaged, it is 
generally preferable to use preparative RP-HPLC in order to avoid any loss of 
material. 
We purchased similar cartridges from Applied Biosystems but packed with 
polystyrene beads. Polystyrene has the advantage over C18 silica gel to be stable at 
pH > 10. Hence the loading of the ammonia solution (denaturing conditions) 
containing the crude oligonucleotide could be envisaged. The purification of the 12-
mer oligonucleotide mentioned above was carried out using the same protocol as for 
SEP-PAK cartridges. Fig. 2.17 shows the HPLC trace of the eluates after removal of 
the truncated sequences (a) and after deprotection with TFA (b). A small amount of 
Thf-DMTr bound oligonucleotide broke through the polystyrene column but could be 
reloaded by passing the eluate through the column once again. This breakthrough is 
probably due to the poor packing of the cartridges. The free oligonucleotide could be 
eluted as a single peak, therefore demonstrating that this purification method is also 







Fig. 2.17: Purification with a polystyrene cartridge 
In summary, we have demonstrated that the purification of short 
oligonucleotides can be done by stepwise isocratic rather than the time consuming 
gradient elution and hence the overall DNA synthesis may be facilitated. This method 
enables column-capturing of the desired oligomer on small RP-C18 silica gel or 
polystyrene cartridges. 
2.8 Purification of Long Oligonucleotides 
The synthesis of oligonucleotides longer than 50 monomer units becomes a 
challenge as over 200 chemical steps are involved, each of them producing impurities 
which build up, complicating the purification. In a good synthesis the coupling yields 
after each step are normally not greater than 98.5%; this means that the overall yield 
of a 50-mer oligonucleotide would be <47%, for a 100-mer it would be <22% and 
for a 150-mer it would be c 10%. These theoretical calculations illustrate how 
important the purification factor has become in a situation where the amount of 
impurities exceeds greatly that of product. Long oligonucleotides also become more 
hydrophobic and therefore the difference in retention time on RP-HPLC between 
failure sequences and the tritylated product is lowered. Often the product peak will 
also appear very broad due to several stable conformations, a phenomenon which can 
increase and overlap with the impurity peaks. In order to demonstrate the usefulness 
of the Thf-DMTr group in the purification of long oligonucleotides, we synthesized 
various DNA sequences of different lengths and varying terminal nucleotide. A 51-
mer oligonucleotide (101) was synthesized in 0.2 p.mol scale on CPG support with the 









Fig. 2.18: HPLC profile of (101) ((a), Gradient III) and (102) ((b), Gradient I) 
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The same sequence bearing the DMTr group at the 5'-end (102) was synthesized for 
comparison. The HPLC profiles of the two crude products at 280 nm are shown in 
Fig. 2.18. No significant difference in yield was observed for both products; 
confirming on one side that the syntheses proceeded normally and that the Thf-
DMTritylation reaction was performed successfully. Subsequently a preparative 
HPLC was performed to collect the fluorescent Thf-DMTr fraction, the latter was 
treated with 80% acetic acid to remove the protecting group and desalted on an 
Sephadex G-25 column. During the desalting step a number of contaminants are 
removed, such as benzamide, isobutyramide, Thf-DMTr-OH, ammonium acetate and 
other organic and inorganic impurities, consequently the analyses and purification 
provide more accurate results. At this stage the product was analysed by capillary 
zone gel electrophoresis, see Fig. 2.19. As a result of the removal of the Thf-DMTr 
group, two sequences of different size were revealed. The by-product could not have 
arisen from the acetic acid treatment because depurination may not occur at this stage 
as the bases are much more stable to acid after the base deprotection. The more likely 
explanation for this additional product, is that an incomplete capping step during the 
build up of the sequence left a reactive site for the final Thf-DMTritylation. This 
observation emphasizes the importance of the capping steps during oligonucleotide 
synthesis which may have to be doubled in the synthesis of longer strands. The 51-mer 
was finally purified by a second preparative HPLC to give a product exhibiting a 
single peak on HPLC (Gradient II, see Section 3.1) yielding —5 OD units. The purity 
was confirmed by capillary zone gel electrophoresis, see electropherogram Fig. 2.20, 
and PAGE, see Fig. 2.21. 
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Lime 
Fig. 2.19: CE trace after deprotection 	Fig. 2.20: CE trace of pure Si-aner 
Fig. 2.21: PAGE of the purified 51-mer (lane 1) 
and a 45-titer reference sequence (lane 2) 
Next a 102-mer oligonucleotide (102) was synthesized by the standard protocol 
on a 0.2 Rmol scale with double capping steps. The sequence chosen consisted of 
twice the sequence of the above 51-mer (101) so that the occurrence of the uncapped 
truncated sequence observed in the 51 -mer can be attributed to either insufficient 





With a coupling yield of 98.5% on average, the expected overall yield ought to be 
21.4%. From the integrated HPLC trace of the crude oligonucleotide (102) (Fig. 
2.22) an overall yield of 11% was obtained. Although the deviation from the 
theoretical yield is great, it was considered as satisfactory because yields of long 
oligonucleotides can vary greatly according to the sequence and the freshness of the 
monomers. After preparative RP-HPLC and removal of the Thf-DMTr group, two 
products were again obtained (Fig. 2.23), thus suggesting that the formation of this 
by-product due to an inefficient capping step, is sequence specific. The product was 
finally obtained as a single peak after a second preparative HPLC yielding —1 OD unit. 
Attempts to analyse the oligodeoxyribonucleotide by PAGE or capillary zone gel 
electrophoresis (CE) was unsuccessful in this case as well as for the longer 
oligodeoxyribonucleotides because of small amounts of material available after 
purification. In PAGE, UV shadowing analysis or ethidium bromide staining analysis 
requires high amount of oligonucleotide, typically 0.5 to 1.5 OD units for sequences c 
50 bases and 1.5 to 3 OD units for oligonucleotides > 50 bases. In capillary zone gel 







Figure 2.23: HPW profile of crude (102) (a), gradient III 
and after deprotection (b), gradient II 
The DNA synthesis efficiency of oligonucleotide > 100-mer can be increased 
when polystyrene support loadings are used. 218 Because polystyrene is hydrophobic, 
traces of water are less likely to be present as in CPG and moreover CPG beads may 
contain some uncapped silanol. The commercially available polystyrene supports have 







The synthesis was performed with double capping steps and fresh reagents. The 
HPLC profile of the crude 153-mer (103) is shown in Fig. 2.24 (a). From the 
integration of the spectra, a product yield of 7% was obtained which compares to the 
calculated yield of 10% (with an avenge coupling step of 98.5%). Long 
oligonucleolides can form secondary structures with stable conformations which often 
results in a broadening of the peaks or in the appearance of several peaks. For these 
reasons the HPLC analysis of this 153-mer oligonucleotide was performed under a 
different gradient (Gradient IV, see Section 3.1) whereby the Thf-DMTr- 
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oligonucleotide elutes under non-isocratic conditions. Fortunately this particular 
sequence eluted as a narrow peak. After collecting the more hydrophobic fraction and 
deprotecting it, the free oligonucleolide was analysed by HPLC and revealed a 
impurity peak with a shorter retention time, see Fig. 2.24 (b). The sequence of (103) 
was designed to be three times the sequence of (101) where a similar HPLC pattern 
was obtained after removal of the Thf-DMTr group. This observation again confirms 
that this recurrent side-product resulting from the Thf-DMTritylation of an uncapped 
sequence is a sequence specific problem. With the final yields being so small this 
impurity could not be isolated and compared with those detected in (101) and (102). 
The purified oligonucleotide (103) was finally obtained as a single peak, see Fig. 2.24 







Figure 2.24: HPLC profile of (103) (a): crude, gradient IV; 
(b): after deprotection, gradient IV; (c): purified, gradient IV 
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The hydrophobic 5'-DMTr-oligonucleotides usually appear as separate peaks 
from the failure sequences but for longer sequences they can elute as shoulders of the 
main peak (failure sequences peak), due to the increased hydrophobic character of 
longer failure sequences. In this case it can be difficult to know when to start or to 
stop collecting. The following example illustrates the usefulness of the much more 
hydrophobic Thf-DMTr group in the synthesis and purification of the two 130-mer 









The two syntheses were carried out on a 0.2 jimolar scale on CPG support. The RP-
HPLC profile of the two crude oligonucleotides are shown in Fig. 2.25. The Thf-
DMTr bound oligonucleotide does clearly elute later than the failure sequences 
whereas the DMTr bound oligonucleotide (104) elutes closely to the truncated 
sequences and to what appear to be stable secondary structures of the product. The 
Tbf-DMTr-oligonucleotide was eluted under isocratic conditions with gradient III 
whereby no secondary structures of the product can be detected. Instead a sharp peak 
was obtained that enabled easy collection of the fraction. Oligonucleotide (105) was 
subsequently treated with acid to remove the Thf-DMTr group, desalted over 






Figure 225: HPLC profiles; (a): crude (105), gradient I 
(b): crude (105), gradient III 
As an alternative to hydrocarbon-bonded silica columns, a polymeric adsorbent 
such as highly cross-linked, rigid polystyrene beads, can be considered. They offer 
stability a high temperature and pH and would probably have a very high capacity for 
"Thf-DMTr-on" oligonucleotides, which would enable to run HPLC under denaturing 
conditions, therefore eliminating most secondary problems that one could encounter 
with long oligodeoxyribonucleotides; the resolution could be enhanced. RP-HPLC at 
alkaline pH would also eliminate the potential loss of Thf-DMTr groups during the 
purification procedure. 
2.9 Synthesis of a New Fluorescent Label for Oligonucleotides 
The base-pairing property of oligomeric strands of DNA allows specific 
recognition of a particular base sequence in a target strand by a complementary base 
sequence in a probe strand. However since DNA probe strands do not naturally 
contain any convenient reporter groups, spectroscopic monitoring of hybridization is 
difficult. 
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contain any convenient reporter groupG, opeotroQoopic monitoring of hybridization is 
-difficult. 
A method to overcome this problem is to prepare a synthetic oligonucleotide 
with the desired base sequence that also contains a covalently attached label (reporter 
group). In general, the functionajization of oligonucleotides for substituting reporter 
or reactive groups can be achieved using the following methods: 
- Modification of nucleosides so that they contain a masked primary amino 
group on the heterocyclic base. These are incorporated into the 
oligonucleotide during synthesis. 219 '220 
- Functionalization of deprotected oligonucleotides through their 5'- 
phosphate (which can be introduced by enzymatic reactions). 221 '222 
- Coupling of suitably protected chemical moieties at the 5'- or 3'-terminus of 
the protected oligonucleotide. 223 '224 
In our approach, we intended to introduce the reporter group during automated 
DNA synthesis at the 5'- or 3-terminus for reasons of simplicity. Solid phase 
modifications of the oligonucleotide 3'-end are more difficult to develop and need the 
preparation of a modified support. Hence, we decided to introduce our labelling 
group at the 5'-end. 
Earlier we mentioned the use of tetrabenzo[a,c,g,i]fluorene (53) for the 
purification of oligodeoxyribonucleotides. We have also investigated the fluorescent 
properties of this molecule and have used it as the basis for the development of a non-
radioactive labelling group. We wished to design the labelling group so that it would 
be introduced onto the 5'-terminus of an oligonucleotide via an inert spacer. The 
synthetic fluorescent marker ought to be compatible with J3-cyanoethyl 
phosphoramidite chemistry used on most DNA synthesizers. 
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Methyl 4-(17'-tetrabenzo[a,c,g,ilfluorenylmethyl)  benzoate (76) was already 
useful in the synthesis of Thf-DMTr-OH (84) and its reduction to the corresponding 
benzyl alcohol derivative (106) would enable direct activation into a phosphoramidite 
species for introduction onto an oligonucleotide. The synthesis of 4-(17'-
tetrabenzo[a,c,g,i]fluorenylmethyl) benzyl alcohol (106) was carried out under strong 
reductive conditions using diisobutylaluminium hydride (DIBAL) in THF yielding 
85%, see Scheme 2.16. The first attempts using lithium aluminium hydride failed. 
(76) 	 (106) 
P --- CN 
(107) 
Scheme 2.16; 1: DIBAL, TIfF; ii: bis(diisopropylammonium)tetrazolide, 
(2-cyanoelhoxy)bis(diisopropylamino)phosphine 
With this concept in mind, we successfully synthesized 4-(17'-
tetrabenzo[a,c,g,i]fluorenylmethyl) benzyl-(N,N-diisopropyl-J3-cyanoethyl) 
phosphoramidite (107) but when we tried to react it with the 5'-hydroxyl of a 20-mer 
oligonucleotide (5'-CCT-AAC-1TC-GAT-CCT-AGG-AT-3') bound to CPG no 
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fluorescent product was observed after treatment with ammonia. HPLC analysis of 
the crude also confirmed that the oligonucleotide was not coupled to compound 
(107). In order to test the stability of phosphate derivatives of (106) in concentrated 
ammonia, we reacted chiorodiphenyl phosphate with (106) in the presence of 
n-iethylamine in DCM to obtain the corresponding phosphate-triester (108), see Fig. 
2.26. The phosphate produced was left in ammonia at 50°C for several hours whereby 
its stability was monitored by 31P nmr. A single signal at -10.6 ppm was observed 
throughout the experiment indicating that the phosphate-triester (108) is stable under 
the cleavage conditions used in the oligonucleotide phosphoramidite chemistry. 
Consequently the absence of compound (107) on the 20-mer oligonucleotide is not 
due to a chemical problem but to the steric bulk of the structure. 
0 




Subsequently we investigated on the synthesis of a fluorescent compound 
with less steric hindrance. This may be achieved by increasing the length of the spacer 
arm between the fluorescent group and the oligonucleotide with an aliphatic chain of 
at least three carbon atoms. The bulk of the Thf structure would therefore move 
further away from the reactive phosphorous atom thus minimising the possibility of 
interaction which may interfere with coupling. In section 2.3.3.1 we described the 






esters and anhydrides. By a similar approach we synthesized 1-(diphenanthren-9'-yl)-
1,6-hexanediol (I 10) from phenanthrenemagnesium bromide and e-caprolactone (109) 
in 26 % yield. Subsequently we attempted the cydisation of (I 10) in the presence of 
TFA to give 6-(17'-tetrabenzo[a,c,gjjfluorenyl)hexanol (111) but instead the 
elimination product 1-(diphenanthren-9'-yl)-1-hexene-6-ol (112) was obtained in 81 % 
yield alter purification by dry flash chromatography (Scheme 2.17). Neither did the 
[2+2] cycisation occur when using milder acids such as TCA, acetic acid, sulphuric 
acid nor with heat. 
LJLMgBr I. THF 





Next we investigated the alkylation of Thf with a protected alcohol alkyl 
halide which after deprotection would release a hydroxyl function which in turn can 
be phosphitylated. Using an excess of 1 ,5-pentanediol and a low concentration in the 
reaction with trityl chloride, we could selectively monotritylate the diol to obtain 5-
hydroxy-1-triphenylmethoxy-pentane (113) in 51 % yield as a white solid. The less 
polar ditritylated derivative was only detected in traces by t.l.c. The free hydroxyl 
function was subsequently brominated with N-bromosuccinimide in carbon 
tetrachloride to give the crystalline 1-thphenylmethoxy-5-bromopentane (114) in 77% 
yield. The lithium derivative (73) of Thf was prepared in a similar fashion (see section 
2.3.3.2) and then reacted with the alkyl bromide (114) at -78°C and separatly at room 
temperature in THF but neither reaction gave any of the product (115) (Scheme 2.18). 
We considered the use of iodo derivatives, but this is unlikely to improve upon the 
reaction. Because allyl halides are more reactive to direct nucleophiic substitution 














 THF -78°C 
Scheme 2.18 
(114) 
The synthetic route finally chosen to produce the new fluorescent label is 
shown in Scheme 2.19. The anion of Thf (73) was prepared by addition of 
butyllithium at low temperature and this highly reactive species readily reacted with 
allyl bromide to give the alkene (75) in 63 % yield, this reaction was previously 
described in section 2.3.3.2. This alkene was successfully hydroborated using 9-BBN 
(9-borabicyclo[3.3.1]nonane) in THF and subsequently reacted with sodium 
hydroxide and hydrogen peroxide to generate the corresponding primary alcohol 3-
( 1 7'-tetrabenzo[a,c,g,i]fluorenyl)propanol (116) in 57% yield. Lower yields were 
obtained when sodium borohydride was used instead of 9-BBN. The phosphitylation 
of (116) was carried out in anhydrous THF using chloro-N,N,diisopropylamino- 
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cyanoethoxyphosphine. 68 The reaction gave one product on t.l.c. and after rapid 
aqueous work-up 3-( 17'-tetrabenzo[a,c,g,z]fluorenyl) propyl-N,N-diisopropyl-13 
cyanoethyl phosphorarnidite (117) was obtained as a yellow foam in 86% yield. The 
overall yield starting from tetrabenzofluorene was 38%. For reasons of simplicity we 
abbreviate compound (116) with Thf-Prop (Tetrabenzo[a,c,g,i]fluorenylpropyl)  and 
Thf-Prop-P (Tetrabenzo[a,c,gjjfluorenylpmpyl  phosphate) when tagged to an 
oligonucleotide. 









2.10 Tbf-Prop-P Labelled Oligonucleotides 
Compound (117) was found to be poorly soluble in anhydrous acetonitrile, the 
standard solvent for DNA synthesis monomers. Hence the resulting amidite (117) 
was dissolved in anhydrous acetonitrile/DCM : 9/1 at a concentration of 0.1 M. A 
series of short test sequences were synthesized using a 380B DNA synthesizer from 
Applied Biosystems with the standard cycle for 0.2 I.Lmol scale DNA synthesis, with 
a normal 30 s coupling time. The first sequence was a polythymidine oligonucleotide 
(T)6 whereby the coupling efficiency of the fluorescent label was determined. The 
Tbf-Prop-P (17-tetrabenzofluorenylpropyl phosphate) tagged oligonucleotide was 
obtained in 82% yield according to the integrated HPLC spectrum. This result is 
comparable to the expected theoretical yield with coupling efficiencies of 98.5% per 
step. Subsequently we synthesized Tbf-Prop-P labelled oligonucleotides on a 0.2 
ismol and 1 p.mol scale, the results of which are exemplified with the following 20-
mer oligonucleotide (118): 
(118) 5'-Tbf-Prop-P-flG-AGT-GCG-TCG-TGG-TCT-CA-3' 
Fig. 2.27: HPLC Spectra of crude oligonucleotide (118), (a) at 280 tim, 
(b) at 365 tim 
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After deprotection in ammonia at 50°C the oligonucleotide was analysed by 
analytical RP-C 18 HPLC at 280 nm, see fTig. 2.27 (al The HPLC characteristics of 
oligonucleotides containing the hydrophobic Thf-Prop label were very different to 
those of unlabelled failure sequences. The mi-Prop oligonucleotides had retention 
times between 5 and 10 min longer than unlabelled oligonucleotides. Clearly the 
hydrophobicity of the reporter group increases the retention time of the product 
drastically and therefore makes the purification easier. In 7q. 2.27 (6) the detector was 
set at 365 nm where only the fluorescent label absorbs. We are therefore able to 
monitor the labelled oligonucleotide outside 254-260 nm and thus avoid the DNA 
damaging wavelengths. The labelled oligonucleotide was finally purified by HPLC 
and desalted using a NAP-10 cartridge to give 53 OD units of pure fluorescent 
product as demonstrated by capillary gel electrophoresis with a single peak at 17 
mm, 7&.2.28. 
IMInI 
Fig. 2.28: Capillary Gel Elecirophoresis of purified oligonucleotide (118) 
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Fig. 2.29: UV absorption spectra of (116) in DCM 
Int 
  
420 	 InmI 
Fig. 2.30: Fluorescence spectra of (116) in DCM (Excitation spectra in dotted line, 
Emission spectra in plain line). 
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2.29 shows the UV absorption spectrum of the Thf-Prop label in DCM. 
The absorption band between 330 and 400 nm is characteristic of the 
tetrabenzo[a,c,g4]fluorene structure and can be used for monitoring the processes 
undergone by a labelled primer at wavelengths where most molecules do not absorb. 
Moreover when excited at 300 or 375 nm, the fluorescent label emits light with a 
maximum at 416 nm, see 7g. 2.30. In order to illustrate this important characteristic 
Yjg. 2.31 shows a PAGE of the pure oligonucleotide (118) in lane 2 and a reference 
40-mer sequence unlabelled in lane 1. When the gel slab is irradiated by UV light 
(254 nm) only the Thf-Prop-P-oligonucleotide is visualised thanks to its fluorescent 
tag. Both oligonucleotides can be revealed when stained with ethidium bromide. The 
detection limit was determined with an aqueous solution of (118) by successive 
dilution and measured on an Perkin-Elmer LS-50 luminescence spectrophotometer. 
By subtraction of the water background the labelled oligonucleotide could be 
detected at a concentration of 10 -11 M, see Tjg. 232. 
(a) 	 (b) 
Fig. 2.31: PAGE 12% of oligonucleotide (118) (Lane 2) and a reference  40-mer 
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Fig. 2.32: Fluorescence emission spectra of oligonucleotide (118) at various 
concentrations 
Given the ability to synthesize these internally labelled oligonucleotides, it 
was necessary to confirm that covalent attachment of the label does not adversely 
affect either the label itself or the modified oligonucleotide. The first effect can be 
determined by measuring the UV spectrum of the Thf-Prop-labelled oligonucleotide 
over a period of time. The fluorescent oligonucleotide remained fluorescent 
indefinitely and the UV absorption spectrum was identical to the one of Thf-Prop on 
its own. The second effect was determined by making melting temperature 
measurements when hybridized with its complementary strand. Two identical 
duplexes, but one containing the Thf-Prop-labelled strand were made. The buffer 
system used for the melting curves determination was 100 mM sodium chloride, 10 
mM sodium phosphate, 1 mM sodium EDTA adjusted to pH 7 by using NaOH. The 
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complementary strands were annealed by heating equimolar solutions to 80°C and 
cooling to room temperature for 1 h. The melting curves were obtained by slowly 
heating the samples to the high end of the run (80°C) and allowing equilibration for 
20 ruin. The samples were then cooled to the low end of the run (20°C) at a rate of 
10°C/h. The absorbance readings were made at 264 nm. The result of this experiment 
shows that the melting temperature of the Thf-Prop-labelled duplex is 2.7±1°C lower 
than for the unlabelled duplex. Although this value is almost within the error margin 
one could still speculate that the intercalation of TV would be expected to lead to 
stabilization of the duplex (increase of the melting temperature), but the opposite 
phenomenon was observed. This may be caused by the steric interaction of the 
somewhat bulky Thf-Prop group with the duplex formation. This interaction could be 
reduced if the spacer chain between the Thf group and the phosphorous atom was 
extended. 
2.11 Conclusions 
The synthesis of tetrabenzo[a,c,g,i]fluorene and some of its derivatives has been 
investigated. Some of these derivatives present interesting characteristics, they 
represented the basis for the development of a new hydrophobic 5'-protecting group 
Thf-DMTr for oligonucleotide synthesis and purification. We have shown that Thf-
DMTr-Cl can be used to introduce the Thf-DMTr group directly onto the support 
bound oligonucleotides, without lowering the synthesis yield. Synthetic 
oligonucleotides of more than 150 monomer units can equally be substituted with the 
Thf-DMTr group. The removal of this new protecting group in acid is twice as fast as 
DMTr and its fluorescent properties enable easy detection at DNA non-damaging 
wavelengths. Due to the high hydrophobicity of Thf-DMTr, the purification of long 
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oligonucleotides> 100 units is easily achieved by RP-HPLC. Purification is usually 
carried out in two steps. In the first step, 5'-Thf-DMTrityl terminated oligonucleotides 
are separated from the crude reaction mixture by HPLC. In the second step, 
detritylation of the material in the separated fraction from the first step is performed, 
and the desired oligomers are separated from this reaction mixture by HPLC. Thf-
DMTr has a great potential as a useful 5'-protecting group for RNA synthesis and in 
carbohydrate chemistry. 
We have shown that tetrabenzo[a,c,g,i]fluorene  can be used as a fluorophore 
in the labelling of oligonucleotide by a technique involving the standard 
phosphoramidite chemistry used in oligonucleotide synthesis. This fluorescent label 
offers significant advantages over common fluorescent labels. It is chemically inert 
and therefore will not adversely affect the oligonucleotide and its environment. It is 
entirely compatible with the established 0-cyanoethyl phosphoramidite chemistry and 
does not require any derivatisation of the heterocyclic bases or the use of an 
aminohexyl linker. The hydroxyl group is at the opposite end of the molecule to the 
Thf moiety, hence minimising any possibility of steric interaction between the bulky 
Thf group and the phosphoramidite group which may interfere with coupling. It is 
achiral. Its strongly fluorescent property enables the detection of oligonucleotides at 
very low concentrations. The synthesis of this reporter group involves few steps and 
low cost. It is unlike any other molecule previously used to label oligonucleotides, and 
is thus unlikely to infringe existing patents. Thf-Prop should also be investigated for 
its intercalating effects on DNA double strands a phenomenon which might be 
expected to occur should the spacer aim between the TV group and the phosphorous 
atom be extended. Polycyclic aromatic hydrocarbons in general are known to 
associate with natural DNA duplexes under certain conditionS. 225  
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Chapter 3: Experimental 
3.1 Instrumentation and General Techniques 
NMR Spectroscopy 
'H NMR 
Routine proton nuclear magnetic resonance, 1 H NMR, spectra were obtained 
using a Jeol PMX-60 MHz spectrometer. Higher field spectra were obtained on a 
Bruker WP-80 (80 MHz), WP-200 (200 MHz) or a WH-360 (360 MHz) 
spectrometer. Measurements were carried out in the solvent indicated and chemical 
shifts (8) reported in parts per million using tetramethylsilane (8 = 0.00) as an external 
reference. 
'c NMR 
Carbon nuclear magnetic resonance, 13C NIMR, spectra were recorded at 50.3 
MHz on a Bruker WP-200 spectrometer or at 90.6 MHz on a Bruker WH-360 
spectrometer. Measurements were carried out in the solvent indicated and chemical 




Phosphorus 31P NMR spectra were recorded at 36 MHz on a Jeol FX 90 or a 
Bruker WP-200 operating at 81 MHz. Measurements were carried out in the solvent 
indicated and chemical shifts (8) reported in parts per million using phosphoric acid (8 
= 0.00) as an external reference. 
Infra-red Spectroscopy 
Infra-red spectra were recorded on a Perkin-Elmer 781 spectrophotometer or a 
Biorad SPC 3200. Samples were examined as bromoform mulls or methylene chloride 
solutions, both on potassium bromide plates. Calibration was achieved by reference to 
the characteristic polystyrene peak at 1603 cm -1 . 
Mass Spectrometry 
Mass spectra, both low and high resolution were recorded on a Kratos MS-SO 
TC spectrometer operated by Mr. A. Taylor or on a AEI MS-902 spectrometer 
operated by Miss E. Stevenson. Fast Atom Bombardment (FAB) techniques were 
carried out with the Kratos spectrometer using 3-nitrobenzyl alcohol as the matrix, 
accurate mass spectra were calibrated with CsI. Electron Impact (El) techniques were 
carried out on the AEI spectrometer. 
Elemental Analysis 
Elemental analysis for carbon, hydrogen and nitrogen were carried out on a 
Carlo-Erba elemental analyser, model 1106, operated by Mrs E. McDougall or Ms L. 
Eades. The compounds that bear a polycydic aromatic structure such as Thf, were 
generally measured with low carbon values. A study with extended combustion time 
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and the use of a catalyst such as vanadium oxide did not improve the results obtained 
for the carbon values. 227 
X-Ray Crystallography 
Single crystal X-ray structure determination was determined on a Stoe Stadi-4, 
four circle diffractometer, graphite monochromated (Cu-Ka radiation; 1 = 1.54184 A) 
by Dr. S. Blake and Dr. R. Gould. 
Melting Points and Boiling Points 
Melting points were measured in open capillaries on an electrically heated 
Buechi 510 melting point apparatus, or on an electrically heated Reichert 7905 hot 
stage and are quoted without correction. Boiling points were measured using a 
Buechi Kugelrohr distillation apparatus; the temperatures were recorded by placing a 
thermometer inside the glass oven. 
HPLC 
High performance liquid chromatography (HPLC) was performed using either 
a Gilson system i.e. 2 x 306 pumps, a 81 lB automatic gradient controller and a model 
115 ultraviolet detector; or an Applied Biosystems system, i.e. 1783A Absorbance 
Detector-Controller, a 1406A Solvent Delivery System and a 491 Dynamic 
Mixer/Injector. Analytical separations by HPLC were carried out on ABI (RP-C 1 8) 
Aquapore OD-300 columns, 300 A pore size, 7 mm spherical silica (4.6 mm x 220 
mm), loop volume = 1 ml, with a flow rate of 1 ml/min. Preparative separations were 
performed with Brownlee Aquapore C8 columns, 25 cm x 10 mm, loop volume = 1 
ml and a flow rate of 3 ml/min. The following gradients were used: 
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Gradient! 
Time (min) 0 3 4 23 24 27 28 30 
0 0 15 70 100 100 0 0 
Buffer A = 100% 0.1M aqueous ammonium acetate 
Buffer B = 50% acetonitrile / 50% 0.1 M aqueous ammonium acetate 
Gradient II 
Time (min) 0 3 4 23 24 27 28 30 
0 0 15 70 100 100 0 0 
Buffer A = 100% 0.1M aqueous ammonium acetate 
Buffer B'= 20% acetonitrile/ 80% 0.1M aqueous ammonium acetate 
Gradient III 
Time (min) 0 3 4 23 24 35 36 40 
%B 0 0 15 70 100 100 0 0 
Buffer A = 100% 0.1M aqueous ammonium acetate 
Buffer B = 50% acetonithle / 50% 0. 1M aqueous ammonium acetate 
Gradient IV 
Time (min) 	0 3 20 23 
0 0 90 0 
Buffer A = 100% 0.1M aqueous ammonium acetate 
Buffer B" = 100% acetonitrile 
135 
Capillary zone gel electrophoresis 
Analyses of oligonucleotides by capillary zone gel electrophoresis (CE), were 
conducted on a Applied Biosystems Model 270A with Microgel capillaries. The 
following conditions were used: Buffer 75 mM Tris-phosphate/lO % methanol, pH 
7.5; detector 260 nm samples —5 .tM; loading voltage = -5 kV; temperature = 30°C; 
running voltage = -15 W. 
Polyacrylamide gel electrophoresis 
Polyacrylamide Gel Electrophoresis (PAGE) was performed with a slab gel 
apparatus of 1 mm width and 20 cm length. The sample wells were loaded with —3 R 1 
of 6 OD unit oligonucleotide solutions. 12% Acrylamide gel were used for the 
separation of 40 to 200 bp fragments, their preparation was made according to the 
ABI method226. The runs were carried out at 30 mA for —2 h. The analyses were 
carried out in the department of Biochemistry with the assistance of Dr. L. Powell. 
U.V. Spectroscopy 
Ultraviolet spectra were run on a Varian Cary 210 spectrophotometer using 
dichloromethane as the solvent and matched 1 cm silica cells, fluorescence spectra 
were recorded a Perkin Elmer LS-50 luminescence spectrophotometer. 
Thin Layer Chromatography 
For analytical purposes, aluminium backed plates, coated with a 0.2 mm layer of 
silica gel 60 GF (Merck 5735), and containing a fluorescent indicator were used. 






diethyl ether/n-hexane (3:7) 
dichloromethane/acetonitrile (8:2) 
ethylacetate 
diethyl ether/dichloromethane/triethylaniine (45:45:1) 
ethyl acetatelcyclohexane (4:1) 
The component spots were visualised by ultra-violet light at 254 nm or 352 nm 
or iodine spray. A sulfuric acid (in methanol) spray was used to visualise the position 
of Irityl containing compounds and an anisaldehyde spray (in acidic ethanol) to reveal 
sugar containing compounds. 
Drying and Purification of Solvents 
All solvents were distilled before use and the following were dried using the 
drying reagents indicated when required: benzene (sodium wire), dichloromethane 
(calcium hydride), diethyl ether (sodium wire), n-hexane (molecular sieves type 4 A), 
N,N-dimethylformamide (calcium hydride), pyridine (calcium hydride), 
tetrahydrofuran (sodium wire). 
Purchase of Reagents and Chemicals 
Nucleosides and nucleotides were purchased from Applied Biosystems, 
Cruachem or Raylo Chemicals. Other organic compounds were purchased from 
Aldrich or Fluka. 
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3.2 Synthetic Procedures 
Di(phenanthren-9-yl) methanol (69) 
9-Brornophenanthrene (5 g, 19.5 mmol) was dissolved in dry THF (10 ml) and 
slowly added to magnesium turnings (0.5 g, 2.1 mmol) together with a crystal of 
iodine under nitrogen. The exothermic reaction was controlled with the addition of 9-
bromophenanthrene. After 1 h stirring, a solution of methyl formate (0.43 g, 9.7 
mmol) in thy THF (5 ml) was slowly added. After 2 h, ice (5 g) then aqueous 
ammonium chloride (5 g in 10 ml water) was added and a white solid precipitated. 
The precipitate was filtered off and washed with water. The white solid was dissolved 
in DCM and combined with the DCM extract of the aqueous filtrate. The solution 
was dried over magnesium sulphate and the solvent removed in vacua The residue 
was finally triturated with diethyl ether to give a white solid (2.3 g, 60%); m.p. 238-
.239°C; C,H,N found: C, 91.03; H, 5.69; C291-1200 requires C, 90.59; H, 5.25 %; t.I.c. 
(A) 0.27; Vmn  (bromoform mull) 3420 (OH), 3080 (aromatic CH), 1610, 1500 
(aromatic rings) cm-1; kmax  298 (e 20110 dm 3mol-1 cm-1 ), 278 (25010), 255 (111000) 
nm (CDC13 , 200 MHz), 8.77 (21-1, d, 3J = 7.7 Hz, aromatic), 8.69 (21-1, d, 3J = 8.3 
Hz, aromatic), 8.09 (21-1, d, 3j = 8.6 Hz, aromatic), 7.79-7.49 (12H, m, aromatic), 
7.26 (11-1, d, 3J = 4.6 Hz, CH); m/z (FAB) 384 (M+), 367, 178; FIRMS (FAB) found 
384.15141, C291-1200 requires 384. 15140, (< lppm). 
8bH-Tetrabenzo[a,c,g,ijfluorene (70) 
Di(phenanthren-9-yl-methanol (48.0 g, 0.13 mol) was suspended in 
dichloromethane (200 ml) and irifluoroacetic acid (ca. 50 ml) was carefully added at 
this stage the reaction can be monitored by the brief appearance of a blue colour. The 
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yellow suspension was left stirring for 10 min after which it was evaporated to 
dryness. Trifluoroacetic acid was extracted by successive evaporation of freshly added 
dichlommethane. Fmally the yellow residue was triturated with diethyl ether and 
filtered off to afford the title compound as a yellow solid, (41.0 g, 86%); m.p. 280-
282°C; C,H,N found: C, 95.25; H, 5.15; CH requires C, 95.05; H, 4.95 %; tic. 
(A) 0.69, Rf(E) 0.39; Vm  (bromoform mull) 3054 (CH stretching, aromatic), 
1610, 1505 (aromatic rings) cm-1; X., a%  374 (c 8947 dm3mol1cm- '), 300 (21553), 
288 (20943), 254 (52867) nn 6H  (CDC13, 200 MHz), 8.84-8.69 (2H, m, aromatic), 
8.29-7.07 (15H, m, aromatic), 5.40 (11-1, s, CH); m/z (FAB) 366 (M+); HRMS (FAB) 
found 366.14087 C29H13 requires 366.14085, (c lppm). 
Tetrabenzo[a,c,g,i]fluorene (53) 
8bH-tetrabenzo[a,c,g,i]fluorene (0.50 g, 1.37 mmol) was suspended in THF (50 
ml) and a few drops of triethylamine were added. The suspension was stirred for 5 
min after which the solvent was removed in vacuo. The yellow solid was then 
triturated in diethyl ether and filtered off to give the title compound as a yellow solid 
(0.42 g, 89%); m.p. 280-282°C (lit 195 275-2760C); C,H,N found: C, 95.11; H, 5.03; 
C 9H18 requires C, 95.05; H, 4.95 %; U.C. Rf(A) 0.69; Vm  (bromoform mull) 3045 
(CH stretching, aromatic), 1610, 1505 (aromatic rings) car'; A..1 ,1  374 (e 10450 
dm3mol- 'cm-I), 365 (11220), 300 (21470), 288 (19143), 254 (50365) nm 
(CDC1 3, 200 MHz), 8.82-8.67 (6H, m, aromatic), 8.20-8.14 (211, m, aromatic), 7.79-
7.57 (8H, m, aromatic), 4.59 (211, s, CH2); m/z (FAB) 366 (M+); FIRMS (FAB) 




8bH-Tetrabenzo[a,c,g,ijfluorene (0.50 g, 1.37 mmol) was suspended in THF 
(60 ml) in an open flask when sodium methoxide (0.22 g, 3 equiv.) was added. The 
reaction mixture turned dark red, it was stirred at room temperature ovenight. The 
solution was then extracted in DCM, washed with 2 M aq. HO and water twice, and 
dried over magnesium sulphate. After removal of the solvents, the residue was 
triturated with diethylether to give a brown red solid, (0.27, 52%); m.p. > 295°C; 
C,H,N found: C, 90.87; H, 4.60; C14 160 requires C, 91.56; H, 4.24 %; t.I.c. Rf(A) 
0.70; Vmn  (bromoform mull) 3080 (aromatic CH), 1700 (CO, ketone), 1610, 1500 
(aromatic rings) cm -1 ; X 	337 (e 20064 dm3mok1 cm1 ), 256 (50160) nm 
(CDCI3, 200 MHz), 9.23-9.18 (2H, dd, aromatic), 8.78-8.74 (4H, dd, aromatic), 
8.31-8.27 (2H, d, aromatic), 7.83-7.61 (8H, m, aromatic); ö (CDC13, 50 MHz), 
134.6-122.7 (aromatic C's), weak sample; m/z (FAB) 381 (M+), 366; FIRMS (FAB) 
found 381.12796, C 29H170 requires 381.12793, (c lppm). 
17-Hydroxytetrabenzo[a,c,g,i]fluorene (79) 
Sodium borohydride (1.0 g, 26 mmol) was added to a solution of 
tetrabenzo[a,c,g,z]fluorenone (0.52 g, 1.37 mmol) in 11-IF (100 ml) and stirred at 
room temperature for 2 h. The deep red solution turned yellow after 15-25 mm. After 
cooling with an ice-bath, the solution is acidified to pH - 1.5 by slow addition of HO 
aq. 10%. The product was finally extracted with DCM, washed with Na}1CO 3 aq. and 
water, and dried over magnesium sulphate. The solvents were evaporated to leave a 
yellow foam which was recrystallised from DCM/Petrol 60-80 to give a yellow solid, 
(0.37 g, 71%); m.p. (decomp.) 270-272°C; C,H,N found: C, 89.39; H, 4.90; CH 180 
requires C, 91.07; H, 4.74 %; t.I.c. R(A)  0.47;  (c)  0.90; Vmn  (bromoform mull) 
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3550, 3520 (OH stretching), 3080 (aromatic CH), 1610, 1500 (aromatic rings) cm - t; 
378 (e  8404 dm31Ml- 'cm-1 ), 303 (25518), 293 (23684) nm H  (CDC131  200 
MFIz), 9.05-8.91 (4H, m, aromatic), 8.65-8.47 (4H, dd, aromatic), 7.81-7.70 (8H, m, 
aromatic), 6.39 (111, s, CH); 6 (CDC1 3, 50 MHz), 141.9, 139.4, 134.8, 131.4-122.4 
(aromatic Cs), 74.4 (CH); m/z (El) 381 (M+), 380, 365; FIRMS (EL) found 
382.1359, CH 18O requires 382.13576, (c lppm). 
17-Bromotetrabenzo[a,c,g,i]fluorene (81) 
N-Broniosuccinimide (1.60 g, 9.0 mmol) was added to a solution of 8bH-
tetrabenzo[a,c,g,i]fluorene (3.0 g, 8.2 mmol) in carbon tetrachloride (50 ml). Traces 
of dibenzoylperoxide were subsequently added to the yellow suspension which was 
heated to reflux for 1 h, whilst being irradiated by a 500W halogen lamp. After 
cooling to room temperature the solvents were evaporated, the orange residue taken 
up in DCM (1.3 1) and extracted with water (2 x 70 ml) and finally dried over 
magnesium sulphate. The solvent was evaporated and the product crystallised in 
diethylether to give an orange solid, (2.70 g, 75%); m.p. (decomp.) 265°C; C,H,N 
found: C, 77.80; H, 3.97; C29H, 7Br requires C, 78.37; H, 3.86 %; t.I.c. Rf(A) 0.68; 
Vmn (bromoform mull) 3060 (aromatic CH), 2970 (alkyl CH), 1610, 1500 (aromatic 
rings) cm-1 ; A. 	308 (e  32040 dm3mol- 'cm-1 ), 262 (64080), 255 (65860) nm 
(CDC13 , 200 MHz), 8.83-8.38 (8H, m, aromatic), 7.81-7.60 (8H, m, aromatic), 6.59 
(1H, s, CH); 5 (CDCI3, 50 M1-lz), 132.4, 130.9, 128.0, 126.9, 126.7, 125.4, 124.7, 
123.7, 123.3, (aromatic C's), 44.3 (CH); m/z (FAB) 444 (M+), 365; FIRMS (FAB) 
found 444.05146, C29H,7Br requires 444.051410, (c  lppm). 
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Methyl 4-(17'.tetrabenzo[a,c,g,i]fluorenyl)oxybenzoate (82) 
Sodium pieces (0.03 g, 1.23 mmol) were added to a solution of methyl-4-
hydroxybenzoate (0.19 g, 1.23 mmol) in TIT (10 ml) at room temperature under 
nitrogen. The suspension was stirred for 2.5 h until no more hydrogen evolution could 
be observed. Then 17-bromotetrabenzo[a,c,g,z]fluorene (0.50 g, 1.12 mmol) was 
added to the white suspension and was heated to reflux for 8 h. The reaction mixture 
was then evaporated in vacuo to give a yellow residue which was redissolved in DCM 
(20 ml). The resulting solution was washed twice with water (2 x 40 ml) and dried 
over magnesium sulphate. The volatiles were removed in vacuo and the product was 
purified by flash chromatography, eluting with DCM. The title compound was 
obtained as a bright yellow solid, (0.15 g, 26%); m.p. (decomp.) 250-255°C; C,H,N 
found: C, 86.10; H, 5.00; C 37112403 requires C, 86.03; H, 4.68 %; t.I.c. Rf(A)  0.38, 
Rf(D) 0.68;  Vm  (bromoform mull) 3080, 3060 (aromatic CH), 2950 (alkyl CH), 
1725 (ester CO), 1605, 1505 (aromatic rings) car'; Xmax 384 (e 3922 dm3moF'cnr'), 
255 (31373) nm; 5H  (DMSO-d6, 200 MHz), 8.9-8.2 (m, broad, aromatic), 7.7-7.2 
(m, broad, aromatic), 7.28, 7.23 (211, d, CH aromatic), 6.60, 6.55 (2H, d, CH 
aromatic), 6.81 (lH, s, CH), 3.51 (3H, s, CH 3); m/z (FAR) 515 (M+), 365; HRMS 
(FAR) found 515.16476, C 37H2303 requires 515.16476, (c  lppm). 
1-(17'-Tetrabenzo[a,c,g,i]fluorenyl)-prop-2-ene (75) 
A solution of n-butyllithium in cyclohexane (1.1 ml, 1.51 mmol; 1.1 equiv.; 1.26 
M titrated) was added dropwise to a suspension of 8bH-tetrabenzo[a,c,g,i]fluorene 
(0.50 g, 1.37 mmol) in dry THF (10 ml) at -78°C under nitrogen. The orange 
suspension was stirred for I h at -7 8°C . Then allyl bromide (0.17 g, 1.37 mmol; 1 
equiv.) was added giving an orange solution which was stirred for 30 min at -78°C 
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and a further 3 It at room temperature. The reaction mixture was then evaporated in 
vacuo to give a brown oil which was redissolved in DCM (20 ml). The resulting 
solution was washed twice with water and dried over magnesium sulphate. The 
volatiles were removed in vacuo to give a brown oil which was crystallized from 
DCM/n-hexane and subsequently recrystallised from diethylether. The title compound 
was obtained as a beige solid which was filtered and dried, (0.35 g, 63%); m.p. 118-
120°C; C,H,N found: C, 89.62; H, 5.57; C32H requires C, 94.55; H, 5.45 %; t.I.c. 
Rf(A) 0.70, Rf 0.33; V inax  (bromoform mull) 3070 (CH stretching, aromatic), 2970, 
2910, 2860 (CH stretching, alkyl), 1640 (C=C alkene) 1605, 1500 (aromatic rings) 
cm-1 ; Xm  380 (e 16565 dm 3mol-1cnr 1 ), 365 (17215), 300 (39626), 288 (31506), 
253 (64310) nm H  (CDC13, 200 MHz), 8.83-8.66 (61-1, m, aromatic), 8.26-8.19 
(21-1, m, aromatic), 7.77-7.58 (81-1, m, aromatic), 5.00 (11-1, s, CH Tbf), 4.79-4.68 
(IH, m, CH), 4.42-4.23 (2H, m, CE! 2 3-propene), 3.36-3.30 (21-1, dd, CH2 1-
propene); ö (CDCI 31  50 MHz), 143.6, 136.8, 131.2, 130.3, 128.6, 127.9, 
(quaternary aromatic C's), 131.9, 126.7, 125.8, 125.6, 125.1, 124.9, 124.4, 123.4 
(aromatic CH's), 116.6 (=CH2), 46.8 (Tbf CE!), 37.6 (CH2); m/z (FAB) 406 (M+), 
365, HRMS (FAB) found 406.17217, C321-122 requires 406.17215, (c lppm). 
Methyl.4-(bromomethyl)benzoate (78) 
N-Bromosuccinimide (979 g, 0.55 mol) and a catalytic amount of 
dibenzoylpemxide were added to a solution of methyl-2-methylbenzoate (75.1 g, 0.50 
mol) in carbon tetrachloride (300 ml). The mixture was then heated under reflux 
whilst irradiating with a 500W halogen lamp. The reaction became vigorous for the 
first 20 min. After 2h, the mixture was allowed to cool to room temperature, then 
filtered and the filtrate concentrated in vacuc to give the product as a yellow oil which 
crystallized overnight. It was purified by distillation under reduced pressure to give a 
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colourless solid, (89.0 g, 77%); b.p. 124°CY1.5 Ton; C,H,N Found: C, 46.91; H, 
4.41; C9H9Br02 requires: C, 47.19; H, 3.96 %; tJ.c. Rf(A) 0.50; V max  (bromoform 
mull) 3005 (CH stretching, aromatic), 2900, 2843 (CH stretching, alkyl), 1724 
(C=O), 1612, 1508 (aromatic rings) cm'; Xmax  246 (e 14313 dm3moPcm') nnz 
(CDC1 3, 80 MHz), 8.02, 7.91 (2H, d, J = 8.5 Hz, CH aromatic), 7.46, 7.35 (2H, d, J = 
8.5 Hz, CH aromatic), 4.45 (2H, s, C11 2), 3.87 (3H, s, C113); 8c (CDCI3, 50 MHz), 
165.8 (C=O), 142.2 (quaternary aromatic C), 129.5, 128.5 (aromatic CH's), 51.7 
(CE!3), 31.9 (CH2); m/z (EL) 229 (M+), 149. 
Ethyl-17-ethoxycabonyl-(17-tetrabenzo[a,c,g,i]fluorenyl)-3'-propionate (72) 
A solution of ethylacrylate (0.11 g, 1.14 mmol), piperidine (0.097 g, 1.14 
mmol) in dioxane (5 ml) was stirred for 15 min at room temperature. Then, 17-
ethoxycarbonyltetrabenzo[a,c,g,i]fluorene (0.50 g, 1.14 mmol) was added and stirred 
over 4 days at room temperature to give a yellow solution. The reaction mixture was 
then evaporated in vacuo to give a brown oil which was redissolved in DCM (20 ml). 
The resulting solution was washed twice with water (2 x 40 ml) and dried over 
magnesium sulphate. The volatiles were removed in vacuo to give a brown oil which 
was purified by flash chromatography, eluting with dichioromethane. Finally the 
product was recrystallised from ethanol to give yellow crystals, (0.12 g, 20%); m.p. 
127-129°C; C,H,N found: C, 81.83; H, 5.83; C37113004 requires C, 82.50; H, 5.62 %; 
U.C. 1(A)  0.17, p1(D)  0.36; Vm  (bromoform mull) 2975 (CH stretching, alkyl), 
1722 (CO, ester), 1612, 1501 (aromatic rings) cm -1; 380 (c  16140 dm3moF 1 cnr 
'), 305 (52972), 293 (44695), 253 (189541) nm 11  (CDC13, 80 MHz), 8.86-8.54 
(611, m, aromatic), 8.36-8.19 (21-1, m, aromatic), 7.84-7.50 (8H, m, aromatic), 3.98 
(211, q, 3j = 7.2 Hz, C112-0-CO), 3.68 (2H, q, 3J = 7.2 Hz, C112-0-CO), 2.62 (4H, 
broad, CH2), 1.20 (311, t, CH 3), 0.74 (31-1, t, CE!3); b (CDCI3, 50 MHz), 175.3 
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(carbonyl C), 140.4, 137.6, 132.3, 131.0, (quaternary aromatic C's), 128.0, 127.4, 
126.6, 126.4, 125.2, 123.5, 123.3 (aromatic CH's), 84.4 (quaternary 17-C), 62.8 
(CHOCO), 58.3 (CH2), 18.2, 13.6 (CH3); m/z (FAB) 538 (M+), 437; HR?vIS 
(FAB) found 538.21442, C311-13004 requires 538.21439, ('c lppm). 
Ethyl 3-(17'-tetrabenzo[a,c,g,:]fluorenyl) propanoate (74) 
A solution of n-butyllithium in cyclohexane (0.94 ml, 1.51 mmol, 1.1 equiv.; 
1.6M titrated) was added dropwise to a suspension of 8bH-
tetrabenzo[a,c,g,i]fluorene (0.50 g, 1.37 mmol) in dry THF (5 ml) at -78°C under 
nitrogen. The orange suspension was stirred for 30 min at room temperature. Then, 
ethylacrylate (0.15 g, 1.51 mmol, 1.1 equiv.) was added dropwise and stirred at room 
temperature for 2 h. The reaction was quenched by adding water and the product was 
extracted with diethylether. The resulting solution was washed twice with water (2 x 
20 ml) and dried over magnesium sulphate. The volatiles were removed in vacuo to 
give a brown oil. This was purified by flash chromatography, eluting with 
dichioromethane to give the title compound as a pale brown solid, (0.10 g, 16%); 
m.p. 175-177°C; C,H,N found: C, 87.2; H 5.84; C341-102 requires C, 87.53; H, 5.62 
%; U.C. Rf(A)  0.40, Rf(D)  0.65; Vmax (bromoform mull) 2983, 2941 (CH stretching, 
alkyl), 1725 (CO. ester), 1608, 1500 (aromatic rings) cm -1 ; kmax 380 (c 19064 
dm3mol- tcnr'), 365 (20546), 301 (46600), 289 (38550), 254 (76255) nm 
(CDCI3 , 60 MHz), 9.0-8.6 (61-1, m, aromatic), 8.4-8.1 (2H, m, aromatic), 7.9-7.4 (81-1, 
m, aromatic), 5.1 (1H, t, J = 4 Hz, CH), 3.6 (21-1, q, 3J = 7 Hz, CH2-ethyl), 2.9 (211, 
m, CH2), 1.3 (2H, t, CH2-CO), 0.8 (31-1, t, J = 7 Hz, CH3); S (CDCI3 , 50 MHz), 
172.9 (carbonyl C), 142.8, 136.9, 131.3, 130.3, 128.4, 127.7 (quaternary aromatic 
C's), 127.4, 126.9, 126.0 125.7, 125.5, 125.0, 124.2, 123.4, (aromatic CH's), 59.8 
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(CH2-ethyl), 45.7 (CH), 28.2, 27.2 (CH2), 13.6 (CH3); m/z (FAR) 466 (M+), 421, 
365, HRMS (FAB) found 466.19348, C34H02 requires 466.19327, (c lppm). 
Methyl 4-(17'-tetrabenzo[a,c,g,i]fluorenylmethyl) benzoate (76) 
A solution of n-butyllithium in cyclohexane (1.8 ml, 2.27 mmol; 1.1 equiv.; 1.26 
M titrated) was added dropwise to a suspension of 8bH-tetrabenzo[a,c,gjJfluorene 
(0.75 g, 2.0 mmol) in dry TT-IF (10 ml) at -78°C under nitrogen. The suspension was 
stirred for 1 h at -78°C. Then a solution of methyl-4.(bromomethyl)-benzoate (0.52 
g, 2.27 mmol; 1.1 equiv.) in dry THF (1 ml) was added giving an orange solution 
which was stirred a further 3.5 h at room temperature. The reaction mixture was then 
evaporated in vacuo to give a brown oil which was redissolved in DCM (20 ml). The 
resulting solution was washed twice with water (2 x 40 ml) and dried over magnesium 
sulphate. The volatiles were removed in vacuo to give a brown oil which was 
crystallized from DCMJn-hexane. The title compound was obtained as a pale yellow 
solid which was filtered and dried, (0.75 g, 71%); m.p. 241-243°C; t.l.c. Rf(A) 0.37, 
Rf 0.85; C,H,N found: C, 87.23; H, 5.35; C38H02 requires C, 88.68; H, 5.10 %; 
V ma  (bromoform mull) 3063 (CH stretching, aromatic), 2936, 2900 (CM stretching, 
alkyl), 1714 (CO. ester), 1608, 1500 (aromatic rings) cm -1 ; 367 (e  17362 
dm3mol-1 cnr 1 ), 302 (41577), 290 (33810), 254 (110110) nni 5H  (CDC131  80 MHz), 
8.84-8.67 (4H, m, aromatic), 8.36-8.19 (4H, m, aromatic), 7.81-7.37 (8H, in, 
aromatic), 6.98 (2H, d, 3J = 8.49 Hz, aromatic), 5.84 (21-1, d, 3J = 8.49 Hz, aromatic), 
5.17 (1H, t, 3j = 4.50 Hz, CH), 3.79 (21-1, d, 3J = 4.55 Hz, CH2), 3.61 (3H, s, O-CH3 ); 
8c (CDCI3, 50 MHz), 166.6 (carbonyl C), 142.6, 141.0, 137.1, 131.0, 130.3, 128.6, 
127.7, 127.3 (quaternary aromatic C's), 128.3, 127.5, 127.1, 126.8 125.6, 124.9, 
124.3, 123.6, 123.3 (aromatic CH's), 51.4 (CH), 47.6 (CH 3), 39.7 (CH2); m/z (FAB) 
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514 (M+), 365, HRMS (FAB) found 514.19325, C381-102 requires 514.19327 , (< 
lppm). 
4-(17'.Tetrabenzo[a,c,g,i]fluorenylmethyl)-trityl alcohol (83) 
Tbf-Tr-OH 
A solution of bromobenzene (4.27 g, 27.2 mmol) in dry TIIF (20 ml) was added 
to magnesium turnings (0.66 g, 27.2 mmol) and a crystal of iodine. After the reaction 
commenced the temperature was maintained at 20-25°C with an ice bath until the end 
of the addition. The reaction mixture was then heated to reflux for 45 min and then 
cooled to room temperature. A solution of methyl 4-(17'-
tetrabenzo[a,c,g,z]fluorenylmethyl) benzoate (1.40 g, 2.72 mmol) in dry THF (30 ml) 
was added dropwise. The greenish reaction mixture was then heated to reflux for 2 h. 
After cooling to room temperature the solution was poured onto a saturated solution 
of aqueous ammonium chloride (100 ml) and the product extracted with DCM (100 
nil). The organic layer was separated and washed with NaHCO 3 aq. (25 ml), then 
water (25 ml) and finally dried over magnesium sulphate. The volatiles were 
evaporated in vacuo and a brown oil was obtained. The product was purified by silica 
gel dry flash chromatography in DCM and crystallized in DCM/n-hexane, filtered and 
dried, to give the title compound as a beige crystalline solid, (1.1 g, 63%); m.p. 236-
238°C; t.l.c. Rf(A) 0.44; CAN found: C, 91.82; H, 5.30; C 49H340 requires C, 92.13; 
H, 5.36 %; V ma,i  (bromoform mull) 3572, 3433 (OH stretching), 3062 (CH 
stretching, aromatic), 2935, 2865 (CH stretching, alkyl), 1603, 1500 (aromatic rings) 
cm-1 ; A.n  378  (c  13400 dm3mol-'cnr'), 366 (14036), 303 (33814), 290 (26800), 
254 (56144) nm 5H  (CDCI3, 80 MHz), 8.83-8.71 (41-1, m, aromatic), 8.41-8.22 (41-1, 
m, aromatic), 7.75-7.47 (81-1, m, aromatic), 7.09-6.69 (101-1, m, aromatic), 6.17 (2H, 
d, 3J = 8.55 Hz, aromatic), 5.72 (21-1, d, 3J = 8.52 Hz, aromatic), 5.23 (1H, t, 3j = 4.53 
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Hz, CH), 3.76 (21-1, d, 3j = 4.46 Hz, CH2), 2.16 (11-1, s, OH); 8 (CDC13 , 50 MI-li), 
146.4, 144.1, 143.2, 137.1, 134.5, 131.1, 130.2, 128.7, 127.8, 127.1 (quaternary 
aromatic C's), 127.4, 126.8, 126.6, 125.9, 125.8, 125.5, 124.8, 124.4, 123.5, 123.4 
(aromatic CH's), 81.2 (quaternary trityl C), 47.9 (CH), 39.5 (CH 2), 39.7 (CH2); m/z 
(FAB) 640 (M+), 623, 366, HRMS (FAB) found 638.26106, C 491-1340 requires 
638.26096, (c lppm). 
4- ( 17' -tetrabenzo[a,c,g,i]fluorenylmethyl) -4 ' ',4'"-dimethoxytrityl alcohol (84) 
Tbf-DMTr-OH 
A solution of 4-bromoanisole (4.36 g, 23.3 mmol) in dry THF (15 ml) was 
added to magnesium turnings (0.57 g, 23.3 mmol) and a crystal of iodine. After the 
reaction commenced, the temperature was maintained at 20-25°C with an ice bath 
until the end of the addition. The reaction mixture was heated at reflux for 1 h after 
which it was cooled to room temperature. A . solution of methyl 4-(17'-
tetrabenzo[a,c,g,i]fluorenylmethyl) benzoate (4.0 g, 7.78 mmol) in dry THF (50 ml) 
was added dropwise whilst the temperature was maintained below 20°C with an ice 
bath. The greenish reaction mixture was then stirred at room temperature for 3 h. The 
solution was poured into a saturated aqueous solution of ammonium chloride (100 
ml) and the product extracted with DCM (100 ml). The organic layer was separated 
and washed with NaHCO 3 aq. (25 ml), then water (25 ml) and finally dried over 
magnesium sulphate. The volatiles were evaporated in vacuo and a brown oil was 
obtained. The product was purified by silica gel dry flash chromatography in DCM 
and crystallized in DCM/n-hexane, filtered and dried, to give the tide compound as a 
beige crystalline solid, (3.0 g, 55%); m.p. 209-211°C; t.l.c. Rf(A) 0.26, Rf(0) 0.72; 
C,H,N found: C, 87.57; H, 5.69; C 51 1-13303 requires C, 87.64; H, 5.48 %; V max 
(bromoform mull) 3583, 3550 (OH stretching), 3070 (CH stretching, aromatic), 2955, 
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2929, 2835 (CH stretching, alkyl), 1608, 1508 (aromatic rings), 1249, 1032 (C-O 
ether stretching) cm - '; )L,m 380 (e  17013 dm3mol- 'cnr'), 366 (17450), 302 (41880), 
290 (34900), 254 (70236), 237 (68928) nm 11  (cDC13, 80 MHz), 8.82-8.71 (41-1, 
in, aromatic), 8.41-8.22 (4H, in, aromatic), 7.75-7.47 (8H, m, aromatic), 6.59-6.56 
(81-1, d, aromatic), 6.15 (21-1, d, 3J = 8,39 Hz, aromatic), 5.68 (2H, d, 3J = 8.40 Hz, 
aromatic), 5.22 (11-1, t, 3J = 4.17 Hz, CH), 3.75 (211, d, 3j = 4.20 Hz, CH2), 3.72 (611, 
s, 0130-), 2.14 (11-1, s, OH); 8c (CDCI3 , 50 MHz), 158.0 (quaternary aromatic C, 
C-0) 144.4, 143.2, 139.1, 136.9, 134.2, 131.0, 130.1 (quaternary aromatic C's), 
128.6, 127.6, 127.0, 126.7, 125.7, 125.6, 125.3, 124.6, 124.4, 123.4, 112.5 (aromatic 
CH's), 80.6 (quaternary trityl C), 55.0 (CH30), 47.8 (CH), 39.5 (CH 2), 39.4 (CE12); 
m/z (FAB) 698 (M+), 681, 365, HRMS (FAB) found 698.28213, C 51 1-13803 requires 
698.28208, (c lppm); X-Ray analysis, see section 2.4. 
4-(17 ' -Tetrabenzo[a,c,g,i]fluorenylmethyl) -trityl chloride (85) 
Tbf-Tr-C1 
Acetyl chloride (0.61 g, 7.84 mmol), previously distilled over phosphorus 
pentachloride, was added to a suspension of 4-(17'- 
tetrabenzo[a,c,g,z]fluorenylmethyl)-trityl alcohol (0.50 g, 0.784 mmol) in dry benzene 
(20 ml) at room temperature. It was heated to reflux for 3 h and then cooled to room 
temperature. The volatiles were evaporated in vacuo to give an orange solid. Finally 
the product was recrystallised from fresh benzene (10 ml) to give a pale yellow solid 
(0.45 g, 88%); m.p. 214-215°C; t.l.c. Rf(A)  0.67; CAN found: C, 88.70; H, 6.43; 
C49H33C1 requires C, 89.55; H, 5.06 %; V m  (bromofonri mull) 3061 (CH stretching, 
aromatic), 2914, 2846 (CH stretching, alkyl), 1605, 1495 (aromatic rings); 380 
(c 16851 dm3moF1 cnr 1 ), 367 (17250), 303 (40336), 290 (33702), 254 (140115) nnz 
5H (CDCI3, 200 MHz), 8.79-8.77 (411, m, aromatic), 8.39-8.31 (41-1, m, aromatic), 
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7.75-7.51 (8H, m, aromatic), 7.13-6.72 (10H, in, aromatic), 6.17 (2H, d, 3J = 8.5 Hz, 
aromatic), 5.71 (2H, d, 3J = 8.5 Hz, aromatic), 5.26 (1H, t, 3j = 4.5 Hz, CH), 3.80 
(2H, d, 3J = 4.5 Hz, CH2); ö (CDCI3, 50 MHz), 144.9, 143.1, 142.3, 137.1, 135. 1, 
131.1, 130.2, 128.7 (quaternary aromatic C's), 129.2, 127.6, 127.2, 126.8, 125.8, 
125.5, 124.9. 124.4, 123.6, 123.4 (aromatic CH's), 80.8 (quaternary trityl C), 47.8 
(CH), 39.4 (CH.); m/z (FAB) 773 (M + matrix), 621, 365. 
4-(17 ' -tetrabenzo[a,c,gjjfluorenylmethyl)- 4",4"-dimethoxytrityl chloride (86) 
Tbf-DMTr-Cl 
Acetyl chloride (1.12 g, 14.3 mmol), previously distilled over phosphorus 
pentachioride, was added to a suspension of 4-(17'-
tetrabenzo[a,c,g,i]fluorenylmethyl)-4",4"-dimethoxytrityl alcohol (1.0 g, 1.43 mmol) 
in benzene (10 ml) at room temperature. The mixture was heated to reflux for 4 h and 
then cooled to room temperature. The volatiles were evaporated in vacuo to give an 
orange solid. Finally the product was recrystallised in fresh benzene (10 ml) to give a 
pale yellow solid (0.95 g, 93%); m.p. 176-179°C; t.l.c. Rf 0.70; Vm  (bromoform 
mull) 3068 (CH stretching, aromatic), 2955, 2929, 2836 (CH stretching, alkyl), 1605, 
1508 (aromatic rings), 1250, 1032 (C-O ether stretching) cm -1 ; 	498 (c 6900 
dm3moF'cm-1 ), 438 (3450), 382 (16851), 368 (17250), 304 (40336), 290 (33702), 
254 (140115) nm 6H  (CDC1 3, 200 MHz), 8.78-8.74 (4H, m, aromatic), 8.38-8.24 
(4H, m, aromatic), 7.78-7.45 (8H, m, aromatic), 6.64-6.48 (8H, d, aromatic), 6.15 
(2H, d, 3J = 8.39 Hz, aromatic), 5.67 (2H, d, 3J = 8.40 Hz, aromatic), 5.i4 (1H, t, 3J 
= 4.17 Hz, CH), 3.75 (2H, d, 3J = 4.20 Hz, CH2), 3.76 (6H, s, CH30-); m/z (FAR) 




Thyntidine (0.17 g, 0.70 mmol) was twice co-evaporated with dry pyridine then 
dissolved in 10 ml of pyridine, distilled triethylamine (0.06 g, 0.70 mmol) and a trace 
of NN-dimethylaminopyridine. Thf-Tr-Cl (0.52 g, 0.78 mmol) was added at room 
temperature under argon and stirred for 18 h. It was then evaporated to dryness in 
vacuo and dissolved in dichloromethane (20 ml). The solution was washed 
successively with saturated sodium carbonate solution and water, dried over 
magnesium sulphate, and the solvent removed in vacuo to give a brown oil. This was 
purified by flash chromatography, eluting with 0-10% methanol in dichlommethane, 
the product was crystallised from dichloromethane/n-hexane to produce the title 
compound as a white solid, (0.21 g, 35%); m.p. (softening point) 156-158°C; t.I.c. 
Rf(c) 0.30, Rf(A) 0.05; CAN found: C, 81.40; H, 5.89; N, 3.19; C 59HN205 
requires C, 82.10; H, 5.38; N, 3.25 %; V m  (bromoform mull) 3387, 3193 (OH, NH 
stretching), 2931, 2869 (CH stretching, alkyl), 1682, (C=O ketone), 1610, (aromatic 
rings), 1276 (C-O ether stretching) cm -1 ; 	380 (e 20257 dm3mol1cnr 1 ), 366 
(20688), 303 (50858), 290 (43962), 254 (137920), 237 (136196) nm 5H  (CDC1 80 
MHz), 8.83-8.72 (4H, m, aromatic), 8.41-8.25 (4H, m, aromatic), 8.10 (1H, s, 6-H), 
7.75-7.45 (81-1, m, aromatic), 7.09-6.76 (81-1, m, aromatic), 6.27 (21-1, d, 3J = 4.4 Hz, 
aromatic), 6.22 (11-1, t, 1'-H), 5.73 (21-1, d, 3J = 8.4 Hz, aromatic), 5.27 (1H, t, TV-
CH), 4.12 (11-1, m, 4'-H), 3.77 (2H, d, Thf-Cl 2), 2.75 (21-1, dd, 5'-CH2), 2.13 (21-1, m, 
2'-Cl-12); 8 (CDCI3 , 50 MHz), 163.7 (2-C=O), 150.4 (4-C=O), 143.9, 140.9, 136.2, 
135.6, 134.4, 130.8 (quaternary aromatic C's), 129.4, 129.1, 128.5, 127.2, 126.5, 
126.2, 126.0, 125.3, 125.0, 124.0, 112.9 (aromatic CH's), 109.5 (5-C), 85.8 
(quatemarytrityl C), 85.3 (3'-C), 83.7 (1'-C), 70.5 (4'-C), 63.5 (5'-C), 47.6 (Tbf-CH), 
40.0 (Tbf-CH 2), 40.0 (2'-CH2), 11.6 (5-CH3 ); m/z (FAB) 864 (M+), 775, 639, 366, 





Thymidine (0.25 g, 1.03 mmol) was twice co-evaporated with dry pyridine then 
dissolved in 3 ml of pyridine, distilled triethylamine (0.11 g, 1.13 mmol) and a trace of 
N,N-dimethylaminopyridine. Thf-DMTr-Cl (0.96 g, 1.34 mmol, 1.3 equiv.) was added 
at room temperature under argon and stirred for 18 h. Methanol (3 ml) was added to 
quench the reaction. Then, it was evaporated to dryness in vacuo and dissolved in 
dichioromethane (20 ml). The solution was washed with saturated sodium carbonate 
and water, dried over magnesium sulphate, and the solvent removed in vacuo to give 
a brown oil. This was purified by flash chromatography, eluting with 0-10% methanol 
in dichloromethane, the product was crystallised from dichloromethane/n-hexane to 
produce the title compound as a pale solid, (0.43 g, 45%); m.p. 175-177°C; t.I.c. 
Rf(C) 0.38, Rf(A) 0.05; Vm (bromofomi mull) 3401, 3314, 3181 (OH, NH 
stretching), 2926, 2833 (CH stretching, alkyl), 1700, 1666 (C=O ketone), 1606, 1505 
(aromatic rings), 1253, 1037 (C-O ether stretching) citY'; Aimn 380 (e 14137 
dm3moF'cnr'), 366 (14137), 303 (35036), 290 (31348), 254 (62696), 238 (61467) 
nnz 8H  (CDC1 3, 200 MHz), 11.29 (11-1, s, NH) 8.97-8.93 (41-1, d, aromatic), 8.47- 
8.29 (411, dd, aromatic), 7.83-7.56 (81-1, m, aromatic), 7.20 (11-1, s, 6-H), 6.72-6.58 
(8H, m, aromatic), 6.19 (21-1, d, 3J = 8.2 Hz, aromatic), 6.07 (11-1, t, 1'-H), 5.59 (2H, 
d, 3J = 8.2 Hz, aromatic), 5.59 (11-1, t, Thf-CH), 5.20 (111, d, 3'-01-1), 4.02 (1H, m, 4'-
H), 3.66 (21-1, d, Thf-CI-1 2), 3.36 (6H, s, CH30-), 2.76 (21-1, m, 5'-CH.), 1.97 (21-1, m, 
2'-CEI2)
1 
 1.17 (31-1, s, CH3); S (CDCI3, 50 MFIz), 163.7 ( 2- C=O), 150.4 (4- C=O), 
143.9, 140.9, 136.2, 135.6, 134.4, 130.8 (quaternary aromatic C's), 129.4, 129.1, 
128.5, 127.2, 126.5, 126.2, 126.0, 125.3, 125.0, 124.0, 112.9 (aromatic CFI's), 112.9 
(5-C), 85.3 (quaternary trityl C), 85.3 (3'-C), 83.7 (1-C), 70.6 (4'-C), 63.4 (5'-C), 
55.1 (CH30), 47.6 (Tbf-CH), 40.0 (Tbf-CH2), 40.0 (2'.CH2), 12.5 (5-CH3); mlz 
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(FAB) 922 (M+), 681, 365, FIRMS (FAB) found 922.36181, C 61HN201 requires 
922.36178, (c lppm). 
S' -O-(4- (17" -tetrabenzo[a,c,g,i]fluorenylmethyl) -4 '",4 '"' -dimethoxytrityl)-
thymidine-3'-O-N,N.diisopropyI--cyanoethyI phosphoramidite (91) 
5'-O-(4-( 17"-Tetrabenzo[a,c,g,i]fluorenylmethyl)-4",4"-dimethoxytrityl)-
thymidine (0.25 g, 0.271 mmol) was co-evaporated twice in methylene chloride (10 
ml) and then the flask was closed with a septum pierced with a needle and filled with 
argon and the needle removed. An argon filled balloon was attached to the flask and 
the nucleoside was dissolved in dry methylene chloride (10 ml). N,N-
Diisopropylamine (0.070 g, 0.54 mmol) and then N,N-diisopropyl-3-cyanoethyl 
phosphoramidyl chloride (0.077 g, 0.32 mmol) were added and the reaction was 
stirred for 30 min before being quenched with methanol (0.8 equiv.) and poured into 
10 ml each of DCM and sat. aqueous sodium carbonate and extracted. The organic 
layer was washed with water (10 ml) and dried over magnesium sulphate and the 
solvent removed in vacuo to give a brown oil. The residue was dissolved in DCM (5 
ml) and precipitated with n-hexane (250 ml) at -20°C. The solid was filtered off and 
dried in an evacuated dessicator to give the title compound as a white powder (0.20, 
66%); m.p. (softening point) 71-75°C; t.I.c. Rfq 0.71; Vmax  (bromoform mull) 
2930, 2830 (CH stretching, alkyl), 1700, 1682 (C=O ketone), 1608, 1508 (aromatic 
rings), 1253, 1034 (C-O ether stretching) cm-1; 5H  (C003, 200 MHz), 11.34 (lH, s, 
NH) 8.98-8.95 (41-1, d, aromatic), 8.50-8.26 (4H, dd, aromatic), 7.84-7.61 (81-1, in, 
aromatic), 7.22 (11-1, s, 6-H), 6.74-6.48 (8H, m, aromatic), 6.20 (21-1, d, 3J = 8.1 Hz, 
aromatic), 6.18 (11-1, t, F-H), 5.59 (21-1, d, 3J = 8.2 Hz, aromatic), 4.26 (11-1, m, 4'-H), 
3.71-3.28 (Tbf-CH21 C1'30-, 3'-H, j3-cyanoethyl CH2), 2.76 (21-1, m, 5'-CH 2), 1.97 
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(2H, in, 2'-CH2), 1.22-0.76 (5-CH3, 1pr CH3); 8p  (CDC13, 36 MHz), 148.51, 148.03; 
m/z (FAB) 1124 (M+), 682, 365. 
4-(17'-Tetrabenzo[a,c,g,ilfluorenylmethyl) benzyl alcohol (106) 
Methyl 4-(17'-tetrabenzo[a,c,g,i]fluorenylmethyl) benzoate (2.06 g, 4.0 mmol) 
was dissolved in dry THF (40 ml) under nitrogen whereupon diisobutylaluminium 
hydride DIBAL (8.8 ml, 4.4 mmol, 1.0 M in DCM) was carefully added at room 
temperature. After 2 h stirring the solution had faded from orange to yellow and was 
poured onto aqueous HC1 2 M (60 ml). The product was extracted with ethyl acetate 
(70 ml), washed with aqueous sodium hydrogen carbonate (40 ml) and water (50 ml), 
and dried over magnesium sulphate. After evaporation of the solvents, the crude beige 
solid was recrystallized from ethyl acetate / methanol to give a beige solid, (1.65 g, 
85%); m.p. 230-232°C; C,H,N found: C, 91.44; H, 5.89; C37H0 requires C, 91.33; 
H, 5.39 %; t.l.c. R(A) 0.20, Rf(c)  0.82;  Vmn  (bromoform mull) 3584, 3555, 3473 
(OH stretching), 2927, 2858 (CH stretching, alkyl), 1607, 1500 (aromatic rings) cm -1 ; 
A.max  380 (c 11340 dm3mol- 'cm-1 ), 366 (11664), 303 (28188), 291 (23004), 254 
(46332) nnz Fluorescence Ex 385 rim, Em,,, 427 nm; 8H  (CDC13, 80 MHz), 8.84 
8.68 (4H, m, aromatic), 8.37-8.16 (41-1, m, aromatic), 7.81-7.35 (8H, m, aromatic), 
6.24 (21-1, d, 3J = 8.0 Hz, aromatic), 5.75 (21 -1, d, 3J = 8.0 Hz, aromatic), 5.15 (11-1, t, 
= 4.4 Hz, CH), 4.05 (21-1, s, CH2), 3.73 (21-1, d, 3J = 4.5 Hz, CH,); 8c  (CDC13, 50 
MHz), 143.1, 137.9, 137.0, 134.8, 131.0, 130.2, 128.4 (quaternary aromatic Cs), 
128.7, 127.0, 126.8, 125.8, 125.4, 124.9, 124.7, 124.4, 123.5, 123.3, (aromatic 
CH's), 64.7 (CH20H), 47.9 (CH), 39.5 (CH 2); m/z (FAB) 487 (M+), 366, HEMS 
(FAB) found 486.19836, C3IH260  requires 486.19835, (c lppm). 
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4-(17'-Tetrabenzo[a,c,g,i]fluorenylmethyl) benzyI-(N,N-diisopropyI--
cyanoethyl) phosphoramidite (107) 
4-(17'Tetrabenzo[a,c,g,i]fluorenylmethyl) benzyF alcohol (0.70 g, 1.44 mnxil) 
was co-evaporated twice in methylene chloride (10 ml) and then the flask was closed 
with a septum pierced with a needle and filled with argon and the needle removed. An 
argon filled balloon was attached to the flask and the solid was dissolved in thy 
methylene chloride (30 ml). Bis(diisopropylaznmonium) tetrazolide (0.18 g, 0.75 
equiv.), the catalyst, and then (-cyanoethoxy)bis(diisopropylamino) phosphine (0.87 
g, 2 equiv.) were added under argon and the reaction was stirred for 1 h before being 
poured into DCM (15 ml and saturated aqueous sodium hydrogen carbonate (15 ml) 
and extracted. The aqueous layer was washed with DCM (10 ml) and the collected 
organic fractions were washed with brine (30 ml). Finally they were dried over 
magnesium sulphate and evaporated in vacuo to give a brown oil. The residue was 
purified by short column chromatography on silica gel with ethyl acetate / DCM / 
triethylamine: 9 /9 I 2. The collected fractions were evaporated to give a pale yellow 
solid (0.85, 86%); m.p. (softening point) 75-78°C; t.I.c. Rf 0.77; V mn 
(bromoform mull) 2940, 2850 (CH stretching, alkyl), 1604, 1508 (aromatic rings), 
cm-1 ; H (CDC!3, 80 MHz), 8.84-8.69 (41-1, m, aromatic), 8.39-8.16 (41-1, m, 
aromatic), 7.81-7.37 (81-1, m, aromatic), 6.31 (21-1, d, 3J = 8.1 Hz, aromatic), 5.80 
(2H, d, 3J = 8.1 Hz, aromatic), 5.16 (11-1, t, Thf-CH), 4.23-3.39 (81-1, m, Thf-CH 2 
'20' 1pCH), 2.35 (2H, t, CH 2CN), 1.31-0.82 (12H, m, 1pr CH3); O (CDCI3 , 50 
MHz), 143.2, 137.0, 136.3, 136.1, 134.8, 131.0, 130.2, (quaternary aromatic C's), 
128.7, 128.2, 127.8, 126.8, 126.2, 125.8, 125.1, 124.8, 124.5, 123.5, (aromatic 
CH's), 117.5 (CN), 64.9 (CH 20), 58.3 (CH2CN), 48.0 (Tbf-CH), 42.8 (ipCH),  39.6 
(Tbf-CH2), 24.3 (ipr  CH3), 20.1 (0C112); op  (CDC13, 36 MHz), 148.48; m/z (FAB) 
686 (M+), 633, 469, 365; HRMS (FAB) found 687.3 1405, C 46H44N202P requires 
687.31405, (c  lppm). 
155 
1-(Diphenanthren-9'-yl)-1,6-hexanediol (110) 
9-Bromophenanthrene (2.83 g, 11 mmol) was dissolved in dry THF (40 ml) and 
slowly added to magnesium turnings (0.28 g, 11.5 mmol) together with a crystal of 
iodine under nitrogen. The exothermic reaction was controlled with the addition of 9-
bromophenanthrene. After 30 nun stirring, a solution of e-caprolactone (0.57 g, 5 
mmol) in dry THF (30 ml) was slowly added. After 2 h at reflux, ice then aqueous 
ammonium chloride was added until pH 3. The product was extracted into ethyl 
acetate, washed with aqueous sodium hydrogen carbonate (40 ml) and brine (50 ml), 
and dried over magnesium sulphate. After evaporation of the solvents, the residue was 
crystallised in DCM to give a white solid, (0.6 g, 26%); m.p. 238-240°C; C,H,N 
found: C, 86.16; H, 6.74; C34H3002 requires C, 86.78; H, 6.43 %; t.l.c. Rf(q 0.58; 
Vnum (bromoform mull) 3559, 3470 (OH), 3059 (aliphatic CH), 2947, 2848 (CH, 
aromatic) 1597, 1493 (aromatic rings) cm -1; X,( 278 (e 22410 dm3mol 1 cm'), 254 
(122600) nm 11  (CDCI3, 80 MHz), 8.79-7.03 (18H, m, aromatic), 3.30 (4H, s, 
CH2), 1.49-1.16 (6H, m, CH2), m/z (FAB) 470 (Me), 452, 383; HRMS (FAB) found 
470.22458, C34H3002 requires 470.22457, (c lppm). 
Tetrabenzo[a,c,g,i]fluorene/Picric acid Complex 
In order to grow crystals of the charge transfer complex between 
telrabenzo[a,c,g,i]fluorene and picric acid for X-ray analysis, equimolar amounts of 
both compounds were first dissolved separately in a minimum of hot benzene. The 
two solutions were subsequently mixed together to give a dark red solution. Dark red 
crystals grew upon cooling to room temperature and after partial evaporation of the 
solvent overnight. After filtration and washing with cold benzene, the crystals were 
dried in a vacuum oven at 40°C. m.p. 231-233°C; t.l.c. Rf(A) 0.10 and 0.70 (two 
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spots); V, 	(bmmoform mull) 3400 (OH), 3094 (CH stretching, aromatic), 2925 
(CH stretching, alkyl), 1699 (C=O, ketone), 1631, 1604, (aromatic rings), 1544, 1342 
(N=O, nitro) cm-1 ; m/z (El) 381, 366 (M+), 229 (M+); X-Ray analysis, see section 
2.3.2. 
1-(Diphenanthren-9'-yI)-1-hexene-6-ol (112) 
1-(Diphenanthren-9'-yl)-1,6-hexanediol (13-0 g, 0-028 mol) was suspended in 
DCM (100 ml) and TFA (-2.5 ml) was added dropwise, a blue coloration appearing 
after each drop. The brown solution was neutralized with triethylamine whilst being 
cooled with an ice bath. It was then washed with water, aqueous sodium hydrogen 
carbonate and brine, and finally dried over magnesium sulphate. The product was 
purified by dry flash cromatography with DCM / methanol to give a white solid 
(10.25 g, 81%); m.p. 67-70°C; C,H,N found: C, 89.56; H, 6.75; C341-1280 requires C, 
90.23; H, 6.24 %; t.I.c. Rf(c)  0.52;  Vmiy  (bromoform mull) 3600, 3405 (OH), 3019 
(CH stretching, aromatic), 2935, 2857 (CH stretching, alkyl), 1680 (C=C, alkene), 
1594, 1492 (aromatic rings) cur'; itmax  300 (e 19675 dm3mol-1 cm-1 ), 254 (100110) 
nm oH  (CDC13 , 200 MHz), 8.83-7.47 (18H, m, aromatic), 6.36 (IH, t, 3j = 7.3 Hz, 
CH alkene), 3.52 (21-1, t, 3j = 6.2 Hz, OCH2), 2.20-2.17 (21-1, m, CH2), 1.72 (1H, s, 
OH), 1.56 (4H, m, CH,); O (CDC1 3 , 50 Ml-lz), 139.6, 137.3, 1370, 131.3, 131.1, 
130.9, 130.7 (quaternary aromatic C's), 136.7 (CH alkene), 128.7, 128.4, 128.1, 
127.8, 127.3, 126.8, 126.6, 126.4, 126.4, 126.1, 125.7, 123.4, 122.9, 122.3, 122.1 
(aromatic CH's), 62.3 (HOCH 2), 32.1, 30.1, 25.5 (CH2), 39.7 (CH2); mlz (FAB) 452 
(M+), 363, HRMS (FAB) found 452.21404, C 341-1280 requires 452.21399, (c  lppm). 
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5-Hydroxy-1-triphenylmethoxy-pentane (113) 
Triphenylmethyl chloride (11.15 g, 0.04 mol) was added to a solution of 1,5-
pentandiol (4.17 g, 0.04 mol) in dry pyridine (170 ml) at 0°C under nitrogen. The 
clear solution was stirred at room temperature for 24 h. The reaction was quenched 
by adding methanol (20 ml) and evaporated to dryness in vacuo. The white residue 
was taken up in ethyl acetate and washed with water, aqueous sodium hydrogen 
carbonate and water and finally dried over magnesium sulphate. After evaporation of 
the solvent, the product was purified by flash chromatography with DCM to give a 
white solid, (7.0 g, 51%); m.p. 65-69°C; C,H,N found: C, 84.40; H, 8.00; C241 -102 
requires C, 83.19; H, 7.57 %; t.I.c. Rf(A)  0.10, Rf 0.53; VMax (bromoform mull) 
3601, 3390 (OH), 3055 (CH stretching, aromatic), 2938, 2867 (CH stretching, alkyl), 
1597, 1489 (aromatic rings), 1076 (ether C-O stretching) cm -1 ; ?Lmn  280  (e  19850 
dm3mol- 'cnr 1 ), 254 (110150) nm 5H  (CDC13 , 200 MHz), 7.57-7.24 (15H, m, 
aromatic), 3.61 (21-1, t, 3j = 6.3 Hz, OCH2), 3.16 (21-1, t, 3J = 6.5 Hz, OCH2), 2.18 
(11-1, s, OH), 1.73-1.53 (61-1, m, CE! 2); ö (CDCI3, 50 MHz), 144.3 (quaternary 
aromatic C), 128.5, 127.5, 126.7 (aromatic CH's), 86.1 (quaternary trityl C), 63.3, 
62.6 (OCH2), 32.4, 29.6, 22.3 (CH 2); mlz (El) 347 (Mi-), 243, HRMS (El) found 
346.1931, C1102 requires 346.19327, (c lppm). 
1-Triphenylmethoxy-5-bromopentane (114) 
Carbon tetrabromide (9.5 g, 28 mmol) was added to a solution of 5-hydmxy-1-
triphenyhnethoxy-pentane (5.0 g, 14 mmol) and triphenylphosphine (4.5 g, 15.4 
mmol) in dry DMF (75 ml) at 0°C. A few drops of diisopropylamine were added and 
after 15 min the reaction was quenched with methanol (20 ml). The yellow brown 
solution was evaporated to dryness and the residue taken up in ethyl acetate (150 ml) 
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and washed with aqueous sodium hydrogen carbonate and water, then dried over 
magneium sulphate. After evaporation of the solvent, the crude product was purified 
by flash chromatography with DCM. The product was finally crystallised in n-hexane / 
diethyl ether to give a white solid, (4.51 g, 77 %); m.p. 86-87°C; C,H,N found: C, 
71.53; H, 6.48; C24HBrO requires C, 70.57; H, 6.17 %; t.I.c. Rf(A) 0.60; V, 
(bromoform mull) 3045 (CH stretching, aromatic), 2940, 2866 (CH stretching, alkyl), 
1596, 1492 (aromatic rings), 1073 (ether C-O stretching) cm -1 ; A., 281 (e  20653 
dm3tnol4cnr 1 ), 254 (105110) nm 6H  (CDC13, 200 MHz), 7.50-7.20 (15H, in, 
aromatic), 3.40 (21-1, t,  J = 6.8 Hz, BrCH2), 3.10 (21-1, t, 3j = 6.3 Hz, OCH2), 1.85-
1.49 (61-1, m, CH2); ö (CDCI3, 50 MHz), 144.2 (quaternary aromatic C), 128.5, 
127.6, 126.7 (aromatic CH's), 86.2 (quaternary trityl C), 63.0 (OCH 2), 33.7 (BrCH2), 
32.4, 29.0, 24.8 (CH2); m/z (El) 410 (M+), 332, 240; HRMS (El) found 410.1080, 
CHOBr requires 410.10695. 
3-(17'-tetrabenzo[a,c,g,i]fluorenyl) propanol (116) 
A solution of 9-BBN (17.7 ml, 0.5M, 8.9 mmol) in THF was added to a 
solution of 1-(17'-tetrabenzo[a,c,g,z]fluorenyl)-prop-2-ene (3.0 g, 7.4 mmol) in dry 
THF (20 ml) under nitrogen. The tempearture was maintained below 20°C. After 3 h 
stirring the solution became lighter, aqueous sodium hydroxide (0.35 g in 2 ml water, 
8.9 mmol) was first added then hydrogen peroxide (1 ml, 30% in water, 8.9 mmol) 
the temperature rose to 45 °C. The reaction mixture was stirred at 60°C for 1 h and 
then cooled to room temperature. Fresh hydrogen peroxide (1 equiv) was added and 
left to stir overnight at room temperature. The product was extracted with DCM / 
methanol (9/1, 100 ml), washed with water, aqueous sodium hydrogen carbonate and 
dried over magnesium sulphate. After evaporation of the solvents, the residue was 
recrystallised in THE / DCM to give a white solid, (1.80 g, 57 %); m.p. 188-190°C; 
1W] 
C,H,N found: C, 90.58; H, 6.04; C321-1240 requires C, 90.53; H, 5.70 %; U.C. Rf(A) 
0.13; V.. (bromoform mull) 3326 (OH), 3021 (CH stretching, aromatic), 2950, 
2859 (CH stretching, Sky!), 1604, 1497 (aromatic rings) cm -1 ; A.,, 380 (c 17366 
dm3mol-1 cm- '), 365 (18326), 300 (37548), 288 (32548), 254 (86966) nm 811 
(CDC13, 200 MHz), 8.97-8.87 (4H, m, aromatic), 8.57 (2H, d, 3J = 8.2 Hz, aromatic), 
8.34 (2H, d, 3J = 8.3 Hz, aromatic), 7.81-7.64 (81 -1, m, aromatic), 5.31 (1H, s, CH 
Tbf), 3.98 (111, t, 3J = 5.2 Hz, OH), 2.87-2.78 (211, m, CH.), 2.60-2.49 (21-1, m, 
CH2), 0.35-0.23 (21-1, m, CE!2); ö (CDC13, 50 MHz), 144.6, 135.9, 130.9, 130.5, 
129.9, (quaternary aromatic C's), 128.3, 127.8, 127.3, 126.7, 126.5, 126.1, 125.5, 
124.7, 124.1, 123.8 (aromatic CH's), 60.7 (HOCH2), 46.4 (Tbf CH), 30.1, 25.8 
(CH2); m/z (FAB) 425 (M+), 408, 366, FIRMS (FAB) found 424.18273, C 32H240 
requires 424.18270, (c 1 ppm). 
3-(17'-tetrabenzo[a,c,g,i]fluorenyl) propyl-NN-diisopropyl-j3-cyanoethyl 
phosphoramidite (117) 
3- ( 17 '-tetrabenzo[a,c,g,ilfluorenyl)propanol (0.64 g, 1.5 mmol) was co-
evaporated twice with dry methylene chloride (10 ml) and then the flask was closed 
with a septum pierced with a needle and filled with nitrogen and the needle removed. 
An nitrogen filled balloon was attached to the flask and the solid was dissolved in dry 
methylene chloride (15 ml). Diisopropylethylamine (0.59 g, 4.5 mmol) and N,N-
diisopmpy1-3-cyanoethyl phosphoramidyl chloride (0.36 g, 1.5 mmol) were added 
under nitrogen and the reaction was stirred for 1 h before being poured into saturated 
aqueous sodium hydrogen carbonate (30 ml). The organic fraction was washed with 
water and dried over magnesium sulphate. After evaporation in vacuo the brown oil 
was purified by short column chromatography on silica gel with ethyl 
acetatefcyclohexane 4/1. The collected fractions were evaporated to give a yellow 
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foam like solid (0.81, 86 %); m.p. 62-65°C; C,H,N found: C, 78.28; H, 7.18; N, 
4.74; C41 H4102PN2 requires C, 78.82; H, 6.61; N, 4.48 %; t.I.c. Rfw  0.73;  VMAX  
(bmmofonn mull) 3072, 3023 (CH stretching aromatic), 2929, 2870 (CH stretching, 
alkyl), 2253 (CN), 1608, 1500 (aromatic rings), cm-1; SH  (CDC13, 200 MHz), 8.82- 
8.76 (4H, in, aromatic), 8.67 (21-1, d, 3J = 8.0 Hz, aromatic), 8.24 (2H, d, 3J = 8.0 Hz, 
aromatic), 7.73-7.55 (8H, m, aromatic), 5.06 (1H, t, Thf-CH), 3.41-3.04 (61-1, in, Thf- 
CH2, 0120, 1p1CH), 2.78-2.67 (21-1, m, Tbf-CH2), 2.21 (21-1, t, 3j = 6.6 Hz, CH2CN), 
1.30-1.18 (21-1, m, C1-1 2), 1.00-0.79 (12H, dd, 'pr CH 3), 0.67-0.52 (21-1, in, Thf-CH2); 
Oc (CDC13, 50 MHz), 143.7, 136.8, 131.2, 130.3, 128.6, 127.4 (quaternary aromatic 
C's), 126.8, 125.8, 125.6, 125.0, 124.3, 123.4 (aromatic CH's), 117.5 (CN), 63.1 
(CH20), 58.0 (CH2CN), 46.4 (Tbf-CH), 42.6 (1pCH), 30.0 (Tbf-CH2), 24.2 (ipr 
CE!3), 19.9 (OCH2); op  (CDCI3, 36 MHz), 147.47; m/z (FAB) 625 (M+), 633, 407, 
364; HRMS (FAB) found 624.29063, C41 1-141 N202P requires 624.29055, (c lppm). 
3.3 Oligodeoxyribonucleotide Synthesis 
The synthesis of oligodeoxyribonucleotides was performed on an Applied 
Biosystems 380B DNA Synthesizer. A,C,G,T phosphoramidite monomers, tetrazole 
coupling catalyst, acetic anhydride and N-methyl imidazole capping reagents, 
trichloroacetic acid deprotection solution, iodine oxidation mixture, acetonitrile wash 
solvent, aqueous ammonia cleavage solution and the solid support were all purchased 
from Applied Biosystems or Cruachem Ltd. The monomers were dissolved in 
anhydrous acetonitrile. Synthesis scale varied from 0.2 p.mol to 1 I.Lmol using 
controlled pore glass (CPO) as the solid support and 40 nmol for polystyrene 
supports. In each case the first nucleoside was already attached to the support via a 
succinyl linker by the time of purchase. At the end of the synthesis the 
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oligonucleotides were cleaved from the solid support by treatment with concentrated 
aqueous ammonia and the exocyclic amine protecting groups were removed by 
heating the ammonium hydroxide solution to 50°C for 4 h. The water and ammonia 
were removed in vacuo and the residue was dissolved in 2 ml of water and analysed 
by RP-HPLC. 
The chemical steps for one synthesis cycle are presented in appendix I. Multiple 
washes with the same solvent involve filtration between wash steps. Each step volume 
is 1 ml. For each jimol of nucleoside attached covalently to the support, O.4M 
tetrazole and 0.1 M monomer phosphoramidite are premixed in acetonitrile. 12 solution 
is THF/lutidine/water: 2/2/1 containing 0.2M iodine. 
3.4 S'-Tbf-DMTr-oligodeoxyribonucleotide Synthesis 
The preparation of 5'-Thf-DMTr-oligodeoxyribonucleotides, as presented in 
chapter 2.6.2, is generally performed manually directly with the synthesis columns. 
The oligodeoxyribonucleotide is synthesised according to the standard -cyanoethyl 
phosphoramidite protocol in the "Trityl-off' and manual deprotection mode. The 3'-
end of the oligonucleotide is therefore bound to the CPG-support while the 5'-end is 
free to react with the Thf-DMTr-Cl protecting group. Prior to the reaction, a 0.4-0.3 
M solution of Thf-DMTr-Cl in dry pyridine is prepared from freshly synthesized Thf-
DMTr-Cl. Typically for 0.2 and 1 p.mol syntheses, 1 ml of the orange solution is 
flushed through the column with two 1 ml syringes, see Fig. 2.12. For 10 p.mol 
syntheses, 3 ml of Thf-DMTr-Cl solution is necessary. Air bubbles can be expelled by 
keeping the column-syringe system upright. The protecting group is then left to react 
with the free 5'-hydroxyl groups for 1.5 to 2 h at room temperature. The nearly 
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saturated solution of Thf-DMTr-Cl should not precipitate in the column. If it does it 
should be diluted with fresh pyridine. The column is then flushed slowly, so as not to 
break the fragile filters, with pyridine (5 ml) and acetonitrile (5 ml). The column can 
be put back onto the DNA synthesizer and the deprotection programmed in the 
"Trityl-On" and automatic deprotection mode. The 5'-Thf-DMTr-oligonucleotide with 
the exocyclic amines still protected, is subsequently obtained in solution in ammonia. 
The base deprotection and subsequent work-up rejoins the standard protocol. 
3.5 Oligodeoxyribonucleotide Deprotection and Purification 
For phosphoramidite synthesized oligodeoxyribonucleotides, a final reaction 
step involving warming in the presence of concentrated ammonia is required for 
deprotection of the base protecting group. This is usually achieved by inserting the 
vial containing the crude product in a heating block at 50°C for 4 h. Afterwhat the 
only remaining protecting group is Thf-DMTr at the 5'-end. The crude 5'-Thf-DMTr-
oligonucleotide is evaporated to dryness in vacuo or liophilized and dissolved in 0.7 
ml of distilled water. For short sequences the purification is effected as outlined in 
section 2.8, whereas for longer sequences (> 30-mer) the purification is carried out by 
preparative RP-HPLC with a binary solvent system to give a gradient of acetonitrile in 
aqueous ammonium acetate buffer (section 3.1). The fluorescent hydrophobic Thf-
DMTr containing fractions are collected and evaporated or liophilized. The 5'-
deprotection is then carried out by dissolving the residue in 1 ml of water and 4 ml of 
acetic acid. The solution is left to react for 45 mm, after which it is evaporated or 
liophilized three times using 2 ml of water for each redissolution. The residue is 
subsequently dissolved in exactly 1 ml of water and loaded onto a Sephadex G-25 
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column for desalting. The pure oligonucleotide is finally obtained in an aqueous 
solution following elution of the Sephadex column with 1.5 ml of water. 
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Abbreviations 
9-BBN 9-borabicyclo[3.3. l]nonane 
A Adenine 
AP Alkaline phosphatase 
bp Base pair 
C Cytosine 
CE Capillary gel electrophoresis 
CNE f3-Cyanoethyl 




DIBAL Diisobutylaluminium hydride 
DMAP N,N-Dimethylaminopyridine 
DMTr 4,4'-Dimethoxytrityl 
DNA Deoxyribonucleic acid 
DNP 2,4-Dinitrophenyl 
EDTA Ethylene diamine tetra-acetic acid 
Fmoc Fluoren-9-ylmethoxycarbonyl 
G Guanine 
HPLC High performance liquid chromatography 
HRP Horseradish peroxidase 
MMTr 4-monomethoxytrityl 
mRNA Messenger RNA 
MSNT 1-Mesitylenesulphonyl-3-nitro- 1,2,4-triazole 
nmr Nuclear magnetic resonance 
NPE 2-(p-Nitmphenyl)ethyl 
PAGE Polyacrylamide gel electrophoresis 
PGC Porous graphitised carbon 
RNA Ribonucleic acid 
RP-HPLC Reverse-phase HPLC 
SPS Solid phase synthesis 
T Thymine 
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t.I.c. 	 Thin layer chromatography 
TBAF Tetra-n-butylammonium fluoride 
Tbf 	 Tetrabenzo[a,c,g,ijfluorene 
Tbf-DMTr 	4-( l7 LTetrabenzo[a,c,g,z]fluorenylmethyl) -4",4"-dimethoxytrityl 
Tbf-DMTr-CI 4-(l7'-Tetraberizo[a,c,g,ijfluorenyhnethyl)-4",4'"-dimethoxylrityl 
chloride 
Tbf-DMTr-OH 4-( 17'-Tetrabenzo[a,c,gjjfluorenylmethyl) -4",4"'-dimethoxytrityl 
alcohol 
Tbf-Prop 	Teu-abenzo[a,c,g,i]fluorenylpropyl 
Tbf-Prop-Ph Tetrabenzo[a,c,g,i]fluorenylpropyl phosphate 
Tbf-Tr 4-( 1 7 t-Tetrabenzo[a,c,g,z]fluorenylmethyl) -lrityl 
TbI-Tr-CI 4-( 1 T-Tetrabenzo[a,c,g,z]fluorenylmethyl)-trityl chloride 
Tbf-Tr-OH 4-( 1 7'-Tetrabenzo[a,c,g,ijfluorenylmethyl)-trityl alcohol 
Tbf-Trityl 4-(1 7' -Tetrabenzo[a,c,g,i]fluorenyhnethyl) -trityl 
Tbfmoc Tetrabenzo[a,c,g,i]fluorenyl -  1 7-methyloxycarbonyl 
TCA Trichlomacetic acid 
TFA Trifluoroacetic acid 
THF Tetrahydrofuran 
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APPENDIX 
Standard synthesis cycle on a ABI 380 DNA synthesiser, 2 Ismol scale synthesis by 
the phosphoramidite method. 
STEP FUNCTION STEP STEP ACTIVE FOR BASES 
NUMBER 'CiltE AG C T56 7 
10 £18 To Waste 4 Yes Yes Yes Yes Yes Yes Yes 
2 9 £18 To Column 60 Yes Yes Yes Yes Yes Yes Yes 
3 2 Reverse Flush 20 Yes Yes Yes Yes Yes Yes Yes 
4 1 Block Flush 4 Yes Yes Yes Yes Yes Yes Yes 
5 28 Phos Prep 3 Yes Yes. Yea Yes Yes Yes Yes 
6 +45 Group 1 On 1 Yes Yes Yes Yes Yes Yes Yes 
7 90 TET to column 2 Yes Yes Yes Yes Yes Yes Yes 
8 19 B+TET To Col 1 3 Yes Yes Yes Yes Yes Yes Yes 
9 90 TET to column 2 Yes Yes Yes Yes Yes Yes Yes 
10 19 B+TET To Col 1 2 Yes Yes Yes-Yes Yes Yes Yes 
11 9 £18 To Column 2 Yes Yes Yes Yes Yes Yes Yes 
12 -46 Group 1 Off I Yes Yes Yes Yes \ - 
13 +47 Group 2 On 1 Yes Yes Yes Yes Yes - 
14 10 £18 To Waste 7 es is \es Yes Ins 
15. I Block 	Flush Ye Yes Yes Yes Yes 
16 90 YET 	Le column :0 'cs \es Yes Yes Yes -s 
17 20 B+rET To Col 	2 Yes Yes Yes Yes Yes 
90 TEl to column Yes Yes Yes  
U) 20 A+TET To Col 	2 
20 9 £18 To Column - --'s es Yes Yes Yes 
21 -48 (:roi 	2 	f) f Yes Yes Yes Yes Yes Yes 
22 +49 c;.rc. 	- Yes Yes Yes Yes Yes Yes Yes 
23 10 £IH To Waste 7 Yes Yes Yes Yes Yes Yes Yes 
I Block Flush 4 Yes Yes Yes Yes Yes Yes Yes 
25 90 TET to column 2 Yes Yes Yes Yes Yes Yes Yes 
26 21 B+TET To Go! 3 3 Yes Yes Yes Yes Yes Yes Yes 
27 90 TET to column 2 Yes Yes Yes Yes Yes Yes Yes 
28 21 B+TET To Col 3 2 Yes Yes Yes Yes Yes Yes Yes 
29 9 £18 To Column 2 Yes Yes Yes Yes Yes Yes Yes 
30 -50 Group 3 Off 1 Yes Yes Yes Yes Yes Yes Yes 
31 4 Wait 30 Yes Yes Yes Yes Yes Yes Yes 
32 16 Cap Prep 10 Yes Yes Yes Yes Yes Yes Yes 
33 10 £18 To Waste S Yes Yes Yes Yes Yes Yes Yes 
34 - 	 2 Reverse Flush 5 Yes Yes Yes Yes Yes Yes Yes 
35 1 Block Flush 4 Yes Yes Yes Yes Yes Yes Yes 
36 +45 Group 1 On 1 Yes Yes Yes Yes Yes Yes Yes 
37 22 Cap To Col 1 15 Yes Yes Yes Yes Yes Yes Yes 
38 -46 Group 1 Off 1 Yes Yes Yes Yes Yes Yes Yes 
39 +47 Group 2 On 1 Yes Yes Yes Yes Yes Yes Yes 
40 23 Cap To Col 2 12 Yes Yes Yes Yes Yes Yes Yes 
- 	 41 -48 Group 2 Off 1 Yes Yes Yes Yes Yes Yes Yes 
42 +49 Group 3 On 1 Yes Yes Yes Yes Yes Yes Yes 
43 24 Cap To Col 3 12 Yes Yes Yes Yes Yes Yes Yes 
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STEP FUNCTION STEP STEP ACTIVE FOR BASES 
NUMBER £ NAME TIME A U C T 5 6 7 
44 -50 Group 3 Off I Yes Yes Yes Yes Yes Yes Ye 
45 4 Wait 1 Yes Yes Yes Yes Yes Yes Ye 
46 - 	10 £18 To Waste 7 Yes Yes Yea Yes Yes Yes Ye 
47 2 Reverse Flush 5 Yes Yes Yes Yes Yes Yes Ye 
48 1 Block Flush 4 Yes Yes Yes Yes Yes Yes Ye 
49 81 £15 To Waste 7 Yes Yes Yes Yes Yes Yes Ye 
50 13 £15 To Column 15 Yes Yes Yes Yes Yes Yes Ye 
51 4 Wait 30 Yes Yes Yes Yes Yes Yes Ye 
52 10 £18 To Waste 10 Yes Yes Yes Yes Yes Yes Ye 
-53 2 Reverse Flush 20 Yes Yes Yes Yes Yes Yes Ye 
54 1 Block Flush 4 Yes Yes Yes Yes Yes Yes Ye 
55 9 £18 To Column 20 Yes Yes Yes Yes Yes Yes Yes 
56 2 Reverse Flush 5 Yes Yes Yes Yes Yes Yes Ye 
57 9 £18 To Column 10 Yes Yes Yes Yes Yes Yes Ye, 
58 2 Reverse Flush 5 Yes Yes Yes Yes Yes Yes Yes  
59 9 £18 To Column 10 Yes Yes Yes Yes Yes Yes Ye, 
60 2 Reverse Flush 5 Yes Yes Yes Yes Yes Yes Ye, 
61 9 £18 To Column 10 Yes Yes Yes Yes Yes Yes Yes 
62 2 Reverse Flush 5 Yes Yes Yes Yes Yes Yes Ye, 
63 1 Block Flush 4 Yes Yes Yes Yes Yes Yes Yes 
64 33 Cycle Entry 1 Yes Yes Yes Yes Yes Yes Yes 
65 10 £18 To Waste 3 Yes Yes Yes Yes Yes Yes Yes 
66 9 £18 To Column 20 Yes Yes Yes Yes Yes Yes Yes 
67 2 Reverse Flush 5 Yes Yes Yes Yes Yes Yes Yes 
68 1 Block Flush 6 Yes Yes Yes Yes Yes Yes Ye, 
69 6 Waste-Port 1 Yes Yes Yes Yes Yes Yes Yes 
70 5 Advance FC 1 Yes Yes Yes Yes Yes Yes Yes 
71 82 £14 To Waste 5 Yes Yes Yes Yes Yes Yes Yes 
72 14 £14 To Column 10 Yes Yes Yes Yes Yes Yes Ye, 
73 2 Reverse Flush 1 Yes Yes Yes Yes Yes Yes Yes 
74 14 £14 To Column 10 Yes Yes Yes Yes Yes Yes Yes 
75 2 Reverse Flush 1 Yes Yes Yes Yes Yes Yes Yes 
76 14 £14 To Column 10 Yes Yes Yes Yes Yes Yes Yes 
77 2 Reverse Flush 1 Yes Yes Yes Yes Yes Yes Yes 
78 14 £14 To Column 10 Yes Yes Yes Yes Yes Yes Yes 
79 2 Reverse Flush 1 Yes Yes Yes Yes Yes Yes Yes 
80 14 £14 To Column 10 Yes Yes Yes Yes Yes Yes Yes 
81 1 Block Flush 4 Yes Yes Yes Yes Yes Yes Yes 
82 10 £18 To Waste 5 Yes Yes Yes Yes Yes Yes Yes 
83 9. £18 To Column 30 Yes Yes Yes Yes Yes Yes Yes 
84 2 Reverse Flush 5 Yes Yes Yes Yes Yes Yes Ye 
85 10 £18 To Waste 5 Yes Yes Yes Yes Yes \es 
86 	. 9 £18 To Column 30 Yes Yes Yes Yes Yes Yes Yes 
87 2 Reverse Flush 5 Yes Yes Yes Yes Yes Yes Yes 
88 1 Block Flush 4 Yes Yes Yes Yes Yes Yes Yes 
89 7 Waste-Bottle 1 Yes Yes Yes Yes Yes Yes Yes 
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by the synthesizer without altering the synthesis cycle. Figure I shows the RP'HPLC profile of a crude 12-mer oligonucleotide 
(7TC-C3AG-CCA-TAT) at 280 nm bearing DMTr at the 5-terminus and Figure 2 shows the same crude oligonucleotide bearing a 
5'.Thf-DMTr terminus. The difference in retention time is consistent with the hydrophobicity order of the two protecting groups 
and the product peak is well separated from the truncated sequences. Using current methodology for the synthesis of short 
sequences a single peak is usually obtained but for longer sequences a broad product peak or a number of less defined peaks is 
observed especially if the capping steps in the synthesis cycle have not been efficient or if the product has several stable 
conformations. 
10 	20 	30 min 	 tO 	20 	30 	40 min  
	
Figure 	I Figure 2 
In order to prove the usefulness of this protecting group, we synthesised various DNA sequences of different lengths and 
terminal nucleotide. We found that the retention of Thf-DMTr.oligos was so strong that isocratic conditions were sufficient to 
purify oligonucleotides on R1'-C18 SEP.FAKcarlridges. Similar results were obtained with polystyrene cartridges the advantage 
of which is that the ammonia solution of the crude oligonucleotide can be loaded directly without damaging the stationary phase. 
Failure sequences are eluted with 1096 acctonitrile$90% 0.1 M ammonium acetate, then Thf-DMTr. is removed with 2% TEA and 
the product is finally eluted as a single peak with 30% aectonilril70% 0.1 M ammonium acetate. This simple procedure can be 
accomplished within 15 min thus avoiding the time consuming HPLC gradient clution. Further we tested the usefulness of Thf-
DMTr-Cl in the synthesis and purification of longer oligonucleotides. We first synthesised the following 51-mer : 5'-GAT-CTO-
TfG.ACA.Afl.AAT.CAT.CGG.CTC.GTA.TAA.TGtGTG.GAAUO.GTC'OAC-3' Figure 3 shows the HPLC profile of the 
crude 51-mer at 280 nm (Solvent A: aIM ammonium acetate; Solvent B: 50% acetonitrile) and Figure 4 shows the HPLC profile 
of the appropriate uv fractions (Solvent A: 0.IM ammonium acetate; Solvent B: 20% aeetoniuile) after deprotection in 80% 
acetic acid and desalting over Sephadex®G.25 column. Capillary gel clectrophoresis (Figure 5) indicates clearly that the by-
product is a much shorter sequence resulting from an incomplete capping step. Figure 6 shows the product as a single peak on 
capillary gel electrophoresis after preparative HPLC purification. 
10 	20 	30 	40 min 	 10 	20 	30 min  
Figure 3 	 Figure 4 	 Figure 5 
10 	20 	30 	40 ruin 
Figure 6 	 Figure 7 
10 	20 	30 min  
Figure 8 
The following 102.rner was synthesised and purified in the same manner 5'-GATCTO-nG.ACA.ATFAAT.CATCGGCC. 
GTATAA .TGT.GTG .GAA.TFG.GTCGAC.GAT.aO.UG ACA AlT AAT CAT CCC CrC GTA TAA TOT ATC GAA 
11'G-GTC-GAC.3'. Figure 7 shows the RP-f-IPLC profile of the crude at 280 nm (Solvent A: 0. IM ammonium acetate; Solvent B: 
50% acetoniu'ile). After purification by RP-HPLC (Solvent A: 0.IM ammonium acetate; Solvent B: 20% acetonitrile) according 
to our methodology, the product was obtained as a single peak; Figure 8. 
In summary, we have shown that Thf-DMTr.CI can be used to introduce the Thf'DMTr group directly onto the support-bound 
oligonueleotide, without lowering the synthesis yield. The removal of this new protecting group in acid is twice as fast as DMTr 
and its ultra-violet properties enable easy detection at DNA non-damaging wavelengths. Due to the high hydrophobicity of Thf. 
DMTr, impurities can be separated by isocratic conditions on small RP-C18 silica gel or polystyrene cartridges. Furthermore, the 
purification of long oligonueleotities > 100 units is easily achieved by RP-l-IPLC. The trityl analogue 4 is currently under study 
for applications in carbohydrate synthesis. 
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The following IO2'mer was synthesised and purified in the same manner. 5'-GAT-CG.lTG-ACA-An.AAT.CATCGG.aC. 
GTA .TAA .TGT.G G.GAA-nG.GTC-GAC.GAT-aG.nGACA.An AAT CAT COG CrC GTA TAA TOT ATG GAA 
T7G-GTC-GAC.3', Figure 7 shows the RP'l-{PLC profile of the crude at 280 mu (Solvent A: 0. IM ammonium acetate: Solvent B: 
50% acetonjuile), After purification by RP-HPLC (Solvent A: 0. IM ammonium acetate; Solvent B: 20% 'acetonitrile) according 
to our methodology, the product was obtained as a single peak: Figure 8. 
In summary, we have shown that Tbf-DMTr-Cl can be used to introduce the Thf-DMTr group directly onto the support-bound 
oligonucleotide, without lowering the synthesis yield. The removal of this new protecting group in acid is twice as fast as DMTr 
and its ultra-violet properties enable easy detection at DNA non-damaging wavelengths. Due to the high hydrophobicity of Tbf-
DMTr, impurities can be separated by isocratic conditions on small RP-C18 silica gel or polystyrene cartridges. Furthermore, the 
purification of long oligonuelcotides > 100 units is easily achieved by RP-HPLC. The trityl analogue 4 is currently under study 
for applications in carbohydrate synthesis. 
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by the synthesizer without altering the synthesis cycle. Figure 1 shows the RP-l-IPLC profile of a crude 12-mci oligonucleotide 
(TTC-GAG-CCA-TAT) as 280 nm bearing DMTr at the 5-terminus and Figure 2 shows the same crude oligonucleotide bearing a 
5'-Thf-DMTr terminus. The difference in retention time is consistent with the hydrophobicity order of the two protecting groups 
and the product peak is well separated from the truncated sequences. Using current methodology for the synthesis of shon 
sequences a single peak is usually obtained but for longer sequences a broad product peak or a number of less defined peaks is 
observed especially if the capping steps in the synthesis cycle have not been efficient or if the product has several stable 
conformations. 
10 	20 	30 min 	 to 	20 	30 	40 min  
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In order to prove the usefulness of this protecting group, we synthesised various DNA sequences of different lengths and 
terminal nucleotide. We found that the retention of Thf-DMTr-oIigOs was so strong that isocratic conditions were sufficient to 
purify oligonucleotides on RP-C18 Similar results were obtained with polystyrene cartridges the advantage 
of which is that the ammonia solution of the crude oligonucleotide can be loaded directly without damaging the stationary phase. 
Failure sequences are eluted with 10% acetonitrile/90% 0.1 M ammonium acetate, then Thf-DMTr- is removed with 2% TFA and 
the product is finally elated as a single peak with 30% acetoniirileflO% 0.1 M ammonium acetate- This simple procedure can be 
accomplished within 15 min thus avoiding the time consuming I-IPLC gradient elusion. Further we tested the usefulness of Tbf-
DMTr-Cl in the synthesis and purification of longer oligonucleotides. We first synthesised the following 51-mer 5-GAT-CTG- 
Figure 3 shows the HPLC profile of the 
crude 51-11er at 280 nm (Solvent A: 0.lM ammonium acetate; Solvent 8:50% acesonitrile) and Figure 4 shows the UPLC profile 
of the appropriate uv fractions (Solvent A: 0.IM ammonium acetate; Solvent B: 20% acetonitrile) after deprotection in 80% 
acetic acid and desalting over Sephadex®G25 column. Capillary gel elecuophoresis (Figure 5) indicates clearly that the by-
product is a much shorter sequence resulting from an incomplete capping step- Figure 6 shows the product as a single peak on 
capillary gel electrophoresis after preparative HPLC purification. 
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4-(17-Tetrabenzo(a,c,g,i)tluorenytmethyl)-4',4"-Dimethoxytrityl Chloride: 
A Hydrophobic 5'-Protecting Group for the Separation of Synthetic Oligonucleotides. 
Robert Ramage, Franck Olivier Wahl 
Department of Chemistry. University of Edinburgh, West Mains Road, Edinburgh EH9 3M, Scotland 
Keywords: RP-HPL.C; 4-(17.Terrabenzo/a.c.g.iJfluorenylmethyl)-4'.4-Dimethoxytrityl Chloride: Tbf-DAffr; DMTr: Protecting 
group: Ohgonucleotide Synthesis. 
Abstract, A now highly hydrophobic 3'.hydroayl protecting group (Tbi-DMTi) has — designS for - Nfification of synthesic oIigoivJcIeolidea. iN-OMIt. 
oligonucleosides sit suongly ,taaine4 as RP-HPLC allowing • Facile separation From tnnscated sequences. SobsequcuLly the voup  can be removed in acidic 
caidisiasa, The ulirs-violes properties of Th(-DMTr enable easy dcteaias. The sysglscaia and purification, of long oligonucleotides (, 100 ncr) is envisaged. 
With the development of automated DNA synthesis, oligonucleotides can be synthesised efficiently and in a short period of 
Lime. However, syntheses of DNA sequences in excess of 20 nucleotides in length, which involve over 100 chemical steps, 
produce a large amount of impurities which complicate the purification. Usually the identification of the product is achieved by 
leaving the 5'-DMTr (di.p-anisylphenylmethyl) group on the final monomer so that the product can be resolved from non 5-
DMTr terminated sequences on RP-HPLC.' Unfortunately the change in the overall polarity by the introduction of the 
hydrophobic DMTr moiety is greatly reduced for longer oligonucteotides. Seliger and Goertz 2 have modified the DMTr group 
developed by lchorana et al.3  by introducing para-alkyloxy groups and thus improving the separation by HPLC. Lelsinger and 
Finan4  have substituted one phenyl ring by a naphthyl group but this protecting group requires strong acid conditions for its 
removal. Later, Fourrey ci al introduced the fluorescent pyrenyl group. However in both cases only the protected 
phosphoramidite monomer of thymidine has been successfully prepared. Previous work demonstrated that peptidic derivatives of 
tctrabenzo[a.cg.i)fluorene (Tbf) are strongly retained on RP-HPLC columns. 6 Therefore we modified the DMTr group by 
substituting position 4 of one of the phenyl ring with teinbenzo[a,cj.,]fluorenylmethyl. which still preserves the regioselectivity 
of the trityl group for primary hydroxyls while forming an extremely hydrophobic 5-protecting group. Moreover the TV moiety 
shows characteristic UV maxima at 365 and 380 nm which is most useful in monitoring the HPLC purification of 
oligonucleotides. Our strategy consisted of introducing 4.7-tetxabenzo(ac4.afluorenylrnethyl)-4'A"-dirnet1ioxytrityl chloride 
(Tbf-DMTr-Cl) as a new hydrophobic protecting group on the 5-end of long oligonucleotides and exploiting its properties for 
their purification. 
The synthesis of Thf-DMTr-T-phosphoramidite 10 is shown in the Scheme. Tezrabenzo[a.ce.slfluorene 2 was achieved 7 from 
9.bromophenanthrene in a simpler manner than the one described by Dc Ridder and Martin. 8  An alkylation reaction with methyl-
4-bromomethylbenzoate gave the methyl ester 3. The carbinol compounds 4 and 5 were obtained by a Grignard reaction 
involving bromobenzene or bromoanisole respectively. The orange coloured 6 and 7 were obtained by treatment of 4 and S 
respectively with acetyl chloride. Thf-DMTr-Cl 7 and Thf-Tr-Cl 6 were reacted with thymidine in pyridine to yield the 5'. 
protected nucleosides 8 and 9 in 40%. A kinetic study of the deprotection of 9 and 5'-DMTr-O-Thytnidine was undertaken by 
monitoring the absorbance of the resulting trityl carbocation at 500 rim against time. The results were treated as a pseudo-first 




Due to the donating inductive effect of LcUabenzo[a.c.g.4IlIzorenylInethyI. Thf-DMTr is twice as acid labile as the DMTr. 5-mi-
DMTr-thymidine was convened to the cyanoethylphosphoramidite 10 by We method of McBride and Cansthers. 9  The synthesis 
of oligonucleotide was performed by We phosphite-triesier approach using 10 for the last coupling reaction, thus only the desired 
sequence bore the protecting group having a 2, max. 31365 and 380 am. Due to steric factors, coupling yields between 70 and 





























Because phosphoramidite monomers have a lower coupling efficiency we synthesised a sales of oligonucleotides in the trityl-off 
mode and protected the terminal 5-hydroxyl with DMTr-Cl and Thf-DMTr-Cl while still bound to the solid support. We found 
that a 0.4 M solution of DMTr-CI or Thf-DMTr-CI in pyridine reacted completely with We 5-hydroxyl of an oligonucleotide 
attached to the supporL We did not observe any significant change in the I-IPLC of the product when compared to 
oligonucleotides synthesised by the trityl-on mode. This method presents the advantage of using Thf-DMTr-CI as a single reagent 
for A. C. T or C-terminated oligonucleoudes. It can be injected manually into the column as a pyridine solution or automatically 
Due to the donating inductive effect of tetrabenzo[a.c,alfluorenytmethyl. Thf-DMTr is twice as acid labile as the DMTr. 5-mi-
DMTr-thymidine was converted to the cyanoethylphosphoramidite 10 by the method of McBride and Canithers. 9  The synthesis 
of oligonucleotide was performed by the phosphite-thester approach using 10 for the last coupling reaction, thus only the desired 
sequence bore the protecting group having a A. max. at 365 and 380 run. Due to steric factors, coupling yields between 70 and 
88% were obtained compared to >98% obtained for DM'Fr-protected nucleotides. 
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Because phosphoramidite monomers have a lower coupling efficiency we synthesised a series of oligonucleotides in the uityl-off 
mode and protected the terminal S'-hydroxyl with DMTr-Cl and l'bf-DMl'r-Cl while still bound to the solid support. We found 
that a 0.4 M solution of DMTr-Cl or Thf-DMTr-Cl in pyridine reacted completely with the 5-hydroxyl of an oligonucleotide 
attached to the support. We did not observe any significant change in the I-IPLC of the product when compared to 
oligonucleotides synthesised by the trityl-on mode. This method presents the advantage of using Thf-DMTr.Cl as a single reagent 




A Hydrophobic S'-Protecting Group for the Separation of Synthetic Oligonucleotides. 
Robert Ramage, Franck Olivier Wahl 
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Keywords: RP-HPL.C: 4.(17.Tezra ertzo/a,c.g.iJfluorenyImeihyl)-44'-Dimethorytrityi Chloride: Tbf-DMTr: DMTr: Protecting 
group: Oligonucleolide Synthesis. 
Abetract: A new highly hydrophobic S-hydroxyl proterting group (r&-DMTr) ha beat deaigrred for the 1mrificsion of tyTithetic oligottucleotides. Tht-DMTr-
oligonucleosides art strongly retained as RP-HPLC allowing a facile scniion Iron, innsicd sequasro. Subsequently she group can be ranoted in acidic 
conditions. The ultra-violet propenies of Thf-DMTr enable easy deseclion. The ryrabesis aS purification of long oligonucleoiidcr (, lm.') is envisaged. 
With the development of automated DNA synthesis, oligonucleotides can be synthesised efficiently and in a short period of 
Lime. However, syntheses of DNA sequences in excess of 20 nucleotides in length, which involve over 100 chemical steps, 
produce a large amount of impurities which complicate the purification. Usually the identification of the product is achieved by 
leaving the 5-DMTr (di-p-anisylphenylmethyl) group on the final monomer so that the product can be resolved from non 5'-
Dl¼fFr terminated sequences on RP-1-IPLC) Unfortunately the change in the overall polarity by the introdUCLion of the 
hydrophobic DM'rr moiety is greatly reduced for longer oligonucleotides. Seliger and Goertz 2 have modified the DMTr group 
developed by Khorana at a). 3  by introducing para-alkyloxy groups and thus improving the separation by HPI_C. Letsinger and 
Finan4  have substituted one phenyl ring by a naphthyl group but this protecting group requires strong acid conditions for its 
removal. Later, Fourrey at al.5 introduced the fluorescent pyrenyl group. However in both cases only the protected 
phosphoramidite monomer of thymidine has been successfully prepared. Previous work demonstrated that peptidic derivatives of 
tczrabenzo[ax,g.i]fluorene (ml) are strongly retained on RP-HPLC columns. 6 Therefore we modified the DMTr group by 
substituting position 4 of one of the phenyl ring with tesrabenzo[ac.g.sfluorenylmethyl, which still preserves the regioselectivtty 
of the trityl group for primary hydroxyls while forming an extremely hydrophobic 5-protecting group. Moreover the Thf moiety 
shows characteristic UV maxima at 365 and 380 nm which is most useful in monitoring the HPLC purification of 
oligonucleotides. Our strategy consisted of introducing 4-(17-lclrabenzoax4aIluorenytmethyl)-4'.4'4methoxytiityl chloride 
(Tbf-DMTr-Cl) as a new hydrophobic protecting group on the 5'-end of long oligonucleotides and exploiting its properties for 
their purification. 
The synthesis of Thf-DMTr-T-phosphoramidite 10 is shown in the Scheme. Telrabenzo[a,cjMfluorene 2 was achieved 7 from 
9-bromophenanthrene in a simpler manner than the one described by Dc Ridder and Martin. 8  An allcylation reaction with methyl-
4-bromornethylbenzoate gave the methyl ester 3. The carbinol compounds 4 and S were obtained by a Grignard reaction 
involving bromobcnzene or bromoanisole respectively. The orange coloured 6 and 7 were obtained by treatment of 4 and S 
respectively with acetyl chloride. Thf-DMTr-Cl 7 and Thf-Tr-Cl 6 were reacted with thymidine in pyridine to yield the 5'. 
protected nucleosides 8 and 9 in 40%. A kinetic study of the deprocection of 9 and 5'.DMTr-O-Thymidine was undertaken by 
monitoring the absorbance of the resulting trityl carbocation at 500 rim against time. The results were treated as a pseudo-first 
order irreversible reaction and an apparent tate constant of 0.0018 s was found for 5'-DMTr-O-Thymidine and 0.0037s 1 for 9. 
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